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ABSTRACT
FACTORS THAT INFLUENCE SMOKING CESSATION IN WOMEN WHO
EXPERIENCE AN INVASIVE CARDIOVASCULAR PROCEDURE

by
LESLIE C. MOORE
Women smokers with heart disease (HD) are at increased risk for negative health
effects. At the time of invasive cardiovascular (CV) interventions is a critical opportunity
to make lifestyle changes to reduce future CV interventions. The purposes of this study
guided by the Health Belief Model were to determine which factors predict smoking
cessation (SC) in women following an invasive CV procedure and to explore assistance
received with SC.
A correlational, prospective design was used. Data were collected from women
smokers at the time of an invasive CV intervention and three months later. Instruments
measured commitment to stop smoking, perceived threat of HD and future interventions,
cessation self efficacy, barriers to SC, benefits of SC, cues to action, and motivation.
Analyses included Chi-square, t-tests, and multiple, hierarchical, and logistic regression.
On average women (N = 76) were middle-aged (M = 55.9 ± 8.0 yrs), smoked M =
15.3 ± 9.8 daily cigarettes and smoked for M = 33.6 ± 10.2 years. At baseline, fewer
perceived barriers to SC, high cessation self-efficacy, and being more autonomously
motivated to quit smoking explained 67 % of variance in commitment to stop smoking, F
(6, 67) = 19.37, p < .001. At 3 months, only 8 (n = 54) women had quit smoking.
Women smoked fewer daily cigarettes (M = 10.6 ± SD = 8.5) at 3 months compared to
vi

time of procedure (M = 15.3 ± 9.8), t(51) = 3.43, p < .01. Higher baseline cessation selfefficacy and lower HD threat were predictors of SC at three months, X2 (4, N=54) =
18.67, p = .001. At the three month follow up, the most common barrier to SC was
anxiety (24%) and cigarette cravings (24%). While women were highly committed and
confident they could quit, they reported receiving little help from their health care
provider (HCP) other than simple advice to quit smoking.
Most women undergoing an invasive CV procedure were unable to quit smoking
even with a high desire to do so. Referrals for assistance from HCP to decrease anxiety
and nicotine dependence and to address ongoing challenges to SC are needed.
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CHAPTER I
Introduction
This chapter will provide an overview of the significance of coronary heart
disease (CHD), invasive treatments for CHD, and smoking as health problems
particularly in women. The importance of secondary prevention in CHD, especially
benefits related to smoking cessation, will be described. Lastly, use of the Health Belief
Model (HBM), as applied in the context of smoking cessation for women undergoing
invasive cardiovascular (CV) interventions, will be proposed.
Overview of Coronary Heart Disease and Smoking
Significance of Coronary Heart Disease
CHD is the largest cause of death for men and women in the United States (U.S.),
with approximately 16.8 million adults dying from the disease in 2006 (American Heart
Association [AHA], 2009). Of these deaths, 8.7 million were men and 8.1 million were
women. The 2005 death rate for CHD was 144.4 per 100,000, and varied among gender
and race/ethnicity: males had a higher death rate than females, and African Americans
had a higher death rate than Whites, Hispanics, Asians, and American Indian/Native
Alaskans (AHA, 2009). Costs in the U.S. for CHD, both direct and indirect, were
expected to total an estimated $156.4 billion for 2008. Patients with CHD have reported
a lower quality of life than those without CHD, and women with CHD have reported
lower QOL than men (Ford et al., 2008). Two common invasive treatments for CHD are
Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting
1
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(CABG) surgery. In 2005, there were about 1,271,000 inpatient PCI procedures and
469,000 CABG surgeries performed in the U.S. as treatment for CHD. In 2005, the
average charge for an inpatient heart catheterization procedure was $26,910, and $85,653
for a CABG surgery (AHA, 2008). Health-related quality of life in women following
CABG surgery has been found to be lower after one year than in men (Lindquist et al.,
2003).
Major risk factors have been identified for CHD and include non-modifiable
factors such as older age, male gender, and non-Caucasian heredity, and modifiable
factors such as tobacco use, hypertension, diabetes mellitus, dyslipidemia, obesity,
sedentary lifestyle, and atherogenic diet (Bello & Mosca, 2004). CHD diagnosis is
generally ten years later for women than men, which creates poorer outcomes due to the
greater number of co-morbidities at a later age (Bello & Mosca). While risk factors for
CHD are similar for men and women, once CHD is diagnosed, disparities between men
and women with respect to CHD outcomes have been documented. More women will
die than men within the first five years following their first myocardial infarction (MI)
(43% versus 33%), and African American men and women will die 6-10% more often
than Whites within five years of their first MI (AHA, 2008). Women will also suffer
from heart failure and stroke following a diagnosis of CHD more often than men,
possibly due to the increased age at diagnosis. Menopause creates additional risk for
CHD (Bello & Mosca). It is thought that the risk of dyslipidemia, especially a reduction
in high density lipoprotein cholesterol, increases after onset of menopause in women
(Bello & Mosca). Hormone therapy in older women has also been linked to an increased
risk of CHD, although this risk decreases over time (Salpeter, Walsh, Greyer, & Salpeter,
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2006). CHD is a major health problem and outcomes for women related to increased
risk, comorbidities, and mortality. Therefore, the focus of this study was women with
CHD undergoing an invasive CV intervention.
Smoking as a Health Problem
Disease related to smoking is the number one preventable cause of death for men
and women in the U.S. and was therefore the focus of this study (Centers for Disease
Control and Prevention [CDC], 2007). In 2006, the prevalence for smoking among adult
men and women in the U.S. was 47 million, or 20.8% of the U.S. population (AHA,
2009). Of these, 26.2 million (23.5%) were male and 20.9 million (18.1%) were female.
The direct medical costs associated with smoking totaled $75.5 billion in 2005, and lost
productivity costs totaled $92 billion, for a total one year U.S. cost of $167 billion (AHA,
2009). Many reasons why women smoke have been identified, and include: social
pressures, psychological needs, being targeted by the tobacco industry, personal factors
such as the desire to feel attractive, controlling weight, controlling moods, reducing
stress, knowledge and attitudes towards smoking, and the addictiveness of cigarettes
(Amos, 1996).
As the number of smoking years and the number of cigarettes smoked per day
increases, the risk of death from all causes increases for women smokers compared to
women who have never smoked (AHA, 2008). The annual risk for death from all causes
is 80 to 90 percent greater among women smokers than for women who have never
smoked. Similar to males, female smokers die an average of 14.5 years earlier than
nonsmoking females (AHA, 2009).
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Cigarette smoking has been linked to numerous additional public health risks.
Lung cancer as a health consequence of smoking was established by Sir Richard Doll in
the 1950s (Mackay, Eriksen, & Shafey, 2006). Studies suggest that smoking increases a
woman‟s risk for cervical, oropharynx, and bladder cancers and may increase her risk for
vulvar, liver, and colorectal cancers (CDC, 2002). Additionally, the use of oral
contraceptives increases a woman smoker‟s risk for CHD (CDC, 2002).
Smoking prevalence for U.S. adults has decreased by 50.4% from 1965 to 2006
(AHA, 2009). While the prevalence has been higher for men than for women, the
decrease in prevalence has not been as great in women as in men (Giovino, 2002; CDC,
2009). In 1965, 51.9% of men were smokers and this decreased to 23.5% in 2006;
however, in 1965, 33.9% of women were smokers which decreased to 18.1% by 2006.
Although the percentage of women smokers is lower than men smokers, the amount of
decline is not as immense (Giovino, 2002; AHA, 2009).
Smoking and CHD
Smoking increases a woman‟s risk for negative health effects and death when
combined with a history of CHD (CDC, 2002). The risk of dying from CHD is two to
four times greater for smokers than for nonsmokers (CDC, 2002). According to the 2001
Surgeon General‟s Report on Women and Smoking (U.S. Department of Health &
Human Services [HHS]), the negative health effects from smoking can be reduced after
one to two years of smoking cessation. Because of the potential benefits to improve
women‟s health, efforts to increase the rate of smoking cessation in women are greatly
needed.
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Invasive CV interventions for treating CHD such as CABG surgery and PCI have
increased associated risk, and continuing to smoke is a significant predictor of death
following CABG (Abramov et al., 2000; Kohl et al., 2006). Patients undergoing PCI
have a mortality risk of approximately 0.5% to 3.5% per year (O‟Neill, 2006;
Noninvasive Heart Center, n.d.; Vanasse, Courteau, & Niyongsenga, 2006), and the
average mortality rate for CABG surgery is about 2.5% (Abramov et al., 2000;
Nainggolan, 2008). Smoking is associated with increased risk for an MI following the
CV intervention, although the exact physiological mechanism is unknown (Kohl et al.,
2006; Merz, Rozanski, & Forrester, 1997). In one study, estimated benefit of survival for
male and female quitters after CABG increased from 3% at 5 years to 14% at 15 years
(Domburg et al. 2000).
Patients undergoing invasive CV interventions can also have negative perceptions
of their recovery (Lindsay, Smith, Hanlon, & Wheatley, 2000). One qualitative study of
men and women (N= 214) found many negative perceptions following CABG surgery,
and included: the CABG was much more traumatizing than expected; the pain was
unbelievable; it was a near death experience; there were ongoing emotional effects; the
return to normal for some took much longer than expected; and the operation experience
was a greater challenge than expected (Lindsay et al., 2000). However, the percentage
reporting these experiences was unclear in the study. Some men and women experienced
a feeling of responsibility for restenosis following their PCI due to their relapse in
smoking (Odell, Grio, & Hallberg, 2006). Therefore, invasive CV treatments may be
associated with emotional and physical costs.
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Continuing to smoke following CABG surgery increases the risk of necessitating
a second surgery CABG to twice that of a non-smoker (Voors et al., 1995). A second
surgery CABG has an increased operative risk for mortality, and smokers more often
require a second surgery CABG than non-smokers (Christenson, Schmuziger, & Simonet,
1997; Domburg et al., 2000). In one prospective 20-year study, angina pectoris, or the
continuation of chest pain following the procedure, was the most common reason for a
second surgery CABG. Patients who continued to smoke for five years following their
CABG or who started to smoke within five years of their CABG were more than twice as
likely to have angina pectoris compared to patients who stopped smoking after surgery
(Voors et al. 1996). Because of the increased risk for a second surgery CABG among
smokers who continue smoking following their initial CABG surgery, and due to
increased risk of mortality during the second surgery CABG for smokers, smoking
cessation as secondary prevention of recurring CHD events is imperative.
Many risks associated with smoking and CHD have been established, which may
increase the possibility of future invasive CV interventions. Undergoing an invasive CV
procedure may present an opportunity to discuss CV risk reduction, and especially
smoking cessation. Standard protocols are in place following the diagnosis of CHD to
focus on risk reducing behaviors such as smoking cessation. Having an MI is a major
predictor of smoking cessation and has been a factor related to smoking cessation in over
50% of smokers in many studies (Wilson, Gibson, Willan, & Cook, 2000). Therefore,
having an invasive CV procedure may have a similar impact on smoking behaviors as
having an MI. Women may be receptive and motivated to change their health behaviors
during this time, and it is therefore important to understand the factors which may
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prevent some women from successfully stopping smoking in order for interventions
which address these can be developed.
Secondary Prevention of CHD
Secondary prevention refers to the reduction of risks related to cardiac event
recurrences in patients with established CHD (Stafford, Jackson, & Berk, 2008). Both
the prevention and control of CHD play a key role in health promotion (Prugger et al.
2008). A main concern of preventive cardiology is to reduce the number of recurring
cardiac events and to extend the survival rate of patients with known CHD (Prugger,
Wellmann, Heidrich, Brand-Herrmann, & Keil, 2008). Recurring cardiac events can
largely be prevented through aggressive risk factor reduction such as pharmacological
and lifestyle modification (Oberg, Fitzpatrick, Lafferty, & LoGerfo, 2009).
Responsibility of achieving secondary risk factor reduction rests with both the health care
provider (HCP) and patient (Eriksen, Green, & Fultz, 1988).
Many organizations such as the AHA and the American College of Cardiology
(ACC) have developed comprehensive guidelines which indicate specific evidence-based
components of secondary prevention for patients with coronary and other vascular
diseases (Fonarow, 2007; Oberg, et al., 2009; Smith et al., 2001). The AHA “Get with
the Guidelines” program helps HCPs and hospitals implement these guidelines for
secondary prevention (Smaha, 2004). Secondary prevention of CHD should include CV
protective medications, risk factors control, and lifestyle modifications (Fonarow).
Specifically, the AHA/ACC guidelines recommend the following components of CHD
secondary prevention: 1) complete smoking cessation; 2) blood pressure control should
maintain a blood pressure of less than 140/90 mm Hg for non-diabetic and non-renal
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patients; 3) lipid management should maintain LDL cholesterol less than 100 mg/dL, or
non-HDL cholesterol less than 130 if total triglycerides are greater than or equal to 200
mg/dL; 4) physical activity should include a minimum of 30 minutes of exercise at least
three to four times per week; 5) weight management should include maintaining a body
mass index of 18.5-24.9 kg/m2; 6) diabetes management should maintain the major
fraction of adult hemoglobin, or HbA1C, less than 7%; 7) stress and depression
management; and 8) CV preventive medications, including antiplatelets, anticoagulants,
angiotensin converting enzyme inhibitors, beta blockers, and antilipids (Anderson et al.
2007; Franklin, 2007; Merz et al., 1997; Smith et al., 2001).
Despite the existing evidence of benefits from secondary CHD prevention,
adherence to the AHA/ACC guidelines is inconsistent, and many patients do not receive
adequate guideline-recommended treatment (Fonarow, 2007; Oberg et al., 2009). These
guidelines can be followed by both the nurse (as a gatekeeper to the patient‟s health) and
by the physician (as a prescriber of therapy). Non-pharmacologic secondary prevention
guidelines may not receive priority as do pharmacologic guidelines (Oberg et al., 2009).
A recent quality improvement assessment of facilities using the AHA “Get with the
Guidelines” program showed that non-pharmacologic interventions were recommended
to patients 26-45% of the time as compared to pharmacologic interventions being
recommended 86-93% of the time (Krantz et al., 2007). One study of men and women
following an acute MI (N= 372) indicated that smoking cessation was associated with a
66% reduction in death from all causes, but only 72.6% of participants were counseled on
smoking cessation (Oberg et al., 2009).
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Other studies suggest that women may be managed less intensively than men for
their angina pectoris, including smoking cessation, which is the most common clinical
manifestation of CHD (Crilly, Bundred, Hu, Leckey, & Johnstone, 2007), and women
may also be undertreated pharmacologically for their CHD risk factors (Vittinghoff et al.,
2003). Women may be less likely to undergo a comprehensive CHD risk factor
assessment as compared to men, including smoking (Crilly et al. 2007).
In summary, although many women with CHD are successfully treated with PCI
and/or CABG surgery, potential risk still exists for future invasive CV interventions,
especially for smokers who continue smoking following their procedure. Because these
women have known CHD, both HCP‟s and patient‟s focus should shift to secondary
prevention which will decrease the likelihood of future invasive CV interventions.
Smoking is the number one modifiable risk factor for CHD, and smoking cessation is one
such secondary prevention intervention that can greatly reduce women‟s risk for future
invasive CV interventions, especially when sustained long-term. Smoking cessation
behaviors were examined in women following an invasive CV procedure within the
theoretical framework of the Health Belief Model (HBM).
Applying the HBM in Women Smokers Undergoing an Invasive CV Intervention
The HBM is one of the most widely used theoretical frameworks for studying
health behaviors, and empirical evidence supports that there is a relationship between the
HBM variables and taking health actions (See Figure 1) (Janz & Becker, 1984). The
HBM were used in this study to explain smoking cessation behavior in women with CHD
who have experienced an invasive CV treatment.
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Overview of the HBM
The HBM explains why people make behavior choices in uncertain environments
such as hospitalization or new medical diagnosis, and is based on the perspective of the
person involved in decision-making (Maiman & Becker, 1974). In order to engage in
recommended health actions, the individual must believe that he or she is susceptible to a
certain health condition, and the presence of illness must have at least a moderate threat
to some aspect of an individual‟s life (Rosenstock, 1974).
Figure 1. The Modified Health Belief Model for Smoking Cessation in Women
Undergoing an Invasive CV Intervention (Rosenstock, 1974).
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This study examined whether women with CHD engage in smoking cessation in
order to reduce their perceived threat of future CV interventions. Typically in the HBM,
the perceptions of threat are of the disease process. Because of the invasive nature of the
CV interventions, it may be the treatment that poses a threat for women. In one study
examining patients undergoing PCI and risk reduction, threat of CHD was associated
with patient‟s psychological health, but not risk reduction (Kimble, 1998). However, the
follow up period in this study was short (2 weeks). To be able to determine which threat
is most relevant, both threat of CHD and threat of future invasive CV interventions will
be included in the proposed study. Perceptions of the threat of future CV interventions
consist of the level of personal susceptibility to future CV interventions and the
perception of the seriousness of future CV interventions. In order to act, the individual
must perceive that taking the health action, or smoking cessation, is beneficial because it
would reduce the susceptibility and/or seriousness of future CV interventions
(Rosenstock, 1974). In this study, women must perceive that smoking cessation is
beneficial to their health by reducing the potential for future CV interventions.
The HBM concepts were grouped into three main categories and conceptualized
as: 1) individual perceptions of perceived threat, represented by the individual‟s
perceived susceptibility and perceived seriousness of future CV interventions; 2)
modifying factors consisting of the demographic, sociopsychological, and structural
variables, and cues to action (receiving smoking cessation assistance from a HCP); and 3)
the likelihood (commitment) of smoking cessation and factors associated with this
likelihood (smoking cessation self-efficacy, perceived barriers, cues to action, depressive
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symptoms, motivation to stop smoking, and perceived threat) and the health action of
smoking cessation (Rosenstock, 1974).
This study applied the following HBM theoretical assumptions to women
undergoing an invasive CV intervention for the treatment of CHD: 1) The individual
must feel susceptible to future CV interventions as a result of continued smoking (i.e.,
perceived susceptibility) (Rosenstock, 1974); 2) The individual must perceive
consequences from having future CV interventions, whether physical, financial, or social
(i.e., perceived seriousness); 3) Smoking cessation is predicted by the perceived threat of
future CV interventions (Maiman & Becker, 1974); 4) The individual‟s appraisal of the
achievability (i.e., self-efficacy to stop smoking) and assessment of smoking cessation‟s
potential benefit in reducing perceived threat of future CV interventions is weighed
against her perceptions of barriers or costs associated with smoking cessation (i.e., costbenefit analysis), and 5) A “cue to action”, or trigger, may stimulate appropriate health
behavior by helping the individual to become consciously aware of her feelings, and can
be internal or external (Maiman & Becker).
Major Concepts of the Theory
Perceived Threat
Perceived threat consists of both the perceived threat of CHD and the perceived
threat of future CV interventions in this study. Perceived susceptibility and perceived
seriousness of future CV interventions represent the perceived threat of future CV
interventions. Susceptibility refers to an individual‟s subjective risk of a particular health
condition, which is defined as future CV interventions for this study (Rosenstock, 1974).
Individual perceptions of susceptibility to a health condition can widely vary
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(Rosenstock, 1974). In the case of CHD in women, one extreme might be the individual
who denies that future CV interventions are even possible. Another individual might
have a more moderate perception of susceptibility where she admits that future CV
interventions are statistically possible, but probably unlikely. Finally, an individual may
perceive that she is in real danger of future CV interventions. There is a requirement of
having some knowledge of the health condition in order to perceive one‟s susceptibility
(Rosenstock, 1974).
Perceptions about the gravity or seriousness of future health conditions may also
vary from person to person (Rosenstock, 1974). Applying this concept to women
undergoing an invasive CV intervention, the perceived seriousness can be measured by
both the emotional arousal as a result of thinking of future CV interventions and the
difficulties that the individual believes future CV interventions may create. An
individual may have concerns about what medical consequences future CV interventions
may have, and questions may arise regarding temporary incapacitation, long-term
disability, or even death. Like perceived susceptibility, perceived severity is at least
partly dependent on the individual having knowledge of the health condition
(Rosenstock, 1974).
Sociopsychological Variables Thought to Influence Perceived Threat
Two sociopsychological variables that were addressed in this study are depressive
symptoms and an individual‟s general motivation to stop smoking, as these are thought to
be modifiable. Depressive symptoms will be addressed since these are common in
persons with CHD (Hare & Davis, 1996) and have been associated with smoking
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cessation (Glassman, Covey, Stetner, & Rivelli, 2001; Kinnunen, Henning, & Nordstrom,
1999; Perkins, 2001; Wilheim, Wedgewood, Niven, & Kay-Lambkin, 2006).
A person‟s motivation to stop smoking was also measured in this study. Selfdetermined (or autonomous) motivation to make health behavior changes has been
associated with maintained behavior change such as smoking cessation (University of
Rochester [UOR], 2008). Motivation to stop smoking was conceptualized in this study as
autonomous and controlled reasons for stopping smoking, and is derived from the SelfDetermination Theory (SDT) (Ryan & Connell, 1989;). The SDT is a comprehensive
theory of human motivation related to the development and function of personality within
social environments. This theory examines the extent to which human behaviors are selfdetermined where individuals have a full perception of choice in the actions he or she
chooses to engage (UOR). Autonomous reasons for taking health action are
conceptualized as the most self-determined form of motivation, versus controlled reasons,
which are conceptualized as the least self-determined form of motivation (UOR).
Cues to Action from HCP about Smoking Cessation
Cues to action are triggers which initiate an individual‟s taking a recommended
health action (Rosenstock, 1974). These cues can be internal, such as an individual‟s
perception of his or her bodily state, or can be external, such as interpersonal interactions,
receiving reminder cards in the mail, or health messages received from the media
(Rosenstock, 1974). These cues to action may increase a woman‟s perceived
susceptibility and seriousness of threat of future CV interventions. Cues to action set the
process of taking a recommended health action in motion, and will be defined in the
present study as whether the patient receives smoking cessation assistance from a HCP.
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The different levels of perceived threat of future CV interventions may require varying
intensity of cues to action in order for an individual to respond (Rosenstock, 1974). The
cues to action in this study are based on the 5 A‟s of smoking cessation treatment, and
include asking the patient‟s smoking status, advising the patient to stop smoking,
assessing the patient‟s willingness to stop smoking, assisting the patient with smoking
cessation, and arranging for follow-up related to their smoking cessation (HHS, 2008).
This approach measures the strength of cues to action received from HCPs rather than
from the community because this study focuses on the factors which affect women‟s
decisions to stop smoking following an invasive CV intervention where women would
likely receive smoking cessation assistance at that time rather than following discharge to
the community. Invasive CV procedures is an opportune time to refocus on secondary
prevention behaviors such as smoking cessation in efforts to secure success in with the
current invasive procedure and to prevent future cardiac events.
Smoking Cessation Self-efficacy
Self-efficacy is conceptualized as confidence in one‟s ability to take action
according to the HBM (Stretcher, Becker, Kirscht, Eraker, & Graham-Tomasi, 1985).
This concept was later added to the HBM as separate independent variable along with the
traditional HBM variables (Stretcher et al., 1985). For this study, smoking cessation selfefficacy is conceptualized as a woman‟s confidence in her ability to stop smoking.
Perceived Barriers to Taking Action
Perceived barriers to smoking cessation are a subjective opinion about the
tangible and psychological costs of taking a recommended health action such as smoking
cessation (Rosenstock, 1974). An individual may perceive that smoking cessation has
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benefit in reducing the threat of future CV interventions; however, it is possible that the
individual may see smoking cessation as too costly. The recommended action may be
inconvenient, expensive, stressful, or may cause weight gain, withdrawal symptoms or
anxiety, among others, for women smokers (Levine, Perkins, & Marcus, 2003). These
negative aspects of smoking cessation may therefore serve as a barrier to stopping
smoking (Rosenstock, 1974).
Perceived Benefits of Taking Action
Smoking cessation is influenced by an individual‟s beliefs about the effectiveness
of each option she has, which includes continuing to smoke or stopping in this study
(Rosenstock, 1974). An individual‟s behavior depends on the perception of benefit that
each option provides, and the individual must have at least one option that she believes is
achievable (Rosenstock, 1974). A “sufficiently threatened” individual may not stop
smoking unless that option was perceived as achievable (Janz & Becker, 1984). One may
perceive an option to be beneficial if she thinks the option lowers her threat of future CV
interventions. Social norms may have influence on the individual‟s choice, especially
when loved ones wish for the smoker to stop smoking (Bursey & Craig, 2000).
Although in the HBM, the perceived benefits is described as the benefits minus the
barriers, in research these benefits and barriers are often measured separately
(Rosenstock, 1974) and barriers appear to be a stronger predictor (Janz & Becker, 1984;
Robertson & Keller, 1992); therefore, barriers was included in the model and benefits
were collected for descriptive purposes and exploratory analysis.
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Commitment to Stop Smoking and Smoking Cessation
The outcome variables for this study were commitment to stop smoking and
smoking cessation. Commitment to stop smoking was conceptualized as “a cognitive
state of being personally bound or obligated to avoid smoking despite any potentially
difficulty, discomfort, or craving associated with quitting, even when the magnitude and
duration of that discomfort are unknown and variable” (Kahler et al. 2007). Smoking
cessation was conceptualized as an individual‟s self-report of total abstinence of smoking
for a period of three months since their invasive CV intervention.
Specific Aims
Based on existing empirical evidence and the HBM, the specific aim of this study
was to predict smoking cessation behaviors in women experiencing an invasive CV
intervention by examining the relationship between smoking cessation and commitment
to stop smoking, perceived threat of CHD, perceived threat of future invasive CV
interventions, perceived benefits of smoking cessation, perceived barriers to smoking
cessation, smoking cessation self-efficacy, cues to action, motivation to stop smoking,
and depressive symptoms. As women receive CV interventions such as PCI or CABG
surgery, a critical opportunity presents to make lifestyle changes in order to improve their
health and reduce the need for future CV interventions. Identifying factors associated
with smoking cessation following an invasive CV intervention can lead to developing
interventions specific to women which promote smoking cessation as a component of
recommended secondary prevention guidelines for CHD. Specifically, the research
hypotheses for this study were:
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Among women smokers receiving an invasive CV intervention (PCI or CABG):
1. Higher perceived threat of CHD and higher threat of future CV interventions will
be associated with commitment to stop smoking, controlling for depression.
2. Receiving cues to action about smoking cessation from a HCP will be associated
with higher perceived threat of future CV interventions.
3. Higher perceived threat of CHD and higher perceived threat of future CV
interventions, higher smoking cessation self-efficacy, and fewer perceived
barriers will be associated with greater commitment to stop smoking, controlling
for depression.
4. Those with greater commitment to stop smoking after an invasive CV procedure
will report higher smoking cessation rates at three months than those with lower
commitment to stop smoking.
5. Fewer perceived barriers to smoking cessation, greater perceived threat of CHD,
greater perceived threat of future CV interventions, receiving cues to action,
fewer depressive symptoms, and higher smoking cessation self-efficacy will be
associated with higher commitment to stop smoking.
6. Fewer perceived barriers to smoking cessation, greater perceived threat of CHD,
greater perceived threat of future CV interventions, receiving cues to action,
fewer depressive symptoms, higher smoking cessation self-efficacy, and higher
commitment to stop smoking will be associated with quitting smoking at 3
months.
An exploratory aim of this study was to examine perceived benefits and barriers
of smoking cessation and cues to action received from the HCP. Therefore, research
questions for this study were:
1. What benefits and barriers to smoking cessation are perceived among women
smokers receiving an invasive CV procedure?
2. What cues to action are received among women smokers receiving an invasive
CV procedure?
3. Is there a change in depressive symptoms from an invasive CV intervention to
three months following the invasive CV intervention?
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4. Are depressive symptoms at three months following an invasive CV intervention
associated with increased commitment to stop smoking?

CHAPTER II
Review of the Literature
An expansive body of empirical literature exists related to factors which influence
smoking behaviors. This review of literature will explore CHD in terms of perceptions of
risk for CHD, risk for future CV interventions, and how smoking affects CHD. Smoking
cessation was explored, particularly with individual characteristics and predictors related
to successful smoking cessation, both benefits and barriers to smoking cessation, and how
commitment and self-efficacy to stop smoking affect an individual‟s smoking cessation
efforts. Smoking cessation strategies specific to both women and patients with CHD was
examined. Factors affecting the delivery of smoking cessation interventions by nurses
and physicians are addressed, followed by a discussion of gaps identified in the review of
literature.
Smoking Cessation
Smoking cessation remains a top health priority in the U.S. (American Lung
Association [ALA], 2008). Many smokers face a difficult challenge when deciding to
stop smoking and often fail, which can leave the smoker with feelings of frustration and
isolation (ALA, 2008). The majority of smokers will make multiple attempts to stop
smoking before he or she is able to stop smoking for good. According to the AHA, 70%
of smokers have the desire to stop smoking, but less than 5% are actually able to remain
tobacco free for more than three to twelve months following their attempt to stop due to
relapse (AHA, 2008). Relapse has been linked to increased levels of nicotine
20
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dependence, exposure to smoking cues, cravings, withdrawal symptoms, and a lack of
smoking cessation aids (Zhou et al. 2009). One study of White male and female smokers
(N=2431) reported that the average number of quit attempts made during the past three
months was 4.1, and that 93% of participants had made a quit attempt during this period
(Zhou et al. 2009). A quit attempt was defined as making a serious attempt to stop
smoking for good that lasted at least 24 hours within the past three months. Smokers
reported a mean motivation to quit score of 6.9 (out of 10), but only 20% wanted to quit
smoking due to a recent hospitalization or current health problem. The smokers were
followed every three months for a total of 18 months, and of the 2431 smokers, 1466
relapsed within the 18 month period (Zhou et al. 2009). Having an MI has been shown to
predict smoking cessation in a meta-analysis of 12 studies (N=5878) measuring smoking
cessation rates following an MI in men and women smokers (Wilson et al., 2000). The
analysis reported that 10 out of 12 of the studies indicated a cessation rate of between 4060%. This suggests that smoking cessation within a population of women undergoing an
invasive CV procedure, many of whom may have experienced an MI, is an important
goal in reducing risk of future CV interventions.
Predicting health behaviors, including smoking cessation, has been the aim of
numerous empirical studies (Brown, & Segal, 1996; Hingson, Strunin, Berlin, & Heeren,
1990; O‟Connor, & Cappelli, 1999; Tan, Ng, & Esa, 2001), and many variables have
been associated with smoking cessation. Smoking cessation in particular has been
examined in a variety of patient populations, including men and women, as well as
patients with CHD. Previous studies have supported a variety of factors which predict
successful smoking cessation, and include individual characteristics (e.g. non-modifiable
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demographics such as age, race, education level, etc.), (Honda, 2005; Lee & Kahende,
2007), self-efficacy to stop smoking (Etter, Prokorov, & Perneger, 2002; Johnston,
Johnston, Pollard, Kinmonth, & Mant, 2004; Manfredi et al. 2007), intention to stop
smoking (Etter, Prokorov, & Perneger, 2002; Johnston et al. 2004; Kovac & Rise, 2007;
Manfredi, Cho, Crittenden, & Dolecek, 2007; Moan & Rise, 2005; Peters, Hughes,
Callas, & Solomon, 2007; Rigotti, McKool, & Shiffman, 1994), commitment to stop
smoking (Kahler et al. 2007) social norms related to smoking behaviors (Bursey, &
Craig, 2000), perceived seriousness of smoking to one‟s health (Bursey, & Craig, 2000;
Honda, 2005) , perceived benefits of smoking cessation (Bursey & Craig, 2000;
Thanavaro, Moore, Anthony, Narsavage, & Delicath, 2006), and perceived susceptibility
to CHD due to smoking (Ali, 2002). Because these variables have been supported as
predictors of health behaviors in previous studies, these variables were measured in
predicting smoking cessation in women following an invasive CV procedure.
Smoking Cessation in Women
Women face a difficult challenge in smoking cessation, and have several factors
influencing their ability to stop smoking which are unique to this group of smokers.
Empirical evidence supports variables within the HBM as influential in women‟s
decisions to stop smoking (Etter, Prokorov, & Perneger, 2002; Johnston et al., 2004;
Kahler et al., 2007; Manfredi et al., 2007; Moran, Glazier, & Armstrong, 2003). These
include women‟s perceptions of the seriousness of disease, barriers to smoking cessation,
perceived threat of disease, cues to action, and commitment to stop smoking, which will
be further discussed below (Etter et al., 2002; Johnston et al., 2004; Kahler et al., 2007;
Manfredi et al., 2007; Moran et al., 2003). A woman‟s menstrual phase has also been
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found to influence the number of attempts to stop smoking, as high estrogen levels and
low progesterone levels have been linked to increased addictive behaviors (Allen, Allen,
Lunos, & Hatsukami, 2009). The HCP may need to consider the menstrual cycle phase
when setting a quit date. What remains unclear is what effects these HBM variables have
on smoking cessation in women undergoing an invasive CV intervention, but were
addressed in the present study.
Smoking as a Risk Factor for CHD
Perceptions of the increased risk for CHD as a result of smoking have been
examined. Evidence suggests that when patients correctly perceive their risk of CHD
(i.e., their perceived risk equals their actual risk), they are more likely to engage in risk
reducing behaviors (Hampson, 2006). One study (N=697) of men and women found that
that those with a higher perceived risk were more likely to report more risk reducing
behaviors related to smoking cessation such as implementing stricter household rules
about smoking and reducing the number of cigarettes smoked in the home (Hampson).
Another study (N=105) of men and women (n=34) newly diagnosed with CHD found
that 64% of smokers identified smoking as a risk factor for CHD, and 28% believed CHD
to be a short-term problem rather than chronic (Zerwic, King, & Wlasowicz, 1997);
however, their intent to stop smoking was not addressed and the sample was
predominantly male.
Perceptions of the increased risk smoking places on women‟s health among those
with CHD have also been explored. While many studies have examined smokers‟
perceptions of CHD risk, the evidence is inconclusive. Some smokers did not view their
smoking as a personal risk for CHD (King et al., 2002; Oliver-McNeil & Artinian, 2002).
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Other studies showed that the smokers did identify smoking as a personal risk factor for
CHD (Moran, Glazier, & Armstrong, 2003; Zerwic et al., 1997). One study of women
(N=1184) found that current women smokers had a higher perception of lifetime risk of
developing heart disease than did former and non-smokers (Moran et al., 2003). The
women also thought their smoking placed them at greater risk for lung cancer than for
CHD. However, only heavy smokers rated their risk for CHD as above average, which
indicated that lighter smokers may underestimate their risk for heart disease. This sample
was predominantly White and well-educated women, so perceptions of other racial
groups and those with less education are still unknown. Another study of 33 women
newly diagnosed with CHD found that while 39% of the women were documented
smokers, only 6% actually identified their smoking as a risk factor (Oliver-McNeil &
Artinian, 2002). This indicates that there may be no relationship between women‟s
knowledge of risk factors and risk factor reducing behaviors among women smokers.
Perceptions of risk related to smoking among a sample population of women with
known CHD has been shown to vary, with some women understanding their personal risk
of smoking and CHD, but with the majority of women not understanding the increased
risk that smoking contributes to their CHD. This may hinder secondary prevention
efforts such as smoking cessation since women may not engage in these prevention
behaviors without the perception that their smoking increases their CHD risk. Many of
these studies addressed women smokers with newly diagnosed CHD, which may limit the
degree of their perceptions of risk as compared to women in the present study whose time
since diagnosis varied and who underwent an invasive CV intervention as treatment for
their CHD.
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Smoking as a Risk Factor for Future Cardiac Events Following an Invasive CV
Intervention
Smoking cessation with CHD (or invasive procedures for CHD) is an important
secondary prevention measure. After experiencing a diagnosis or intervention for CHD,
smoking cessation is often recommended or considered by smokers to reduce their future
risk. Several predictors of smoking cessation after CABG surgery have been identified.
In a small study (N = 32), social norm was an important predictor of smoking cessation in
a sample of men and women (n=8) after their initial CABG surgery, and many
participants perceived that the important people in their lives wanted them to stop
smoking (Bursey & Craig, 2000). A randomized, controlled clinical trial (N=87) of men
and women aimed to test the efficacy of a smoking cessation program and to identify
factors associated with smoking cessation (Rigotti et al., 1994). The study found that
four factors were related to smoking cessation one year following CABG surgery: 1)
fewer than three previous attempts to quit (OR= 7.4); 2) more than one week of
preoperative cessation (OR= 10.0); 3) definite intention to quit smoking (OR= 12.0); and
4) no difficulty in cessation during hospitalization (OR= 9.6). Smoking cessation five
years following CABG surgery was significantly related to two of these factors: fewer
than three quit attempts and intention to stop smoking following surgery. However, no
differences were found in smoking rates between the intervention and control groups, as
55% of participants were no longer smoking after one year, and 41% were still abstinent
after five years post surgery. The intention to stop smoking may have been precipitated
by the experience of an invasive treatment for CHD and threats to future health. If so,
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this presents a pivotal opportunity for intervention for smoking cessation and needs to be
further explored. These findings suggest the need for clinicians to not only assess
smoking status in patients with CHD, but also their previous quit attempts, their difficulty
with cessation during hospitalization, length of cessation prior to surgery, and their
intention to quit.
Factors Associated with Smoking Cessation
Many predictors of smoking cessation have been identified, some being particular
to women smokers. Women may have worse outcomes related to CHD than men, and
smoking intensifies the risk of future CV emergencies. Following an invasive CV
intervention such as CABG surgery or PCI emerges a critical opportunity for these
women to make lifestyle changes which reduce their risk of future CV interventions.
Smoking cessation is a lifestyle change that can greatly reduce their risk within one to
two years of cessation. According to the HBM, the likelihood that these women will
engage in a healthy behavior such as smoking cessation is influenced by the women‟s
individual perceptions of their own risk of future CV interventions, their own perceptions
of the seriousness of having future CV interventions, the perceived benefits of and
barriers to engaging in smoking cessation, the cues that trigger the women into smoking
cessation such as receiving smoking cessation education, modifiable sociopsychological
characteristics such as depression and motivation to stop smoking, and self-efficacy to
stop smoking (Rosenstock, 1974). Because these factors can influence the women‟s
health behavior, determining which factors have the most impact on smoking cessation
among women with CHD following an invasive CV intervention will allow nurses to
develop comprehensive smoking cessation interventions in these areas.
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Commitment and Intention to Stop Smoking
Commitment may be an indicator of one‟s intention to stop smoking. Both
commitment and intention have been identified as predictors of smoking cessation. Both
are concepts within the Transtheoretical Model (TTM), which aims to predict or explain a
person‟s success or failure in adopting healthy behaviors such as smoking cessation
(Prochaska, Velice, DiClement, & Fava, 1988; Cancer Prevention Research Center
[CPRC], n.d). According to the TTM, people progress through five states when
undergoing a lifestyle change. These include: 1) the precontemplation stage,
characterized by unawareness or denial; 2) the contemplation stage, characterized by the
consideration of changes; 3) the preparation stage, characterized by an increased
commitment and taking initial steps; 4) the action stage, characterized by changing the
behavior; and 5) the maintenance stage, characterized by sustaining the behavior (CPRC,
n.d .; Prochaska, Velice, DiClement, & Fava, 1988). Intention can be conceptualized as
occurring in the contemplation stage or in the preparation phase, whereas commitment
occurs in the contemplation stage. This distinction suggests that commitment occurs later
in the stages of change, according to the TTM, and is closer to the action and
maintenance stages of successful smoking cessation (CPRC, n.d.). Intention can be
defined as “something you want or plan to do” (Cambridge University Press, 2009), but
includes no indication of action or the level of dedication to the lifestyle change.
However, commitment can be defined as “when you are willing to give up your time and
energy to do something you believe in, or a promise or firm decision to do something”
(Cambridge University Press), which suggests a greater dedication to the task. Both
intention and commitment have been supported by numerous studies with varying patient
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populations, including smokers with and without CHD (Etter, Prokorov, & Perneger,
2002; Johnston et al. 2004; Kahler et al. 2007; Kovac & Rise, 2007; Manfredi et al. 2007;
Moan & Rise, 2005; Peters et al. 2007; Rigotti, McKool, & Shiffman, 1994). However,
because commitment suggests a greater dedication to smoking cessation and is a
continuous variable measured with a reliable and valid instrument (Kahler), this study
measured commitment to smoking cessation as a predictor of smoking cessation.
Intention to stop smoking was measured with a one-item Likert-type scale and analyzed
for descriptive purposes.
Commitment has been linked with successful smoking cessation (Dalum,
Schaalma, Nielson, & Kok, 2008; Kahler et al., 2007; Kleinjan et al., 2008). A
qualitative study of current smokers and former daily smokers (N=26) reported that the
amount of commitment invested in a quit attempt determined whether the quit attempt
was successful (Dalum et al., 2008). The researchers defined commitment as the amount
of energy put into a successful quit attempt. The committed quitter conveyed a
willingness to invest energy or make sacrifices to become abstinent of smoking in this
study.
A smoking cessation clinical trial of heavily alcohol drinking smokers (N=157)
found that smokers with an increased commitment to quitting smoking at baseline were
more than twice as likely to remain abstinent from smoking after smoking cessation
treatment and after 16 and 26 weeks after their quit date in men and women (p <0.05)
(Kahler et al., 2007). While the sample in this study was comprised of 49% women, it is
unknown what medical history the participants had, and especially whether the patients
had a history of CHD. Commitment also predicted smoking cessation over and above the
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level of tobacco dependence and self-efficacy to remain abstinent (Kahler et al., 2007).
This suggests that commitment may be an important predictor of smoking cessation.
While little literature exists on the relationship between commitment and smoking
cessation, the current study addressed this literature gap in a sample of women smokers
undergoing an invasive CV intervention. Commitment to stop smoking was found to be
a mediator between nicotine dependence and readiness to quit in another study of
adolescent male and female smokers (N=1547) (Kleinjan et al., 2008). In Kleinjan‟s
study, greater commitment was related to greater readiness to quit smoking.
Many studies have found intention to be a significant predictor of smoking
cessation (Etter, Prokorov, & Perneger, 2002; Johnston et al., 2004; Kovac & Rise, 2007;
Manfredi et al., 2007; Moan & Rise, 2005; Peters et al., 2007; Rigotti, McKool, &
Shiffman, 1994). One study of men and women smokers attending a university (N=698)
examined the predictors of smoking cessation using the Theory of Planned Behavior, and
found that intention to stop smoking predicted smoking behavior (Moan & Rise). This
study found that the person‟s attitude towards smoking cessation, perceived behavioral
control over smoking cessation, perceived benefits of smoking cessation, and moral
norms towards smoking accounted for 36% of the variance in intention. Intention was
significantly related to smoking cessation in another study of university student smokers
(men and women), and one‟s future orientation, or the degree to which someone
considers the future, moderated intention and behavior (N=93) (Kovac & Rise). Another
study found in a large sample of men and women (N=2934) participating in a randomized
smoking cessation trial that intention predicted smoking cessation in both groups,
although the women had significantly less intention to stop smoking than the men (Etter

30
et al., 2002). Additionally, Peters (2007) found in a group of men and women smokers
that motivation (i.e., intention to quit) played a large role in setting goals for smoking
cessation, and setting goals predicted which smokers were most likely to attempt to stop
smoking. In another study, findings suggest that men and women‟s positive intention to
stop smoking increased one‟s relative odds of smoking cessation, and that those who
intend to stop smoking tended to be more likely to do so (Johnston et al., 2004).
Intention is also supported as a predictor of smoking cessation among patients
with known CHD. A study of men and women (N=597) one year after initial diagnosis
with CHD found that intention to quit was an important factor in predicting smoking
cessation (Johnston et al., 2004). An additional study (N=87) of men and women
examined the efficacy of an in-patient smoking cessation program following CABG and
identified predictors of smoking cessation (Rigotti et al., 1994). Results indicated that
those with greater intention to stop smoking were twelve times more likely to stop
smoking one year and five years following surgery. This indicates that intention to stop
smoking remains important beyond the initial smoking cessation phase.
The majority of these studies included few women, and no studies were found
which included only women smokers, especially with CHD, and was addressed in the
current study. While these empirical studies provide support for commitment and
intention to quit smoking as an important predictor of smoking cessation, further research
is needed to verify that commitment will predict smoking cessation among women
smokers with CHD following an invasive CV intervention.
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Self-Efficacy and Smoking Cessation
Smoking cessation self-efficacy is defined as one‟s level of confidence in his or
her ability to quit smoking (Etter et al., 2002). Empirical evidence also supports that
smoking cessation self-efficacy can predict smoking cessation (Etter, Prokorov, &
Perneger, 2002; Johnston et al., 2004; Manfredi et al., 2007). A test of the Theory of
Planned Behavior found that both men‟s (n= 358) and women‟s (n= 239) perceived
behavioral control over quitting smoking was a significant predictor of smoking cessation
(Johnston). Interestingly in this study, less than 50% of the participants thought they
could stop smoking. It was also found that self-efficacy was important in predicting
smoking cessation and women had significantly lower intention to stop smoking and
significantly lower self-efficacy to stop smoking (Etter). Similarly, self-efficacy to stop
smoking in women (N=644) directly predicted their smoking cessation, and self-efficacy
mediated the relationship of daily stress and smoking cessation (Manfredi). Barriers to
smoking cessation in this study also included higher perceived stress and lower selfefficacy. Findings from this study suggested that those women who had a higher
perception of stress would decrease the likelihood of smoking cessation by reducing
smoking self-efficacy. Higher smoking self-efficacy may increase the likelihood of
smoking cessation by increasing the immediacy of plans to stop smoking (Manfredi).
A study of men and women (N=2934) found that had lower smoking self-efficacy
scores and were more likely than men to state that smoking cessation would be difficult
(Etter et al., 2002). Johnston‟s 2004 study (N=597, smoker n=143, female smoker n=31)
of men and women with CHD also found that men and women‟s perceived behavioral
control (i.e. self-efficacy) over smoking cessation was a significant predictor of smoking
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cessation. Differences in perceived behavioral control between men and women smokers
were not measured.
Empirical evidence suggests that smoking cessation self-efficacy is a significant
factor in smoking cessation. Women smokers may have lower smoking cessation selfefficacy than men which could impact their ability to stop smoking. Because increased
smoking cessation self-efficacy is thought to be important in smoking cessation and
because the HBM also proposes that self-efficacy to engage in health promoting
behaviors is an important measure, smoking cessation self-efficacy was measured in the
current study among women smokers with CHD.
Benefits and Smoking Cessation
The smoker‟s perception of benefits from smoking cessation is a supported factor
related to smoking (Ali, 2002; Bursey & Craig, 2000; Honda, 2005; Manfredi et al.,
2007; Thanavaro et al., 2006). One study (N=573) aimed to examine gender differences
in perceived risks and benefits of smoking cessation using the Perceived Risks and
Benefits Questionnaire in a sample of men and women entering a smoking cessation trial
(McKee, O‟Malley, Salovey, Krishnan-Sarin, & Mazure, 2005). Females (n=273) had
significantly higher scores on the “perceived benefit” subscale for the categories: health,
well-being, self-esteem, finances, physical appeal, and social approval. Perceived
benefits were significantly associated with motivation to stop smoking prior to treatment
and total abstinence goals. This study found that women perceived higher perceptions of
risk and benefits from smoking cessation than men (p<0.0005). The categories of
perceived benefits included in the proposed study were similar to those explored in
developing the Reasons for Quitting Scale (1990), which included: health concerns, self
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control, immediate reinforcement, and social influence (Curry, Wagner, & Grothaus,
1990). The majority of empirical research has focused on smokers‟ perceptions of risk of
smoking and perceived barriers to smoking cessation as factors associated with
successful smoking cessation rather than perceived benefits from smoking cessation.
Therefore, this study included a research questions which addressed perceived benefits of
smoking cessation among a sample of women smokers undergoing an invasive CV
intervention.
Barriers and Smoking Cessation
Barriers to smoking cessation have been identified by numerous studies in both
men and women, and are an important focus of research. Barriers may provide areas of
focus for smoking cessation interventions since many barriers may be modifiable. Some
barriers are common among men and women, such as fear of weight gain, anxiety, level
of nicotine addiction (Agrawal, Sartor, Pergadia, Huizink, & Lynskey, 2008; Schnoll et
al., 2004; Schofield, Kerr, & Tolson, 2007; Sepinwall & Borrelli, 2004). In one study of
men (n=271) and women (n= 146), higher weight concerns were associated with younger
age, longer duration of health care services, less motivation to stop smoking, more
favorable views of smoking, and lower levels of support (Sepinwall & Borrelli). Two
studies identified anxiety as a barrier to smoking cessation for both men and women
(N=22, N=17,919, respectively) (Schofield et al., 2007; Agrawal et al., 2008). Smoking
as a coping mechanism has also been identified (Shirachi & Spirrison, 2006). The level
of nicotine addiction is relevant to barriers, and high nicotine addiction levels have been
identified as preventing smoking cessation in men and women smokers (Schofield et al.,
2007, Schnoll et al., 2004). A study of men and women and one meta-analysis found that

34
smokers with lower perceived benefits of smoking cessation reported lower cessation
rates and was therefore a barrier to smoking cessation (Hammond, McDonald, Fong, &
Borland, 2004; Schnoll et al., 2004). A lack of knowledge about smoking cessation
techniques in participants who were less likely to stop smoking was also identified as a
barrier (Hammond). Smoking has been positively associated with poverty (Kerr, Watson,
Tolson, Lough, & Brown, 2006), alcohol use (Agrawal et al., 2008), and joblessness
(Weden, Astone, & Bishai, 2006), which may increase one‟s likelihood of continued
smoking. Low perceptions of smoking as a health risk could impede smoking cessation
efforts in men and women, as Kerr et al. (2006) found that although the majority of
participants (N=20) understood that smoking caused damage to their health, some
participants still remained unconvinced.
Women may have more difficulty in smoking cessation than do men (Perkins,
2003). Several barriers to smoking cessation have been greater supported in women, and
include factors such as weight gain, stress, depression, menstrual cycle variation, nicotine
addiction, and lack of social support (Levine, Perkins, & Marcus, 2003; Schnoll,
Patterson, & Lerman, 2007; Franklin et al., 2004; National Institutes of Health [NIH],
2001; Perkins, 2001; Schofield et al., 2007). Although fear of weight gain has been cited
as a reason for smoking relapse in men and women, weight gain may be a greater concern
among women. Fifty-two percent of women reported weight gain as a reason for relapse
in one study (N=6784) versus 32% of men (Pisinger & Jorgensen, 2007). Fear of weight
gain post-cessation has been shown to affect women‟s efforts to stop smoking in many
additional studies (Levine, Perkins, & Marcus, 2001; Levine, et al., 2003; NIH, 2001;
Perkins, 2001), and women may be more fearful than men of gaining weight after they
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stop smoking (NIH, 2001; Perkins, 2001; Sepinwall & Borrelli, 2004). In another study
(N=124) (Dobmeyer, Peterson, Runyan, Hunter, & Blackman, 2005), women (n=54) who
were already dissatisfied with their body image prior to smoking cessation efforts worried
significantly more about post-cessation weight gain than women who were satisfied with
their body image. As a result, the women who were already dissatisfied with their body
image reported higher intentions to resume smoking with post-cessation weight gain
(Dobmeyer et al., 2005).
Women may also experience higher levels of pre-cessation and post-cessation
stress and depression, which can lead to decreased cessation rates compared to men
because of women‟s reliance on smoking to alleviate their stress and depressive
symptoms (N=111) (Schnoll, Patterson, & Lerman, 2007). A woman‟s menstrual cycle
variation is related to cigarette craving as well as post-cessation withdrawal and
depression symptoms (Franklin et al., 2004; NIH, 2001; Perkins, 2001). Another barrier
to smoking cessation for women may be a lack of social support, especially from the
smoker‟s spouse (Goldsmith, Lindholm, & Bute, 2006), and women‟s smoking cessation
rates may be higher when social support is present (NIH, 2001; Perkins, 2001).
Barriers specific to women following an invasive CV intervention are still
unknown. Few studies were found to assess smoking cessation behaviors in women with
known CHD. This study examined how barriers to smoking cessation influenced
women‟s decisions to stop smoking in a sample of women with CHD who underwent an
invasive CV intervention.
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Cues to Action and Smoking Cessation
Empirical evidence was found related to the support of cues to action as a factor
affecting smoking cessation (Decker et al. 2009; Honda, 2005; Lee & Kahende, 2007;
Mosca, McGillen, & Rubenfire, 1998). Often the cues to action were operationalized as
receiving smoking cessation advice, receiving discharge instructions which include
smoking cessation as part of risk factor reduction, or HCP providing support to smokers.
One study (N=2498) of men and women (n=1387) with MI examined patient recall of
receiving discharge instructions on secondary prevention behaviors (e.g., smoking, diet,
taking medications, exercise) and found that of the 2046 patients completing the onemonth interview, all patients recalled receiving instruction on at least one secondary
prevention behavior (Decker et al., 2009). Of the patients receiving smoking cessation
discharge instructions, 76% could recall receiving the instructions. However, the content
of this instruction was unclear in the study. Patients reported their adherence to the
suggested secondary prevention behaviors, and current smokers (n=672) reported
“partial” or “poor” adherence to smoking cessation advice significantly more often than
smokers reporting “very careful” or “careful” adherence to the advice (p<0.001). This
suggests that the cues to action related to smoking cessation may not affect patient‟s
smoking behaviors following discharge. Another study (N=293) of men and women with
CV disease (n=107) evaluated support systems for making positive life changes (Mosca
et al., 1998). While both genders rated physicians as the most important source of
lifestyle change, women rated this support system higher than men (p<0.05). Women in
this study also rated support from dieticians, exercise physiologists, nurses, counselors,
family, and social/religious groups significantly higher than men (p<0.05). This suggests
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that cues to action in the form of support for smoking cessation are perceived more
important to women. Finally, a randomized controlled trial (N=883) of men and women
at risk for CHD found that patients receiving lifestyle counseling were 1.7 times more
likely than those in the control group to move into the action/maintenance stage of
change for smoking cessation, suggesting that receiving cues to action in the form of
lifestyle counseling may be beneficial in engaging in smoking cessation behaviors
(Steptoe, Kerry, Rink, & Hilton, 2001). This is supported with two studies which found
that being informed of the dangers of smoking influenced a smoker‟s decision to stop
smoking (Honda, 2005; Lee & Kahende, 2007).
Cues to action are empirically supported as a factor associated with smoking
cessation and were measured in the present study. The majority of studies related to cues
to action delivered to patients who smoke were conducted in a physician‟s office setting
rather than an acute hospital setting, and this study examined patient‟s perceptions of
smoking cessation education received from HCP surrounding their invasive CV
intervention. While these studies suggest that receiving cues to action from HCP can
assist patients in smoking cessation, it is still unknown what effect undergoing an
invasive CV intervention may have on receiving and adhering to the cues to action
related to smoking cessation. Because these studies included both men and women, a
need for further review in a sample of women smokers with CHD exists, and the present
study addressed this.
Factors Affecting the Delivery of Smoking Cessation Cues to Action. Because
cues to action related to smoking cessation have shown to be an important factor
influencing smokers‟ decisions to stop smoking, it is important to explore factors that
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may affect the delivery of such cues to action. Facilitating healthy lifestyle changes and
reduction of risk factors for CHD is an important secondary prevention intervention for
health care professionals. Both nurses and physicians are in a position to provide smoking
cessation interventions for patients who smoke in accordance with secondary prevention
guidelines (Oberg, Fitzpatrick, Lafferty, &LoGerfo, 2009; Steinberg, Nanavati, Delnevo,
& Abatemarco, 2007; Wetta-Hall, Ablah, Frazier, & Molgaard, 2005). According to
clinical practice guidelines, each patient should be assessed for smoking status at every
visit, followed by advising the patient to quit and assisting the patient with his or her
smoking cessation (HHS, 2008). However, research suggests that these practice
guidelines are not followed by every medical provider at every visit (Duffy, Reeves,
Hermann, Karvonen, & Smith, 2008). For example, one study aimed to determine factors
which both facilitate and serve as barriers to staff members (physicians, nurses, and
others) providing help with their patients‟ smoking cessation efforts in two Veterans
Affairs hospitals (n=89 patients and n=108 staff members) (Duffy et al. 2008). Results
showed that, although 70% of smokers were classified as “motivated smokers” (or those
who were thinking of quitting within the next 30 days), only 17% of these smokers
reported receiving smoking cessation services during their hospitalization. Because
nurses and physicians play a major role in assisting patients with smoking cessation
efforts, it is important to understand both the factors which affect their delivery of
smoking cessation assistance and what barriers are preventing the delivery of these
services.
Many factors have been empirically identified which affect the delivery of
smoking cessation interventions. Factors affecting smoking cessation interventions
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which are common among both nurses and physicians include self-efficacy to provide
smoking cessation interventions (Applegate et al., 2008; Duffy et al., 2008; Hall &
Marteua, 2007; Puffer & Rashidian, 2004; Schkrohowsky, Kalesan, & Alberg, 2007;
Steinberg et al., 2007; Vogt, Hall, & Marteau, 2005; Wetta-Hall et al., 2005), level of
smoking cessation knowledge or training (Applegate, Sheffer, Crews, Payne, & Smith,
2008; Duffy et al., 2008; Scanlon, Clark, & McGuiness, 2008; Schkrohowsky et al.,
2007; Steinberg et al., 2007; Vogt et al., 2005; Wetta-Hall et al., 2005), whether the
provider perceives smoking cessation interventions or education as part of his or her duty
(Duffy et al., 2008; Vogt et al., 2005), and the smoking status of the provider (Borrelli &
Novak, 2007; Pipe, Sorensen, & Reid, 2009; Radsma & Bottorff, 2009). Factors
influencing nursing practice related to smoking cessation include advanced practice nurse
status, number of years of nursing practice, level of nursing education (Wetta-Hall et al.,
2005), and willingness of the nurse to deliver smoking cessation interventions (Scanlon et
al., 2008). Physicians‟ gender as well as type of their practice have been shown to
influence providing smoking cessation interventions, as female physicians were more
than twice as likely to deliver smoking cessation interventions in one study of physician
characteristics associated with increased use of practice guidelines (N=336), and
physicians in private practice rather than agency employed were more than three times as
likely to do so (Steinberg et al., 2007).
One factor recognized as affecting the delivery of smoking cessation interventions
by both nurses and physicians is self-efficacy to deliver smoking cessation interventions,
(Applegate et al., 2008; Duffy et al., 2008; Hall & Marteua, 2007; Puffer & Rashidian,
2004; Schkrohowsky et al., 2007; Steinberg et al., 2007; Vogt et al., 2005; Wetta-Hall et
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al., 2005). In general, the percentage of nurses and physicians providing smoking
cessation interventions increased as self-efficacy to deliver these services also increased.
A meta-analysis of 19 studies examined the negative beliefs and attitudes towards
discussing smoking cessation among physicians, and 22% of physicians reported a lack
of confidence in their ability to discuss smoking cessation with their patients (Vogt et al.,
2005). Similarly, another study sought to determine physician characteristics associated
with increased rates of discussing smoking cessation with their patients (Steinberg et al.,
2007). Physician confidence in using the current smoking cessation guidelines was
associated with a three times greater likelihood of discussing smoking cessation with
their patients.
Another factor influencing physician and nurse delivery of smoking cessation
interventions is the level of their smoking cessation training or skill (Applegate et al.,
2008; Duffy et al., 2008; Scanlon et al., 2008; Schkrohowsky et al., 2007; Steinberg et
al., 2007; Vogt et al., 2005; Wetta-Hall et al., 2005). One study examining nursing
predictors of assessing tobacco use and providing smoking cessation interventions
(n=415) found that nurses are far more likely to assess for patient tobacco use and to
deliver smoking cessation counseling if the nurse believed that he or she had the skill to
do so and if he or she had attended tobacco-related continuing education within the past
year (Wetta-Hall et al., 2005). Similarly, Hall and Marteau (2005) found that among
nurses in a private office setting (n= 152), those who had higher confidence in their
ability to advise their patients to stop smoking were more likely to report doing so.
Additionally, physicians and nurse practitioners with more smoking cessation training
performed more smoking cessation interventions in another study where only 24% of
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providers had received specific smoking cessation training, and 33.7% were aware of
current practice guidelines (Applegate et al., 2008).
Smoking status of the HCP was a major factor influencing both whether the
provider delivered smoking cessation interventions and how they cared for smoking
patients (Borrelli & Novak, 2007; Pipe et al., 2009; Radsma & Bottorff, 2009). One
study (n=2836) sought to determine whether an association exists between physician
smoking status and his or her beliefs about smoking cessation and their interventions
related to smoking cessation (Pipe et al., 2009). Findings showed that physicians who
smoked reported that smoking was a harmful activity significantly less often than
physicians who did not smoke, and smoking physicians were significantly less likely to
initiate smoking cessation interventions. Additionally, Borrelli & Novak reported in
2007 that among 178 nurses, those who smoked were significantly more likely to believe
that health risks related to smoking are exaggerated. A qualitative study of nurses (n=23)
indicated that smoking status affected their smoking cessation interventions
inconsistently (Radsma & Bottorff). For example, while some smoking nurses based
their smoking cessation interventions specifically on the patients‟ tobacco use, other
smoking nurses supported their patients‟ needs to smoke and were more ambivalent to
the patients‟ smoking cessation. Some smoking nurses also minimized the health risk of
smoking and were willing to “turn a blind eye” when their patients smoked while
hospitalized (Radsma & Bottorff).
Additional factors were found to influence the delivery of smoking cessation
interventions. Advanced practice nurses and nurses with greater number of years of
experience were significant predictors of assessing their patients‟ smoking status, but not
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of providing smoking cessation counseling (Wetta-Hall et al., 2005). Additionally,
bachelor‟s prepared nurses were more likely to provide smoking cessation advice
consistently than non-bachelor‟s prepared nurses (Wetta-Hall et al., 2005). Scanlon,
Clark, & McGuiness (2008) found a moderate significant correlation between nurses‟
Index of Smoking Knowledge scores and their willingness to deliver smoking cessation
interventions.
Many barriers to delivering smoking cessation interventions have been identified.
Barriers reported by both nurses and physicians include lack of time (Barnhart, Lewis,
Houghton, & Charney, 2007; Hall & Marteua, 2007; Scanlon et al., 2008; Taggart, 2009;
Vogt et al., 2005), perception that the intervention is ineffective (Vogt, Hall, & Marteau,
2005; Hall & Marteau, 2007; Taggart, 2009), perception that the intervention would be
upsetting to the patient (Duffy et al., 2008; Hall & Marteau, 2007; Vogt, Hall, &
Marteau, 2005), and lack of support or materials to follow-up with patients (Duffy et al.,
2008; Taggart, 2009). Additional barriers identified by physicians include patient‟s lack
of willpower, patient‟s lack of interest, and stress (Pipe et al., 2009).
There are multiple factors such as HCP confidence, education in smoking
cessation, and their own smoking behavior that may influence whether health care
professionals give patients information about quitting smoking. HCP need to follow
guidelines and provide information to patients about how to quit because empirical
evidence suggests the importance of receiving smoking cessation cues to action to
smoking cessation; however, these recommendations may not occur and be a missed
opportunity to emphasize the health benefits that may result from quitting smoking. An
opportunity may also be missed to facilitate the patient in making the decision to quit
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and/or providing specific education and treatment. If no recommendation or treatment is
discussed, patients are left on their own to attempt to quit smoking. In this study guided
by the HBM, receiving information about smoking cessation from health care
professionals after an invasive procedure for CHD was conceptualized as cues to action.
In the HBM, cues for action are thought to indirectly affect one‟s intention to perform a
behavior; that is to intend to quit smoking.
Perceived Threat of CHD
Smokers‟ perceptions of risk for CHD are similar to the concept of perceived
susceptibility in the HBM which is proposed to influence one‟s intention to perform a
behavior such as smoking cessation. It is important to understand how patients perceive
their risk for disease both before diagnosis and after. Perceptions of risk following
diagnosis with CHD may impact secondary prevention behaviors such as smoking
cessation.
Many studies have examined perceptions of CHD risk, and findings are mixed
regarding whether patients can attribute their own risk factors to their CHD. One study
of men and women (N=105) with known CHD risk factors found that they were not sure
of their own personal risk factors, and most could name at least one risk factor, including
smoking, hypertension, and hyperlipidemia, but were unable to name more than one
(Zerwic et al., 1997). This sample was predominantly White and male. This opposes
findings from other studies which suggest that CHD patients can perceive their risk for
CHD. Perceptions of more susceptibility to CHD as well as more perceptions of the
seriousness of CHD explained 76% variance of CHD preventive behaviors in another
study, including smoking cessation (Ali, 2002), therefore indicating these variables are
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important to consider. This was similar to findings an additional study examining illness
beliefs and their association to adherence of secondary preventive behaviors in men and
women (N=193) with CHD (Stafford et al., 2008). Stafford et al. found that perceptions
of more serious consequences of CHD were significantly associated with better
adherence to secondary prevention behaviors. This study included only 14% smokers;
however, 74% of these recognized smoking as a causal factor of CHD.
Perceived Threat of CHD in Women
Women‟s perceptions of risk for CHD may impact their smoking cessation
behaviors. Empirical evidence suggests that women underestimate their risk for CHD
(Arslanian-Engoren, 2007; Hammond et al., 2004; Hart, 2005; King et al., 2002; OliverMcNeil & Artinian, 2002; Zerwic et al., 1997). Some women may even perceive breast
cancer to be a greater personal risk than CHD as in one study (Hart). Many women knew
of risk factors (e.g., diet, smoking, stress, etc.) related to CHD, but they did not equate
these as their own personal risk factors in one study (Hammond et al., 2004). Similarly, a
literature review showed that not only did women underestimate their risk for CHD, but
most women did not comprehend that their co-morbidities were personal risk factors for
CHD (Hart). No relationship was found between the women‟s knowledge of CHD risk
factors and risk-reducing behaviors in four studies (Hart). In a qualitative study of 30
women, 20 women thought that CHD was a White, obese and stressed man‟s disease
(Arslanian-Engoren). The perceptions of risk were similar between White, African
American, and Hispanic women (Arslanian-Engoren).
Women were unable to identify their own personal CHD risk factors (including
smoking) in two additional studies (N=33, N=450, respectively), therefore suggesting a
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lack of perceived susceptibility to CHD (Oliver-McNeil & Artinian, 2002; King et.al,
2002). While women in one study were able to name CHD risk factors, these were not
consistent with those listed in their medical record (Oliver-McNeil). Women recognized
that it would be good for their health to stop smoking, but the women did not view this in
relation to CHD risk (King).
It is also crucial to examine women smokers‟ perceptions of increased CHD risk
due to their smoking, as these perceptions may have a direct impact on their smoking
cessation efforts. Smoker‟s perceived seriousness of smoking, susceptibility to CHD, and
social norms related to smoking behavior have predicted smoking cessation in women
(Ali, 2002; Bursey & Craig, 2000; Honda, 2005; Manfredi et al., 2007; Thanavaro et al.,
2006). Likewise, Bursey & Craig (2000) (N=32) and Thanavaro et al. (2006) (N= 119)
had similar findings that women believed that smoking cessation was good for their
health, and that this belief was a predictor of women engaging in CHD preventive
behaviors, including smoking cessation.
These studies support that women underestimate their risk for CHD, both in
women with known CHD and in women with risk factors for CHD. Underestimating
personal CHD risk, and especially increased risk from smoking, can result in worse
health outcomes if women do not engage in secondary prevention behaviors as a result.
While studies have examined women‟s perceptions of CHD and from smoking, it is still
unknown how women smokers perceive threat to future invasive CV interventions, and
this study addressed this gap in the literature.
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Perceived Threat of Future Invasive CV Interventions
Little existing literature was found related to perceptions of threat of future
invasive CV procedures, especially among women smokers with CHD. Two studies
examined patients‟ perceived treatment benefits from PCI and found that patients
generally reported their health as better following their procedure (Kimble & King, 1998;
Ozkan, Odabasi, & Ozcan 2008). One study aiming to determine perceived benefits of
PCI in a group of men and women found that perceptions of good health significantly
increased from 48.3% before the procedure to 88.3% after (p<0.05) (Ozkan, Odabasi, &
Ozcan 2008). However, the proportion of patients who perceived CHD as seriousness
significantly decreased from 83.3% before to 40% after PCI (p<0.05). Important to note
was the percentage of patients who misinterpreted their ability to completely to recover
from their disease following their procedure (100% of patients before and 96.7% after
PCI) rather than perceiving their CHD as chronic. This suggests that patients with CHD
may not consider themselves with a chronic disease which requires lifestyle
modifications as a secondary prevention measure and therefore may be less likely to
make lifestyle changes. Similarly, Kimble and King found that 79% of men and women
(N=62) reported that PCI “made things better for them” because the procedure provided a
relief or decrease of angina and dyspnea, less fatigue, and an increased sense of
reassurance.
One study used the HBM to examine the relationships between the HBM
variables (severity of disease, barriers, self-efficacy, benefits, cues to action) and
adherence to an exercise regimen which was recommended to men and women (N=51)
following CABG or PCI (Robertson & Keller, 1992). Patients with higher perceived
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benefits (p<0.05) and self-efficacy (p<0.01) were significantly more likely to adhere to
the exercise regimen, and patients with lower perceived barriers were more likely to
adhere as well (p<0.01). Perceived barriers, type of surgery (cues to action), and selfefficacy explained 31% of the variance in adherence to the exercise regimen, but
perceived benefits and severity were not significantly explanatory variables in this model
(Robertson & Keller, 1992).
Only one study was found which examined causal attributions to cardiac risk
among women smokers hospitalized with CABG or MI (N=260) (Murphy et al., 2005).
The relationship between perceived cause of heart disease and their actual risk profile
was inconsistent. Of the 39 smokers, 44% acknowledged smoking as a risk factor for
CHD. Interestingly, 20% of the sample reported having “no idea about the cause of
CHD”. This study did not examine secondary preventive measures taken by the
participants.
While these studies provide important information related to perceptions of health
following an invasive procedure, women smokers were not included in these studies or
were not addressed. It is still unknown what, if any, risk factor modifications were made
following their procedure. It may be assumed based on these studies that patients with
CHD may not perceive CHD as chronic, but the impact that the procedure may have on
smoker‟s perceptions of risk for a future invasive CV procedure is unknown. The HBM
variables have significantly explained health behaviors in CABG and PCI patients.
Therefore, the HBM was used to address the impact that the threat of a future invasive
CV intervention had on women‟s smoking cessation following CABG or PCI.
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Depressive Symptoms and Smoking Cessation
Empirical evidence suggests that there is an association between smoking and
depression. Many smokers report more depressive symptoms compared to non-smokers
(Wilheim, Wedgwood, Niven, & Kay-Lambkin, 2006; Scott et al., 2009; Perkins, 2001;
Kinnunen, Henning, & Nordstrom, 1999; McClave et al., 2009). Common depressive
symptoms include anhedonia, depressed mood, insomnia/hypersomnia, fatigue, appetite
fluctuation, feelings of worthlessness, and decreased concentration (McClave et al.,
2009). Several explanations have been proposed for the increased depressive symptoms
among smokers, and include the use of smoking to cope with stress and the idea that
smoking (or smoking cessation) produces depression; however, no one theory has been
shown to be better in explaining this (Wilheim, Wedgwood, Niven, & Kay-Lambkin,
2006). One study used the 2006 Behavioral Risk Factor Surveillance System data to
examine the association between smoking and depression and anxiety among men and
women (N=248,800) (McClave et al., 2009), and found that unsuccessful quitters were
1.3 times more likely to have received a lifetime diagnosis of depression than successful
quitters (p<0.001). Several meta-analyses suggest that smokers are also more likely to
have difficulty with smoking cessation and often relapse compared to non-smokers
(Glassman et al., 2001; Perkins, 2001; Kinnunen et al., 1999; Wilheim et al., 2006).
Depression has been associated with smoking and smoking cessation among
women smokers with CHD (Czajkowski et al., 1997; Dunkel et al., 2009; Gravely-Witte,
De Gucht, Grace, & Van Elderen, 2007). In a study of both men and women (N=121) the
contribution of a cardiac history and angina to health-related quality of life and
depression over six months was examined (Gravely-Witte et al., 2007). Results showed

49
that cardiac history and angina significantly predicted an increased level of depression.
Similarly, Czajkowski‟s (1997) comparison of preoperative characteristics of men and
women undergoing CABG surgery (N=759) showed that women reported significantly
higher depressive symptoms than men (p<0.001), with a mean Center for Epidemiologic
Studies Depression Scale [CES-D] score of 17.7 for women versus 12.9 for men. Finally,
another study examining depressive risk before CABG among men and women (N=1238)
found that 21.6% of patients had increased depression scores, and women (n=277) were
twice as likely to report higher depression scores as men (p<0.001).
These studies support a higher prevalence of depression among women with CHD
and that depression can impede smoking cessation efforts. Women are more likely to
report depressive symptoms than men when undergoing CABG surgery. Therefore,
depressive symptoms were measured in the present study as a modifiable personal
characteristic.
Motivation and Smoking Cessation
Motivation to stop smoking has been empirically supported as a predictor of
health behaviors, including smoking cessation, diet, and exercise (Ali, 2002; LloydRichardson et al., 2009; Williams, Cox, Kouides, & Deci, 1999; Williams et al., 1996;
Williams, Freedman, & Deci, 1998). Motivation has been tested within the context of the
SDT, and these studies have reported that those with more autonomous motivation to
make a health behavior change rather than controlled motivation (or not autonomous) are
more likely to make health changes and sustain them (Williams, Cox, Kouides, & Deci,
1999; Williams et al., 1996; Williams, Freedman, & Deci, 1998). This was found to be
true in a sample of obese men and women entering a weight loss program (N=128),
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where those with more autonomous motivation were more likely to attend the program
more regularly, lose more weight, and sustain the weight loss at the 23 month follow-up
(Williams et al. 1996). Similarly, autonomous motivation to improve glucose control
(N=128) was related to significant increases in perceived competence (p<0.05), which
was then related to increased glucose control (p<0.001). Only one study of women
without CHD found that general health motivation was a predictor of CHD preventive
behaviors in women (N=178) like smoking cessation (N= 178) (Ali, 2002). Motivation
to stop smoking has been supported in numerous patient populations, including smokers
and women with CHD, as a significant predictor of health behaviors; however, no studies
were found with a sample population of women smokers with CHD. Therefore, the
present study filled this gap in the literature by examining general motivation to stop
smoking in a sample of women smokers following an invasive CV procedure.
Individual Characteristics and Smoking Cessation
Individual characteristics have been recognized as predictors of successful
smoking cessation (Lee & Kahende, 2007; Honda, 2005). Demographics such as race,
age, marital status, level of education, whether the individual has rules about smoking
inside their home, and whether the individual is informed of the dangers of smoking have
been shown to influence the decision to stop smoking. Significant predictors of
successful smoking cessation from the 2000 National Health Interview Survey (N=7421)
included having rules against smoking in the home, being informed of the danger of
second-hand smoke, being aged 35 or older, being married or living with a partner, being
White (non-Hispanic), and having a college education (Lee & Kahende, 2007). Because
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most of these characteristics are non-modifiable, they were not included in hypothesis
testing; however, individual characteristics and clinical data were collected.
Smoking Cessation Techniques in Women
The HHS, along with many other organizations such as the CDC and the National
Heart, Lung, and Blood Institute, collaboratively provide clinical practice guidelines for
the treatment of tobacco use and dependence (HHS, 2008). Included in the guidelines are
brief interventions intended for use by any health provider and to treat any clinical
population. Clinical practice guidelines indicate that medications and counseling work
best when used together in treating tobacco dependence, but each method is also effective
alone and should be used when situations warrant (HHS, 2008).
The U.S. Food and Drug Administration has approved seven first-line
medications for tobacco dependence treatment (HHS, 2008). Nicotine Replacement
Therapy (NRT) is one option designed to provide controlled amounts of nicotine in a
form which does not contain the harmful constituents of tobacco smoke (Schnoll,
Patterson, & Lerman, 2007). NRT also targets alleviating nicotine withdrawal symptoms
and reducing cravings and urges (Schnoll, Patterson, et al. 2007). Included are: 1) the
transdermal nicotine patch, 2) nicotine gum, 3) nicotine nasal spray, 4) nicotine inhaler,
5) nicotine lozenge, 6) bupropion hydrochloride (Zyban® or Wellbutrin®), and 7)
varenicline (Chantix®) (HHS, 2008). Bupropion is an antidepressant originally
prescribed for the treatment of depression, and was approved in the U.S. for smoking
cessation in 1997. Although the full mechanism of bupropion‟s effects is still unknown,
it is thought that it has some dopaminergic and adrenergic agonist and nicotinic receptor
antagonist effects (Schnoll, Patterson et al., 2007; Perkins, 2001). Varenicline is a
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nicotinic receptor partial agonist which reduces cravings and decreases the pleasurable
effects from nicotine (ALA, 2008). Non-pharmacologic treatment options include selfhelp interventions, which consist of booklets, videos, computer-based systems, and prerecorded telephone messages (Naughton, Prevost, & Sutton, 2008), cognitive behavioral
therapy, which can focus on changing negative behaviors and attitudes, individual
counseling, as well as group behavioral interventions, which provide counseling and
social support for abstinence during smoking cessation (Perkins, 2001; Carlson,
Goodney, Bennete, Taenzer, & Koopmans, 2002).
The 2008 clinical practice guideline offers prescription recommendations (HHS,
2008). These recommendations are intended for the treatment of all smokers except
pregnant women, smokeless tobacco users, light smokers, and adolescents. The
transdermal nicotine patch alone has not been shown to be as effective as in combination
with an additional NRT as needed. Smokers are 3.6 times more likely to quit smoking
with the patch/NRT combination. Another treatment option is to prescribe varenicline
2mg daily. There is no well accepted algorithm for guiding the optimal medication
selection. Second-line treatment options, such as Clonidine and nortriptyline, should be
used only when the smoker is unable to use first line treatments or when the first-line
treatments are ineffective. Medications which have been shown to be not effective in
treating tobacco dependence include selective serotonin reuptake inhibitors and
naltrexone (HHS, 2008).
Although numerous cessation techniques exist, studies have shown that their
effectiveness may not be equal for men and women. There is evidence that NRT can be
effective for both men and women; however, evidence is mixed whether NRT is less
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effective for women (HHS, 2008). Some meta-analyses have shown that NRT alone is
not as effective for women as for men (Cepeda-Benito, Perkins, 2001; Reynoso, & Erath,
2004). For example, Killen (1990) found that nicotine gum was significantly more
effective than a placebo in men (n=588) but not in women (n=630). Several studies also
showed significantly poorer cessation outcomes for women than for men when using a
nicotine patch (Davis et al., 1994; Gourlay, Forbes, Marriner, & McNeil, 1994; Swan,
Jack, & Ward, 1997; Wetter et al., 1999). However, another study suggests that the form
of NRT makes a difference in abstinence rates, and that women who were assigned to an
inhaler had a higher abstinence rate than men (West, Hajek, & Nilsson, 2001). CepedaBenito‟s meta-analysis of the efficacy of NRT concluded that NRT in conjunction with
intensive non-pharmacological support was important for women (2004). Clonidine may
be an effective pharmacological treatment for women and smoking cessation (Perkins,
2001). Three studies in this meta-analysis suggested that clonidine was more
significantly effective for women than men in smoking cessation (Glassman, Stetner, &
Walsh, 1988; Glassman, Covey, & Dalack, 1993; Hilleman, Mohiuddin, & Packard,
2004). Addressing fears of weight gain through cognitive behavioral therapy may be an
additional method that can help women accept modest weight gain with smoking
cessation when combined with other cessation methods (Perkins, 2001; Levine, Marcus,
& Perkins, 2003). Smoking relapse is a concern for women because women who relapse
do so for different reasons than men, and include stress, weight gain, and negative
emotions associated with smoking cessation (ALA, 2008).
The 2008 Clinical Practice Guidelines, which result from a collaboration of the
HHS, along with many other organizations such as the CDC and the National Heart,
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Lung, and Blood Institute, address many of concerns of women smokers in their
recommendations for tobacco dependence treatment (HHS, 2008). For smokers who
express weight gain concerns, and particularly women, guidelines recommend
prescribing bupropion and an NRT (such as nicotine gum 4mg or nicotine lozenge 4mg).
This treatment may delay weight gain, but does not prevent it. Similarly, bupropion and
nortriptyline appear to be effective in treating tobacco dependence in smokers with
depression. The transdermal nicotine patch is safe for smokers with CHD (HHS, 2008).
The 2008 clinical practice guidelines (HHS, 2008) provided no racial/ethnicspecific recommendations in treating tobacco dependence. However, it has been
suggested that treatment options such as group counseling and community-based
interventions may increase the effects of smoking cessation interventions with African
American smokers (Webb, 2008). Webb‟s 2008 meta-analysis of 20 empirical studies
assessing smoking cessation interventions among U.S. adult African American smokers
revealed that group counseling had a positive effect on smoking cessation, although some
studies were culturally and church-based. This analysis also found that the odds of
quitting more than doubled when the outcomes were evaluated at the community level.
In the present study, data were collected on ethnicity and racial groups and women of all
ethnicities were eligible to participate.
Smoking Cessation Strategies with CHD Population
Patients with CHD should be treated according to the 2008 clinical practice
guidelines, with the goal of secondary prevention of MI (Oberg et al., 2009). Due to the
sympathomimetic effects of nicotine which can lead to increased heart rate, increased
blood pressure, and coronary vasoconstriction, practitioners may be hesitant to include
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NRT in the treatment of nicotine dependence for smokers with cardiovascular disease.
However, evidence suggests that the transdermal nicotine patch is safe to use in patients
with controlled angina (HHS, 2008; Pisinger, 2007; Ludvig, Miner, & Eisenberg, 2005).
Non-pharmacologic cessation methods have been effective with the CHD patient
population (Froelicher & Christopherson, 2000). In a meta-analysis of smoking cessation
techniques among patients with CHD (N=3525), five of the eight studies reported
continued cessation for behavioral counseling at 6 months (20.4% active group versus
12.1% placebo group) and at 12 months (20% active group versus 13.9% placebo group)
(Ludvig et al., 2005). Overall findings for NRT among these studies showed a higher
abstinence rate for NRT among the active group versus the placebo group. This suggests
that NRT and behavioral therapy are both effective methods for treating nicotine
dependence in smokers with CHD.
Empirical evidence exists for both pharmacologic and non-pharmacologic
treatment of nicotine dependence. Many studies have examined which NRT is most
effective in men and women, and the 2008 clinical practice guideline recommends a
combination of NRTs and /or NRT and behavioral counseling for treating smokers.
However, no clearly accepted algorithm for non-pharmacological treatments such as case
management, group counseling, cardiac rehabilitation programs, etc., is evident.
Therefore, further research is needed which addresses various non-pharmacologic options
which, combined with NRT combinations, could enhance smokers‟ likelihood of
successful smoking cessation. Large-scale clinical trials with a focus on varied sample
populations, including gender, race/ethnicity, and age groups, could provide a holistic
approach to treating tobacco dependence.
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Summary
Little is known about smokers‟ perceptions of benefits of smoking cessation,
barriers to smoking cessation, threat of CHD and from having future invasive CV
interventions, receiving cues to action, commitment to stop smoking, and smoking
cessation among women with CHD and a history of invasive CV interventions. Because
the majority of studies have included men and few women smokers, additional research is
needed which focuses solely on women smokers. This study used the HBM to predict
smoking cessation behavior in women with CHD in a group of women undergoing an
invasive CV intervention. Because focus shifts to secondary prevention of CHD
following diagnosis, smoking cessation should be a major focus for both the HCP and
patient, as smoking is the most preventable risk factor for CHD. Undergoing an invasive
CV intervention may influence women‟s perceptions of their risk of CHD, and women
may become more likely to engage in secondary prevention behaviors at this pivotal
point in their CHD trajectory. Therefore, this study was important step in determining
what factors may prevent smoking cessation so that interventions specific to women
smokers can follow.

CHAPTER III
Methodology
Research Design
A prospective, correlational design was used to test theory driven hypotheses
predicting commitment to quit smoking and smoking cessation in women smokers with
CHD undergoing an invasive CV intervention. Questionnaires were administered at two
time points. The first point, Time 1 (T1), was during hospitalization after the procedure
when the patient was stable and willing or at least within one week after discharge for the
invasive CV intervention, including CABG surgery or PCI. The participant was
contacted again via telephone at 3 months, Time 2 (T2), after the initial interview. Data
collected at T1 included commitment to stop smoking, perceived threat (heart disease
threat and threat of future invasive CV intervention), depressive symptoms, smoking
cessation self-efficacy, cues to action, benefits to smoking cessation, barriers to smoking
cessation, and demographic/clinical information. Data were collected by in-person
administration or telephone administration of questionnaires. A reminder card was mailed
to participants eight to ten weeks following T1 in order to remind participants that the
researcher would be contacting them via telephone to discuss their smoking status at T2.
Three months following their initial interview (T2), the women were interviewed via
telephone to establish their current smoking status. Additional data collected at T2
included commitment to stop smoking (CQSS), depressive symptoms (CES-D), and a
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semi-structured interview about help received and challenges faced related to
smoking cessation.
Setting
The setting for this study was an acute care hospital located in the Southeastern
U.S.. The hospital was a 637-bed, acute care, tertiary not-for-profit medical center and
teaching hospital which served approximately 750,000 insured and uninsured patients in
28 counties in 2008 (MCCG, 2009). Of the 750,000 patients served, 23,281 were cardiac
patients in 2008. The hospital performed approximately 76 CABG surgeries on women
from January to June 2009, and only 23 of these were women smokers (Cleghorn,
personal communication, August 24, 2009). However, the hospital performed many
more PCI procedures during that time frame (Knott, personal communication, October 2,
2009). PCI procedures are performed Monday through Friday at this hospital, and about
15 to 30 are performed daily. Of these, approximately 1/3 are performed on women, and
approximately 40% of these are smokers (or about 40-80 women smokers per month)
(Knott, personal communication, October 2, 2009).
Sample
This study used a non-random sample of women smokers undergoing either
CABG surgery or PCI with a diagnosis of CHD. The sample included women 40 to 80
years of age, since increasing age is a risk factor for CHD (AHA, 2008). Women greater
than 80 years of age who undergo invasive CV interventions such as CABG surgery often
encounter significant variability in their treatment outcomes, and often experience higher
mortality rates than men (Basaran, 2007). Since the prevalence of CV disease in the
1999-2004 NHANES study of women aged 20-39 was only 0.6% of the population,
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perceptions of risk may not be established in women younger than 40, and they are likely
not undergoing invasive CV procedures, thus women under the age of 40 years were
excluded.
Additional inclusion criteria were women who: (1) were identified from the
medical record as a current smoker, where “current smoker” was defined using the
“Healthy People 2010” operational definition as “one who has smoked at least 100
cigarettes in their lifetime and who now report smoking cigarettes every day or some
days” within the past month (CDC, 2007); (2) had a diagnosis of CHD as noted in the
medical record; (3) had an invasive CV intervention defined as a CABG surgery or PCI
(with or without stent placement) within the past week; (4) were willing to provide
contact information for the 3 month follow-up ; (5) had a stable medical condition (i.e.
not awaiting emergent CABG) and were expected to be discharged to the community
post-procedure; and (6) were able to speak in English without assistance. Women who
self-reported as not a current smoker but whose medical record reported them as a current
smoker were enrolled in the study as a current smoker. Women with a current diagnosis
of severe mental illness as noted in the medical record were excluded from this study, as
these diagnoses may have affected their ability to provide informed consent, complete
questionnaires, or perceive the risks of smoking to their health.
Sample Size
A power analysis was conducted using an a-priori statistical power calculator for
hierarchical regression (Soper, 2009) to determine the sample size. For a medium effect
size of 0.15 using Cohen‟s f2, alpha level of 0.05, a statistical power level of 0.80, and 8
predictor variables, a sample size of 104 was determined to be needed to address study
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aims. Since smoking cessation is a dichotomous outcome variable and there is difficulty
in predicting the percentage of women who will stop smoking, the power analysis was
calculated based on the outcome variable “commitment to stop smoking”. Because of the
prospective nature of the design, potential attrition of participants was addressed. Three
recent studies which tested smoking cessation interventions and their effects on smoking
status at six months (rather than three months in this study) indicated attrition rates of
11% (Li & Froelicher, 2008), 6.5% (Bullock, Everett, Mullen, Geden, Longo, & Madsen,
2009), and 12.6% (Andrews, 2007). Therefore, an average anticipated attrition rate of
10% was expected. Consequently, the sample size was increased to 116 to account for
possible attrition. Due to feasibility issues, a sample of 80 women smokers was planned
for this study, which included a minimum of 73 participants plus additional for attrition.
Instruments
Smoking Cessation
Smoking cessation was measured using self-report during a telephone interview
three months (T2) following the initial interview. Smoking cessation was a dichotomous
outcome variable, with a “yes” or “no” response to the question: “Have you smoked at
least 100 cigarettes in your lifetime and do you now smoke cigarettes every day or some
days since your heart procedure?” A “no” response was coded as “0” and a “yes”
response was coded as “1”. In order to elicit additional data related to the participants‟
experiences with smoking cessation since their cardiac procedure, a set of additional
questions asked at T2 was created for this study. Items on the questionnaire included the
number of cigarettes smoked daily, the number of quit attempts, help with smoking
cessation received (counseling, medications, etc.), the challenges of smoking cessation,
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spousal smoking status, the meaning of cigarettes in the participants‟ lives, what got in
the way of smoking cessation, how the participant feels about smoking now, who else
helped with smoking cessation, and whether the participant has plans to continue trying
to stop smoking. These responses were coded and reported with descriptive statistics.
Biochemical measures were not be used in this study to validate self-report smoking
status due to study feasibility, and is thus a study limitation.
Smoking status via self-report has been questioned for fear of under-reporting.
However, one meta-analysis of 51 comparisons between self-reported behavior and
biochemical measures suggests that using self-report smoking status is appropriate under
certain conditions (Patrick et al., 1994). Conclusions from the meta-analysis were based
on findings that among the 51 comparisons, sensitivity overall of self-reported smoking
was 87% and specificity overall of self-reported smoking was 89%. Additional findings
suggest that the study population and measurement methods are important. For example,
sensitivity and specificity are increased for self-reported smoking status when the
questionnaire is interviewer-administered rather than self-administered (Patrick).
Another study found that the agreement between self-reported smoking status and two
biochemical tests was higher for women than men (Assaf, Parker, Lapane, McKenney, &
Carleton, 2002), suggesting that self report for smoking is more appropriate for women.
This study used questionnaires which were administered by the researcher and the sample
consists of women, which together increased confidence in using self-reported smoking
status.
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Commitment to Stop Smoking
Commitment to stop smoking was operationalized as “a cognitive state of being
personally bound or obligated to avoid smoking despite any potentially difficulty,
discomfort, or craving associated with quitting, even when the magnitude and duration of
that discomfort are unknown and variable”, and was measured with the Commitment to
Quitting Smoking Scale (CQSS) (Kahler et al., 2007). This is an 8-item Likert-type scale
to assess commitment to quitting smoking. Sample CQSS items include: “I‟m willing to
put up with whatever discomfort I have in order to quit smoking”, “Feeling very anxious
or restless won‟t prevent me from quitting smoking”, and “I‟m not going to let anything
get in the way of my quitting smoking”. Each item response was scored from 1 (strongly
disagree) to 5 (strongly agree). The total score ranged from 8-40 and was calculated as
the sum of the individual‟s rating of each item. Higher scores indicated a greater
commitment to stop smoking (Kahler).
The scale‟s reliability and validity were initially examined in a sample of heavy
drinkers (Kahler). Internal consistency of the CQSS was adequate with a Cronbach‟s
alpha coefficient of 0.91. Construct validity was established through a principle iterated
common factors analysis which yielded one dimension and accounted for 91% of the
variance among items (Kahler).
Smoking Cessation Self-Efficacy
Self-efficacy for smoking cessation was measured by the Smoking Self-Efficacy
Questionnaire (SEQ-12) (Etter et al., 2000). This is a 12-item Likert-type scale which
measures an individual‟s confidence in their ability to stop smoking in high risk
situations. The SEQ-12 consists of two subscales which measured confidence to refrain
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from smoking when 1) facing internal stimuli such as feeling depressed, and 2) facing
external stimuli such as being with smokers. Each item was rated on a 5-point Likerttype scale, with 1 (not at all sure) to 5 (extremely sure) yielding a total score of 12-60.
The total score was computed by summing the individual‟s ratings of the 12 items, with
higher scores indicating higher smoking self-efficacy (Etter et al., 2000).
Reliability and validity for the SEQ-12 have been established (Christie & Etter,
2005; Etter et al., 2000; Leung, Chan, Lau, & Lam, 2008). Test-retest reliability was
initially established with the administration of the SEQ-12 at two time points with an
average of 38 days between, and the correlation between times for the SEQ-12 was 0.95
for the internal subscale (Etter et al., 2000) and verified in another study with 0.68
(Christie & Etter, 2005) and 0.93 for the external subscale (Etter et al., 2000) and 0.74
(Christie & Etter, 2005). Internal consistency was adequate with a Cronbach‟s alpha
coefficient ranging from 0.77- 0.94 in three studies (Christie & Etter, 2005; Etter et al.,
2000; Leung et al., 2008). Content validity was initially established with the use of
content experts, empirical evidence, and collected qualitative data from current and
former smokers (Etter et al., 2000). Construct validity was also established initially
through a varimax rotated factor analysis which yielded two factors (internal and
external) (Etter et al., 2000) and confirmed with a confirmatory factor analysis (Leung et
al., 2008). Item-scale correlation coefficients ranged from 0.72 to 0.91, and a correlation
coefficient of 0.79 was obtained between the two subscales (internal and external) (Etter
et al., 2000).
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Perceived Benefits to Smoking Cessation
Perceived benefits to smoking cessation were measured with the Perceived
Benefits Scale (PBS) of the Perceived Risk and Benefits Questionnaire (PRBQ) (McKee
et al. 2005). The PRBQ total scale is a 39-item Likert-type scale which was developed to
assess the perceived risks and benefits associated with smoking cessation among 573 men
and women entering smoking cessation trials. The PRBQ contains two separate scales:
one measuring perceived risks to smoking and one measuring perceived benefits of
smoking cessation. The PBS was used in this study, and is a 21-item Likert-type scale
which contains six perceived benefits subscales. These include health benefits, general
well-being, finances, self-esteem, social approval, and physical attractiveness. Sample
items from the PBS include “I will avoid health problems down the road” and “I will feel
more energetic”. Each item on the 7-point Likert-type scale measured how likely each
item would be if the participant were to stop smoking, with ratings of 1 (no chance) to 7
(certain to happen). Items were averaged to create the six individual subscale scores, and
the PBS score was the average of the six individual subscale scores. Higher scores
indicated higher perceived benefits of smoking cessation (McKee et al. 2005).
The reliability and validity for both the PRBQ total scale and the PBS subscale
have been reported in one study (McKee, O‟Malley, Salovey, Krishnan-Sari, & Mazure,
2005). Content validity was established with the use of content experts as well as
empirical evidence in the development of PRBQ total scale items. Construct validity was
established through a factor analysis which yielded two factors (perceived risks and
perceived benefits). The scores on the PRBQ were correlated to scores on the Decisional
Balance Scale, with a significant correlation coefficient of 0.41, therefore supporting
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construct validity of the PRBQ. Internal consistency reliability for the PBS was adequate
with a Cronbach‟s alpha of 0.93 (McKee et al., 2005). Test-retest reliability was
established with the administration of the PBS subscale one to two weeks apart, and the
correlation between the PBS scores at these time points was 0.61 (McKee et al., 2005).
Perceived Barriers to Smoking Cessation
Perceived barriers to smoking cessation were measured using two scales. The
Barriers to Cessation Scale (BCS) addressed barriers to smoking cessation (Macnee &
Talsma, 1995), and the Weight Control Smoking Scale addressed weight control, which
is a specific barrier for women (Pomerleau & Snedecor, 2008). The BCS is a 19-item
Likert-type scale which was developed to test the perceived barriers to smoking cessation
(Macnee & Talsma). Previous studies identified three categories of stressors which can
be barriers to smoking cessation: internal, external and addictive. Internal barriers reflect
affective states, and a sample item from this category includes “feeling less in control of
your moods”. External barriers to smoking cessation reflect factors external to the
individual such as social support and lack of support. A sample item from this category
includes “no encouragement or help from friends”. Addictive barriers reflect the level of
tobacco addiction, such as withdrawal symptoms and smoking stimuli. A sample item
from this category includes “miss the companionship of cigarettes”. Each item was rated
on a 4-point Likert-type scale, with 0 (not a barrier) to 3 (large barrier) yielding a
possible total score of 0-57. The total score was computed as the sum of the individual‟s
rating of the 19 barriers (Macnee & Talsma) with higher scores indicating greater
perceived barriers to quitting smoking.

66
The BCS has been examined for reliability and validity in one published study
(MacNee, 1991), two unpublished studies by the BCS author, and in one pilot study
(Rice, Templin, & Kulwicki, 2003). Test-retest reliability was initially established with
the administration of the BCS two weeks apart, and the correlation coefficient between
the BCS scores at these time points was 0.93 (MacNee, 1991). Item-to-total score
correlations in two studies ranged from 0.27 to 0.60, supporting reliability of the BCS
(Macnee, 1991). Internal consistency was supported with the Cronbach‟s alpha, which
ranged from 0.81 to 0.87 (Macnee, 1991, MacNee, unpublished). Content validity was
established with the use of content experts as well as empirical evidence in the
development of BCS items. Construct validity was established through a principal
components factor analysis which yielded three factors (internal, external, and addictive
barriers), and these three factors explained 49% of the variance in the items (MacNee,
1991). Cronbach‟s alpha coefficients for the BCS were adequate among two published
studies and two unpublished studies, ranging from 0.81 (MacNee, unpublished) -0.92
(Rice et al., 2003). The BCS scores were significantly correlated to scores on the Daily
Hassles Scale, and correlation coefficients ranged from 0.28 (MacNee, unpublished) to
0.71 (MacNee, unpublished) (p<0.001), therefore supporting construct validity of the
BCS.
The Weight Control Smoking Scale (WCSS) was used to measure a specific
smoking cessation barrier for women (Pomerleau & Snedecor, 2008). This scale was
included because the literature identified fear of gaining weight as a potential barrier to
smoking cessation, and the BCS did not include this concept (Levine, Marcus, & Perkins,
2003; Levine et al., 2003; NIH, 2001; Perkins, 2001). The WCSS is a three-item Likert-
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type scale which focuses on smoking-related concerns of weight and appetite (Pomerleau
& Snedecor). The three items were: 1) “I smoke to keep from gaining weight”; 2)
Smoking helps me control my appetite”; 3) “I don‟t get so hungry when I smoke”. Each
item was rated on a 4-point Likert-type scale, with 0 (not at all) to 3 (very much so)
yielding a total score of 0-9. The total score was computed as the sum of the individual‟s
rating of the three items. Higher scores indicated higher smoking-related concerns of
weight and appetite (Pomerleau & Snedecor, 2008).
Internal consistency of the WCSS was adequate with a Cronbach‟s alpha
coefficient of 0.83 (Pomerleau & Snedecor, 2008). Test-retest reliability was established
with the administration of the WCSS at two time points, and the correlation between the
WCSS scores at these time points was adequate at 0.74, therefore establishing reliability
of the WCSS (Pomerleau & Snedecor). The WCSS scores were significantly correlated
to scores on the Dieting and Binging Severity Scale (r=.35, p<0.001), Three Factor
Eating Questionnaire (r= 0.13-0.34, p< 0.01-0.001), Body Satisfaction measurement
(r=0.24, p<0.001), Self-Efficacy about Maintaining Abstinence in the Face of Weight
Gain measurement (r=0.56, p<0.001), and Appetite/Weight Gain as a Withdrawal
Symptom measurement (r=0.53, p<0.001). Correlation coefficients ranged from 0.12 to
0.55, therefore supporting construct validity of the WCSS (Pomerleau & Snedecor).
Health Care Providers as Providers of Cues for Smoking Cessation
Cues to action (CTA) are triggers which initiate an individual‟s taking
recommended action such as smoking cessation (Rosenstock, 1974). Cues to action in
this study included whether the patient received smoking cessation assistance from a
HCP. This was measured by a researcher-developed questionnaire based on the 2008
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Clinical Practice Guidelines for the Treatment of Tobacco Use and Dependence (HHS,
2008). Questions assessed whether the HCP incorporated the “5 A‟s” into smoking
cessation education: ask the patient‟s smoking status, advise the patient to stop smoking,
assess willingness to stop smoking, assist the patient in quitting, and arrange follow-up.
Sample questions to be asked are “Did your HCP ask you if you smoke?”, Did your HCP
advise you to stop smoking?”, “Did your HCP ask you if you are willing to stop
smoking?” “Did your HCP offer you assistance with quitting smoking?”, and “Did your
HCP schedule a follow-up appointment related to your quitting smoking?” Each item
response was scored as “0” for “no” and “1” for “yes”, and the total score of 0-5 reflected
the sum of the five items. A higher score indicated greater cues to action received.
Content validity was established with two smoking cessation experts prior to
administration.
Perceived Threat
Perceived threat was measured using both the threat of CHD and the threat of
future invasive CV interventions. To be able to determine which threat is most relevant,
both threat of CHD and threat of future invasive CV interventions were included in this
study. Threat of CHD was measured with the heart disease threat scale (Kimble, 1998),
and perceived threat of future CV interventions was measured with two subscales
(Susceptibility and Seriousness) of the Champion Health Belief Model Scale (CHBMS)
(Champion, 1984).
Perceived threat of heart disease. The Heart Disease Threat Scale (HDTS) is a
10-item Likert-type scale adapted by Kimble (1998) from Champion‟s Health Belief
Model Scale (1984). This study adopted Kimble‟s definition of threat of heart disease
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which is “the degree to which participants appraise heart disease as threatening to wellbeing now or in the future”. Sample items from this scale included “The thought that I
really do have heart disease scares me”, and “I feel insecure about my future because of
my heart disease”. Each item response was scored from 1 (strongly disagree) to 5
(strongly agree), and the ten item scores were summed and averaged to reflect a possible
range of total score of one to five. Higher scores on this scale indicated greater perceived
threat of heart disease (Kimble).
The HDTS has shown adequate reliability and validity (Kimble 1998; Rosenfeld,
2004). Internal consistency of the scale was adequate (Cronbach‟s alpha coefficient
ranged from 0.85 to 0.91) at three time points in one study of PCI patients (Kimble), and
in another study of women with MI (Rosenfeld). Content validity was established with
the use of content experts (Kimble).
Perceived threat of future invasive CV procedure. Perceived threat of a future
invasive CV procedure was measured with the Threat to Future Cardiovascular
Interventions Scale (TFCIS). This adapted scale was comprised of two subscales of the
Champion Health Belief Model Scale (CHBMS), perceived susceptibility and
seriousness. The full CHBMS is a 39-item Likert-type scale originally developed in 1984
to measure HBM constructs among breast self exam practices in women. Subscales of
the CHBMS include susceptibility, seriousness, benefits, barriers, and motivation.
As indicated by the HBM, the threat of an illness has two components: one‟s
perceived susceptibility and seriousness (Rosenstock, 1974). Therefore, the items on the
Susceptibility and Seriousness subscales were modified to capture the perceived threat of
future invasive CV procedures. The original stem of each question was used and the
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terms “breast cancer” were replaced with “future heart procedures”. During instrument
development, Champion indicated that perceived susceptibility “refers to the subjective
risks of contracting a specific condition within a specified time period”, and that
perceived seriousness “is concerned with perceived degree of personal threat related to a
specific condition” (Champion, p.77, 1984). Threat was then defined as “perceived
harmful consequences of the condition in relation to altering personal physical health,
role and social status, and ability to complete desired tasks”. Sample items from the
Susceptibility subscale include “My chances of future heart procedures are great” and
“My physical health makes it more likely that I will have future heart procedures”.
Sample items from the Seriousness subscale include “The thought of future heart
procedures scares me” and “If I had future heart procedures, my whole life would
change”.
The “Susceptibility” subscale consists of six items, and each item response is
scored from 1 (strongly disagree) to 5 (strongly agree). The “Seriousness” subscale
consists of 12 items, and each item response was scored from 1 (strongly disagree) to 5
(strongly agree). Previous studies have reported the total CHBMS score for subscales
combined, and this is how it was used in the current study. Total scores ranged from 1890 in the current study, and higher scores indicated higher perceived threat of future
invasive CV procedures.
Reliability and validity of the CHBMS and subscales have been established
(Champion, 1984; Gozum & Aydin, 2004; Lee, Kim, & Song, 2002; Parsa, Kandihah,
Nasir, Hejar, & Nor Afiah, 2008). Test-retest reliability was established with the
administration of the CHBMS two weeks apart, and the correlation for the Susceptibility
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subscale at these time points was 0.86, and for the Seriousness subscale at these time
points was 0.76 (Champion, 1984). Internal consistency of the Susceptibility subscale
was adequate and Cronbach‟s alpha coefficient ranged from 0.69 to 0.92 (Champion,
1984; Gozum & Aydin, 2004; Lee et al., 2002; Parsa et al., 2008). Internal consistency
of the Seriousness subscale was adequate and Cronbach‟s alpha coefficient ranged from
0.73 to 0.86 (Champion; Lee et al., 2002; Gozum & Aydin; Parsa et al.). Content validity
was established with the use of content experts, and construct validity for the entire scale
was established through a principal component factor analysis which yielded five
mutually exclusive factors (Susceptibility, Seriousness, Barriers, Benefits, and Health
Motivation) (Champion). These factors were confirmed with three additional factor
analyses (Lee et al.; Gozum & Aydin; Parsa et al.).
Depressive Symptoms
Depressive symptoms were measured using the Center for Epidemiologic Studies
Depression Scale (CES-D) (Radloff, 1977). The CES-D is a widely used and concise
self-report, screening measure of depression (Boutin-Foster, 2008; Clark, Mahoney,
Clark, & Eriksen, 2002; Hann, Winter, & Jacobsen, 1999; Radloff, 1977; Radloff & Teri,
1986). This instrument is a 20-item, 4-point Likert-type scale which includes six major
symptoms areas: depressed mood, guilt/worthlessness, helplessness/hopelessness,
psychomotor retardation, loss of appetite, and sleep disturbance (Frank-Stromborg &
Olsen, 2004). Each item response indicated how often in the past week the respondent
has felt or behaved depressive symptoms, and ranged from 0 (rarely or none of the time)
to 3 (most or all of the time). Sample items include “I was bothered by things that
usually don‟t bother me”, and “I was happy”. The sum of all items yielded a possible
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total score of 0 to 60, with higher scores indicating the presence of more depressive
symptoms. Reversed scoring was used for positive items (questions 4, 8, 12, and 16). A
score of 16 or higher is suggestive of possible clinical depression, and in the current study
participants were referred to their primary health care provider for further depression
evaluation (Radloff, 1977).
The reliability and validity of the CES-D has been established among various
clinical populations (Boutin-Foster, 2008; Clark et al., 2002; Hann, Winter, & Jacobsen,
1999; Radloff, 1977; Radloff & Teri, 1986). The CES-D demonstrates adequate internal
consistency, with Cronbach‟s alpha coefficients ranging from 0.85 to 0.92 (BoutinFoster; Clark et al.; Hann et al.; Winter, & Jacobsen; Radloff; Radloff & Teri). Testretest reliability was established with the administration of the CES-D 2.5 weeks apart,
and the correlation at these time points was 0.57 for the treatment group and 0.51 for the
comparison group (Hann, Winter, & Jacobsen, 1999), although Radloff (1977) suggests
that levels of depression symptoms would expect to vary over time and would therefore
reduce test-retest reliability, especially over longer periods. Construct validity was
initially established through a principle components factor analysis, which revealed four
factors: depressed (negative) affect, positive affect, somatic, and interpersonal (Radloff),
and has been subsequently supported (Clark et al.).
Motivation to Quit Smoking
Motivation to quit smoking was measured using the Treatment Self-Regulation
Questionnaire (TSRQ) (Williams et al., 1996). The TSRQ is a 12-item, 7-point Likerttype scale which is based on the Self-Determination Theory and relates to the reasons
why people engage in healthy behaviors such as smoking cessation, and assesses the
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degree to which one’s motivation to stop smoking is self-determined (or autonomous).
The TSRQ contains two subscales: the autonomous motivation (6 items), which
represents the most self-determined form of motivation, and controlled motivation
subscales (6 items). Each item response ranged from 1 (not true at all) to 7 (very true).
Each of the 12 items complete the statement: “The reason I would not smoke is…” and
sample items include “Because I personally believe it is the best thing for my health”, and
“Because it is an important choice I really want to make”. The responses from the
autonomous motivation subscale were averaged to reflect an autonomous motivation
score, and the responses from the controlled motivation subscale were averaged to reflect
a controlled motivation score. The subscale scores can be used separately, or can be
combined into the Relative Autonomous Motivation Index by subtracting the average for
the controlled reasons from the average for the autonomous reasons. The autonomous
subscale has been reported (Williams et al., 1996). Higher autonomous (or controlled)
scores indicated greater autonomous (or controlled) motivation to stop smoking
(Williams et al., 1996).
The reliability and validity of the TSRQ has been established with various health
behaviors, including smoking cessation, diet, exercise adherence, and alcohol treatment
(Williams et al., 1996; Williams et al.; Ryan, Plant, & O‟Malley, 1995). The TSRQ
demonstrates adequate internal consistency, with Cronbach‟s alpha coefficients ranging
from 0.88 to 0.89, as well as the autonomous subscale separately (0.81-0.85) and
controlled subscale separately (0.80 to 0.86) (Williams et al., 1996; Williams et al., 1998;
Ryan et al., 1995). Construct validity for the entire scale was established through a
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principal component factor analysis which yielded two mutually exclusive factors
(Autonomous Reasons and Controlled Reasons) (Williams et al., 1996).
Individual and Clinical Characteristics of Participants
A structured questionnaire was developed to obtain information about each
participant‟s age, marital status, ethnicity/race, income, education, occupation, medical
history, cardiac history, menopause history, smoking history, and exercise routine. The
primary sources for this information were the patient‟s medical record and patient selfreport. The cardiac history included whether the participant had ever had an MI, previous
PCI or CABG, stent, family history of CHD, or other CV history such as peripheral
vascular disease, and the participant‟s ejection fraction %. Smoking history included the
number of years smoking, the number of cigarettes smoked per day, previous smoking
cessation advice received, and quit attempt history. A quit attempt was defined in this
study as making a serious attempt to stop smoking for good that lasted at least 24 hours
within the past three months. A list of current medications, including prescription and
over-the-counter, was obtained. Also included was a one-item question of who the
participant turns to for advice about her health as well as a one-item rating of: how likely
the participant was to stop smoking after the procedure, the participant‟s intention to stop
smoking after the procedure, how stressful the procedure was, how stressful it was related
to other stressful life events, and whether the participant‟s physical health is important to
the participant. A 5-point Likert-type scale was used for these questions, with a rating of
1 (strongly disagree) to 5 (strongly agree).
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Procedures
After obtaining institutional review board approval from all sites, potential
participants who met eligibility criteria were identified. Cardiac units, Catheterization
laboratories, Cardiovascular Intensive Care unit (CVICU), step-down CVICU units, and
Cardiac Rehabilitation units were used as sites for recruiting, as patients undergoing
CABG surgery or PCI may have been transferred to these units according to their
condition following their CV procedure. To identify eligible participants within the
hospital, the researcher requested a Health Insurance Portability and Accountability Act
(HIPPA) waiver to review medical records for potential participants. The medical
diagnoses, procedures, past and current surgical and medical history, and smoking history
were obtained from the medical record. Referrals from hospital employees such as
charge nurses and physician‟s personal staff were also used to identify potential
participants.
For potential participants undergoing an invasive CV intervention, the researcher
or assistant approached them at bedside when the patient‟s medical condition was stable
as determined by the potential participant‟s nurse following recovery from their
procedure and prior to discharge. A stable condition was defined by stable vital signs,
mental consciousness, and controlled angina whereby emergent CABG surgery was not
necessary. To maximize recruitment efforts and meet HIPAA requirements when the
researcher or research assistant were not present, postcards were printed for discharge
nurses on each unit to ask potential participants about their willingness to be contacted by
the researcher after discharge. If participants agreed, they completed the postcard and left
it with the discharge nurse. The researcher collected the postcards from the discharge
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nurses and contacted the potential participants at the place and time designated on the
postcard to set up a data collection time via telephone.
Written informed consent was obtained from each woman by the researcher or
research assistant. Dates from initial participant recruitment to the completion of the
study were provided to each woman. Each woman who agreed to participate was
administered a set of questionnaires either after the invasive procedure or during the time
surrounding their procedure or within one week following discharge to the community.
The time to complete questionnaires at T1 was approximately 30 to 45 minutes and 20
minutes by telephone at T2. The researcher informed the participants that a reminder
card would be mailed to their address to serve as a reminder that the researcher would
contact them again via telephone in three months to obtain their smoking status. The
researcher mailed the reminder cards approximately eight to ten weeks following the
participant‟s hospital discharge, and then contacted them via telephone 3 months
following hospital discharge. When the T2 interview took place, the researcher set up a
telephone interview or a mutually convenient place to meet participants at a location
deemed convenient and private by them. This follow-up telephone conversation required
a time commitment of approximately 20 minutes in order to determine smoking status
and smoking cessation experiences post-hospitalization. During the follow-up telephone
conversation, if the participant disclosed any medical information to the researcher which
required medical attention, the researcher referred the participant to their medical
provider or to the Emergency Room as appropriate.
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Protection of Human Subjects
Prior to participant recruitment, the study protocol was approved by three
Institutional Review Boards (IRBs): Georgia State University, The Medical Center of
Central Georgia, and Georgia College & State University. Included in the protocol for
each IRB was: statement of the problem, procedures, risks and discomforts, benefits,
alternatives, time and duration of study, compensation, and a statement of confidentiality.
Participation in this study was voluntary, and participants could have withdrawn at any
time. Potential participants were assured that participation in this study would have no
bearing on their medical care. Informed consent was obtained from each potential
participant prior to enrollment in this study. Compensation for participation included a
$5 gift card after completion of the initial interview and an additional $5 gift card which
was mailed to their address upon their study completion. The study participants did not
incur any costs except their time to complete questionnaires.
No foreseeable risks to participation in this study had been identified other than
possible fatigue and that discussion of their illness and possible future procedures may
have been distressing. If the participant expressed fatigue or if a respite was requested
by the participant or HCP, a respite was provided. The burden of completing the
questionnaires was assessed after the first ten participants were enrolled, and a one-item
Likert-type scale was used to determine whether completing the questionnaires was 0
(not burdensome) to 5 (too burdensome to complete). If the participant expressed
discussing his/her illness is distressing, a referral was made to their local health provider
or mental health clinic. If the participants‟ scores on the CES-D indicated marked distress
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exceeding the cut-off score of 16, the researcher referred the participants to their medical
provider for further depression evaluation.
Identification numbers for each participant were assigned in order to maintain
confidentiality. The researcher had access to the roster of participant names and
identification numbers. The participant roster and identification numbers were kept in a
locked file cabinet separately from the data. The participant roster and identification
numbers, as well as all data, will be destroyed one year following study completion.
Overview of Data Analysis
Data from completed questionnaires were entered by the researcher into SPSS
16.0 Graduate Pack for analysis and double checked for completeness and accuracy.
Frequency distributions were examined to assess for coding and/or data entry errors.
Reliability of each instrument was examined with Cronbach‟s alpha after at least ten
packets of instruments were completed to ensure internal consistency of each instrument.
Each interval/ratio level variable was examined for normal distribution to determine
whether parametric or non-parametric testing was appropriate and for missing data. For
single items missing from multiple-item questionnaires, subject mean replacement was
used. An alpha of p <0.05 was used to determine statistical significance. Pearson‟s
Product Moment Correlations for main variables of the study and participant
characteristics were examined for potential covariates. If a variable was significantly
related to the outcome variable, the variable was treated as a covariate and was entered in
first step of hierarchical regression. Main variables of the study were also examined for
multicollinearity with Pearson‟s Product Moment Correlations. Descriptive statistics
were used to describe the sample.
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Hypothesis Testing
Hypothesis One
Hypothesis one (Higher perceived threat of CHD and higher perceived threat of
future cardiovascular interventions will be associated with commitment to stop smoking,
controlling for depression) was tested using Hierarchical Multiple Linear Regression. All
variables in this hypothesis were continuous.
Hypothesis Two
Hypothesis two (Receiving cues to action about smoking cessation from a HCP
will be associated with higher perceived threat of future CV interventions) was tested
with a Pearson‟s Product Moment Correlation. All variables in this hypothesis were
continuous.
Hypothesis Three
Hypothesis three (Higher perceived threat of future CV interventions, higher
perceived threat to CHD, higher smoking cessation self-efficacy, and fewer perceived
barriers will be associated with greater commitment to stop smoking (T1), controlling for
depression) was tested with a hierarchical regression. All variables in this hypothesis
were continuous.
Hypothesis Four
Hypothesis four (Those with greater commitment to stop smoking after an
invasive CV procedure will report higher smoking cessation rates at three months than
those with lower commitment to stop smoking) was tested with a Pearson‟s Product
Moment Correlation. All variables in this hypothesis were continuous.
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Hypothesis Five
Hypothesis five (Fewer perceived barriers to smoking cessation, greater perceived
threat of future CV interventions, greater perceived threat of CHD, receiving cues to
action, fewer depressive symptoms, and higher smoking cessation self-efficacy will be
associated with higher commitment to stop smoking (T1) was tested with a hierarchical
regression. All variables in this hypothesis were continuous.
Hypothesis Six
Hypothesis six (Fewer perceived barriers to smoking cessation, greater perceived
threat of future CV interventions, greater perceived threat of CHD, greater perceived
benefits of smoking cessation, receiving cues to action, fewer depressive symptoms,
higher smoking cessation self-efficacy, and higher commitment to stop smoking will be
associated with quitting smoking at 3 months) was tested with binary logistic regression.
The outcome variable, smoking cessation, was a dichotomous variable, and the predictor
variables were continuous.
Research Questions
Research questions one (What benefits and barriers to smoking cessation are
perceived among women smokers receiving an invasive cardiovascular procedure?), two
(What cues to action are received among women smokers receiving an invasive
cardiovascular procedure?), three (Is there a change in depressive symptoms from an
invasive CV intervention to three months following the invasive CV intervention?), and
four (Are depressive symptoms (T2) associated with increased commitment to stop
smoking (T2)?) were examined with descriptive statistics. Descriptive statistics analyzed
depended on the level of measurement for each variable, but included frequencies for

81
nominal level data, frequencies, and measures of central tendencies (mean (SD), median,
mode) for interval/ratio level data.

CHAPTER IV
Results
The results of this prospective correlational study of commitment to quit smoking
and smoking cessation in women smokers with CHD undergoing an invasive CV
procedure are presented in this chapter. A description of pre-analysis data screening
procedures, description of sample characteristics, findings from the questionnaires, and
hypothesis testing and research questions are reported.
Between April and July 2010, 725 women undergoing a heart catheterization (n=
697) and CABG surgery (n= 28) were screened for eligibility criteria. Figure 1 provides
details of screening and response rates. Of the women undergoing a heart catheterization,
approximately one fifth of women were smokers. Of these women smokers, 63.7% met
all eligibility criteria. Of these women smokers who were eligible for the study, 86.3%
agreed to participate in the study and completed surveys at T1 (N=76). At T2 (three
months post heart catheterization), 54 women were reached via telephone by the
investigator. Two declined to complete the study and the remaining participants were
lost to follow-up either because their telephone was not working or the telephone call was
not returned after three messages were left for the participant for a 28.9% attrition rate.
Of the 28 screened women smokers undergoing a CABG surgery, only three met
inclusion criteria and none agreed to be in the study. Reasons these women gave for not
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participating in the study included “not feeling well”, “too tired”, and “I don‟t fill out
surveys”. The first ten participants enrolled in this study viewed participation as a low
burden (M = 2.10, SD = .88) on a 5 point Likert-type scale.
Study Response Rate at Study Enrollment and Three Month Follow up
Women screened post heart
catheterization (n=697)
n = 697
Smokers 19.8%
(n = 138)
Met Eligibility Criteria
63.7% (n =88)

Women screened post
CABG surgery
(n = 28)
Met Eligibility Criteria
11%
(n = 3)
Enrolled
at Time 1
0% (n =0)

Enrolled at Time 1: 86.3% (N = 76)
Declined at Time 1:13.6% (n =12)

Completed Time 2 Follow up 71.1%
(N = 54)
Total Attrition: 28.9% (n =22)
(Lost to Follow-up T2 (n =20)
(Declined to Continue T2 (n =2)
Figure 2. Response Rate for Women Smokers Undergoing an Invasive Cardiovascular
Procedure
Characteristics of those who remained in the study at T2 (n = 54) were compared
to those who did not (n = 22) (Table 1). Chi-Square statistics were conducted to examine
differences in race, marital status, annual household income, education level, work status,
history of heart catheterization, history of MI, and other smokers in the home. No
statistical differences were noted between the two groups. Independent samples t-tests
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were conducted to examine differences in participant age, the number of years smoked,
the number of daily cigarettes smoked, and the total scores from major concepts of the
HBM (CQSS, SEQ-12, PBQ, BCS, CTAS, HDTS, TFCIS, CES-D, and TSRQ). No
statistical differences were noted between the two groups.
Table 1
Comparison of Participant Characteristics for Completers and Non-Completers

Variable
Age in years
Relationship status
Single
In a Relationship
Race/Nationality
White
Non White
Education
Less than High School
High school graduate
More than high school
Income Level
Less than $30,000
Greater than $30,001
Work Status
Working
Not working
Other smoker in home
Yes
No
History of MI
Yes
No
History of heart
Catheterization
Yes
No
Years Smoked
Number of Daily
Cigarettes

Completed T2
n = 54
%/M (SD)
56.3 (7.42)
48.1
51.9

Dropped Out T2
n = 22
%/ M(SD)
54.8 (9.35)

t statistic/χ2
.78
.61

54.5
45.5
.45

68.5
31.5

77.3
22.7

27.8
25.9
46.3

22.7
31.8
45.5

71.2
28.8

60.0
40.0

24.1
75.9

36.4
63.6

.84

.36

.28

.88
51.9
48.1

50.0
50.0

33.3
66.7

45.5
54.5

.32

.21
57.4
42.6
33.6 (11.02)
15.6 (9.70)

72.7
27.3
33.8 (7.92)
14.8 (10.25)

.10
.31

(Table 1 Continued)
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(Table 1 Continues)
CQSS
SEQ
PBQ
BCS
CTAS
HDTS
TFCIS
CES-D
TSRQa

28.8 (6.42)
40.8 (12.23)
130.9 (15.34)
20.1 (11.31)
2.56 (1.16)
3.52 (.72)
56.3 (10.79)
19.8 (14.71)
55.3 (18.56)

28.3 (4.43)
38.1 (9.36)
131.9 (13.14)
20.6 (12.17)
2.59 (1.10)
3.72 (.52)
56.3 (9.56)
20.0 (13.27)
57.5 (17.26)

.32
.94
.27
.16
.12
1.30
.00
.07
.48

Note: No statistically significant differences on any variable. CQSS= Commitment to Quitting Smoking
Questionnaire; SEQ-12 = Smoking Self-Efficacy Questionnaire; PBQ= Perceived Benefits Questionnaire;
BCS= Barriers to Cessation Scale; WCSS= Weight Control Smoking Scale; CTAS= Cues to Action Scale;
HDTS= Heart Disease Threat Scale; TFCIS= Threat of Future CV Interventions Scale; CESD= Center for
Epidemiologic Studies Depression Scale; TSRQa= Autonomous Subscale of Treatment Self-Regulation
Questionnaire.

Sample Characteristics
Table 2 summarizes descriptive statistics for women smokers undergoing an
invasive CV intervention. The majority of participants were middle-aged, with ages
ranged from 41 to 74 years old, married, and White. About half of the women had high
school or less educational levels. For statistical analysis, technical and/or trade school
was combined with partial college education. Most participants‟ total household income
was less than $40,000, with almost one third living on an income of less than $10,000
annually. A large majority were retired, disabled, or unemployed. Most women lived
with spouses or with other family members such as siblings or children.
Table 2
Post Heart Catheterization Women Smokers’ Characteristics (N = 76)
Characteristic
Age (years)

M

(SD)

55.9

(7.99)

n

(%)

Marital Status
Single

12 (15.8)

Married/Long-Term Relationship

38 (50)

Divorced/Separated

15 (19.7)
(Table 2 Continued)
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(Table 2 Continues)
Characteristic

M

Widowed

(SD)

n

(%)

11 (14.5)

Race / Ethnicity
White

54 (71.1)

Black/African American

20 (26.3)

Asian

1

(1.3)

American Indian/Alaskan Native

1

(1.3)

Highest Level of Education
Less than High School Graduate

20 (26.3)

High School Graduate

21 (27.6)

Some College/ Trade/Technical School

24 (31.6)

College Graduate/Post Graduate Study

11 (14.5)

Annual Household Income (n=73)
Less than $10,000

23 (31.5)

$10,001-$40,000

33 (45.2)

$40,001-$50,000

4

Greater than $50,000

13 (17.8)

(5.5)

Work Status
Full-Time

17 (22.4)

Part-Time

4

Retired/Unemployed/Disabled

55 (72.4)

(5.3)

Lives With
Alone

10 (13.2)

Spouse/Domestic Partner/and Children/Other

29 (38.1)

Other (i.e. Children, Sibling)

37 (48.7)

Note. n varied due to missing data.

Table 3 presents health characteristics of women smokers undergoing a heart
catheterization. Almost all women were post-menopausal. While all women had CHD,
almost three fourths also had been diagnosed with hyperlipidemia and hypertension.
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Table 3
Post Heart Catheterization Women Smokers’ Health Characteristics (n = 76)
Health Characteristic

M

(SD)

N

(%)

Has Not Tried to Quit in Past Three Months

46

(60.5)

Tried to Quit in the Past Three Months

30

(39.5)

Tried 1-3 Times to Quit

28

(93.3)

Tried More than Three Times to Quit

2

(0.7)

Doctor

53

(69.8)

Family

50

(65.8)

No One

6

(8.3)

Myocardial Infarction

28

(36.8)

Previous Heart Catheterization

47

(61.8)

Stent

28

(36.8)

Coronary Artery Bypass Grafting Surgery

10

(13.2)

Chest Pain

54

(71.1)

Family History of CHD

58

(76.3)

Congestive Heart Failure

16

(21.1)

Peripheral Vascular Disease

14

(18.4)

Cerebral Vascular Accident

17

(22.4)

Hypertension

55

(72.4)

Peri-Menopausal

9

(11.8)

Post-Menopausal

67

(88.2)

Diabetes Mellitus

22

(28.9)

Hyperlipidemia

55

(72.4)

Smoking History (years)

33.6

(10.15)

T1 Daily Cigarettes (number)

15.33

(9.8)

Smoking History

a

a

Who Has Talked to Participant About Quitting

Cardiac History
Previous Procedures / Conditions

Current CHD Symptoms and Risk Factors

Other

Ejection Fraction

54.9%

(12.9)

Menopause History

a

Co-Morbidity

(Table 3 Continued)
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Health Characteristic

a

M

(SD)

N

(%)

Arthritis

49

(64.5)

Pulmonary Disease (COPD, Asthma)

31

(40.8)

Gastrointestinal Disease

29

(38.2)

Anti-Hypertension

56

(73.7)

Cholesterol

42

(55.3)

Anti-Platelet

49

(64.5)

Anti-Depressant

28

(36.8)

Anti-Anxiety

20

(26.3)

19

(25)

Antacid

29

(38.2)

Hormone Replacement Therapy

13

(17.1)

Pain

26

(34.2)

None

42

(55.3)

1-2 Times Weekly

10

(13.1)

3 or More Times Weekly

24

(31.6)

Current Medications (n=72)
CHD Risk Reduction

Mental Health

Pulmonary
Inhaler
Other

Typical Frequency of Exercise

Note. n varied due to missing data. aParticipants could indicate more than one category

Participants reported taking on average 3.7 (SD = 1.92) types of medications.
Over two thirds of participants were taking medications for hypertension. More than half
were taking medications for lowering cholesterol and to inhibit thrombus formation.
More than one third of participants reported taking medications for depression and pain,
with almost one quarter taking medications for anxiety. Other medications included
inhaler medications and hormone replacement therapy, with no women taking weight loss
medications.
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Table 4
Description Women Smokers’ Previous Quit Attempts Three Months Prior to Procedure
(n = 30)
Quit Attempt Characteristic

n

(%)

Quit Aids Prior to Heart Catheterization
Tried to Quit Cold Turkey

11 (36.7)

Tried to Quit Using Varenicline

9

(30)

Tried to Quit with Patch

4

(13.3)

Tried to Quit with Gum

4

(13.3)

Tried to Quit by Cutting Down

4

(13.3)

Zyban

3

(10)

Other

3

(10)

Change Smoking Location/Who You Smoke Around

2

(6.7)

Prompted Participant to Try to Quit (n=30)
Health

22 (73.3)

Made Up My Mind/ Tired of Smoking

8

(26.7)

Family/Peer Pressure

5

(16.7)

Note. Participants could indicate more than one category

On average, participants had a long smoking history of over 30 years.
Participants smoked a daily average of about three fourths of a pack of cigarettes at T1
(M =15.3, SD = 10.2), and at T2 (M = 10.6, SD = 8.5) this was significantly reduced to
about half a pack on average per day, paired t(51) = 3.43, p < .01. Participants reported
being somewhat likely to quit smoking following their invasive procedure (M = 3.53, SD
= 1.13) and had some intention of stopping smoking following their procedure (M = 3.79,
SD = 1.14) on a 5 point Likert-type scale. The majority of women had not tried to stop
smoking within the three months prior to their heart catheterization. Of those who had
attempted to quit (n = 30) the majority reported trying to quit one to three times with no
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success. However, women who reported a previous quit attempt also reported
significantly higher commitment to stop smoking t(74) = 2.13, p = .04 (M = 30.5, SD =
5.9) versus women with no previous quit attempt (M = 27.6, SD = 5.6), significantly
higher perceived benefits to stopping t(73) = 3.10, p = .003 (M = 137.0, SD = 10.8)
versus no attempt (M = 127.6, SD = 15.6), and significantly higher perceived threat of
future CV interventions t(73) = 2.41, p = .02 (M = 59.8, SD = 9.7) versus no attempt (M
= 54.1, SD = 10.3). No participants reported trying to quit smoking specifically in
preparation for their heart catheterization. The two most common strategies used to try
and quit smoking were “cold turkey”, or abruptly stopping something one has been
dependent on or addicted to without any aid, and pharmacological varenicline (e.g.
Chantix®) (Table 4). Participants reported the reason for wanting to quit smoking was
their health. Participants reported that their physical health was very important to them
(M = 4.64, SD = .48) on a 5 point Likert-type scale. Half of participants (51%) indicated
living with another smoker in the home, most often being the spouse/significant other
(30%) or children (17%). More than half (66%) of the women reported that their
physician and/or family members had talked to them about quitting smoking.
Descriptive Statistics for Major Study Variables
Pre-analysis data screening was conducted prior to statistical analysis and
included screening for errors of data entry, outliers, normal distribution, multicollinearity,
and missing data. Normality was assessed for all interval/ratio level variables by
analyzing skewness, kurtosis, histograms, and box plots as outlined by Munroe (2005)
and Field (2005). Screening indicated that all variables were normally distributed except
the Perceived Benefits Questionnaire (PBQ), which was negatively skewed, and the
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Weight Control Smoking Scale (WCSS), which was positively skewed. Because the
PBQ was included for descriptive purposes in the research questions and not part of the
hypotheses, no log transformation was calculated. A square root and natural logarithmic
transformation was conducted on the WCSS variable and normal distribution was not
achieved. Therefore, responses were dichotomoized where 0= no concerns about weight
(scored zero on the WCSS) (n = 62, 81.6%) and 1= concerns about weight (scored greater
than zero on the WCSS) (n = 14, 18.4%).
Concepts of the Health Belief Model
Table 5 displays descriptive statistics for all instruments representing theoretical
concepts, including commitment to stop smoking, smoking cessation self-efficacy,
perceived benefits to smoking cessation, perceived barriers to smoking cessation
(including fear of smoking related weight gain), cues to action, perceived threat of heart
disease, perceived threat of future invasive CV interventions, depressive symptoms, and
motivation to stop smoking. Internal consistency reliability coefficients also are
presented in Table 5 for the instruments and all had acceptable Cronbach‟s alpha
coefficients except for the Cues to Action scale. The Cues to Action scale data were
examined including the item-to-correlations; however, removing items did not
sufficiently increase the reliability coefficient. Therefore, although the Cues to Action
Cronbach‟s alpha coefficient was low, the decision was made to include it in the
hypotheses testing. The motivation measure had two subscales, one representing level of
autonomous motivation and the other level of controlled motivation. Because the
subscales were strongly and positively correlated with each other (r = .63, p<.001) and
the autonomous motivation subscale was more highly correlated to commitment to stop
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smoking (r = .60, p<.001) (dependent variable) than the controlled subscale (r = .37,
p<.01), a decision was made to use the autonomous motivation subscale for the
subsequent analysis.
Table 5
Descriptive Statistics and Cronbach’s Alpha for Theoretical Variables at Time of
Invasive CV Procedure (T1) and 3 Month Follow Up (T2)a
Variable

Observed Possible Cronbach’s
Range
Range
Alpha

M

(SD)

28.66

(5.89)

8-40

8-40

.92

Commitment to Stop
Smoking(CQSS) (T2)

29.19

(7.49)

8-40

8-40

.95

Smoking Cessation Self
Efficacy (SEQ-12)

39.99

(11.48)

12-60

12-60

.89

Perceived Benefits to Smoking
Cessation (PBQ)

131.14 (14.66)

93-147

21-147

.91

Perceived Barriers to Smoking
Cessation (BCS)

20.22

(11.48)

1-46

0-57

.84

Fear of Weight Gain (WCSS)

1.7

(2.66)

0-9

0-9

.88

Cues to Action (CTAS)

2.57

(1.14)

2-5

0-5

.55

Perceived Threat of Heart
Disease (HDTS)

3.58

(0.67)

2-5

1-5

.81

Perceived Threat of Future
Invasive Cardiovascular
Interventions (TFCIS)

56.31

(10.38)

36-79

18-90

.83

Depressive Symptoms

19.38

(14.21)

0-53

0-60

.92

11.98

(10.77)

0-45

0-60

.88

Commitment to Stop Smoking
(CQSS) (T1)

(CES-D) (T1)
Depressive Symptoms
(CES-D) (T2)
(Table 5 Continued)
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Autonomous Motivation to
Stop Smoking (TSRQa)

5.56

(1.52)

1-7

1-7

.78

Controlled Motivation to Stop
Smoking (TSRQc)

3.74

(1.83)

1-7

1-7

.75

a

N for T1 = 76, N for T2 = 54.

Commitment and self-efficacy to stop smoking. Women smokers undergoing a
heart catheterization on average had commitment to stop smoking scores (CQSS) that fell
above the midpoint of the scale at T1, indicating a high level of commitment to stop
smoking. At T2 women‟s commitment to stop smoking (CQSS) scores were not
significantly different from T1, paired t(53) = .37, p = .76.
Participants were also asked about their confidence in being able to stop smoking
(SEQ-12). On average women reported high self efficacy to stop smoking. (Table 5)
Perceived benefits vs. barriers to smoking cessation. Women on average
recognized the benefits of smoking cessation (PBQ) and reported few barriers (BCS) to
smoking cessation (Table 5). In addressing Research Question 1, the three highest rated
benefits perceived by women were smelling cleaner (M= 6.79, SD = .58), having fresher
breath (M= 6.78, SD = .58), and that others would be proud that they could quit smoking
(M= 6.78, SD = .69). The three barriers rated highest were receiving no encouragement
at work for smoking cessation (M= 2.67, SD = 1.87), being addicted to cigarettes (M=
1.8, SD = 1.31), and having withdrawal symptoms (M= 1.57, SD = 1.28). Women were
asked about a specific barrier, fear of weight gain with smoking cessation (WCSS). On
average, women reported little fear of weight gain with smoking cessation. Because of
problems with normal distribution of this variable, it was dichotomized and most (82%)
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women did not have concerns about weight gain related to smoking cessation and 18%
had some concern.
Cues to action received from HCP. To address Research Question 2,
participants were then asked about their cues to action from health care professionals
about stopping smoking (CTAS). See Table 6. Because the amount of assistance and
support that women received to stop smoking is of interest clinically, the percentage of
women responding “yes” to these items are reported in Table 6. On average women
reported receiving some information from HCP (Table 5); however, for the vast majority
of women this help was primarily in the form of asking if the participant smoked and
advising them to stop smoking (Table 6). Slightly less than half of the women were
asked by their HCP if they were willing to stop smoking and only one third of their HCPs
offered them assistance to stop smoking. Few women reported their HCPs scheduled a
follow-up appointment for them specifically about their smoking.
Table 6
Descriptive Statistics for Cues to Action Received from HCP
Cue to Action

n

(%)

Asked if Participant Smoked

75 (98.7)

Advised to Stop Smoking

58 (76.3)

Asked if Participant is Willing to Stop Smoking 32 (42.1)
Offered Assistance with Stopping Smoking

26 (34.2)

Follow-Up Appointment Scheduled

4

(5.3)

Heart disease threat vs. threat of future invasive procedures. Women were
asked about their perceived threat of heart disease (HDTS) and threat of future invasive
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cardiovascular interventions (TFCIS) to differentiate disease threat from procedure threat.
Most women reported high perceived threat of heart disease and high threat of future
cardiovascular interventions. Participants reported the current invasive CV procedure as
being somewhat stressful (M = 3.64, SD = 1.33), but not more stressful than other life
stressors (M = 2.74, SD = 1.14) on a 5 point Likert-type scale.
Depressive symptoms and motivation to stop smoking. Depressive symptoms
were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). To
address Research Question 3, depressive symptoms were measured at T1 and T2. At T1
more than half (55%) of the sample scored above the cut-off score of ≥ 16 on the .CES-D
(Table 5), indicating high levels of depressive symptoms. However, depressive
symptoms at T2 on average were lower than the cut-off score and were significantly
lower than T1, paired t(52) = 4.84, p < .001). At T2, 35.2% of women had scores ≥ 16 on
the CES-D, indicating high levels of depressive symptoms.
Finally, participants were asked about the degree to which their motivation to stop
smoking was autonomous (internal) versus controlled (external) using the Treatment
Self-Regulation Questionnaire (TSRQ). Women had high autonomous motivation and
moderate controlled motivation to stop smoking.
Relationships among Descriptive Characteristics and Major Study Variables
Bivariate correlations were used to examine relationships among women
smoker‟s characteristics and the theoretical variables (Tables 7and 8). Because all major
variables were normally distributed except Perceived Benefits to Smoking Cessation,
Pearson‟s product moment correlation coefficients (r) were calculated and are reported in
Tables 7 and 8. Spearman‟s rho correlation coefficients (rs) were calculated and are
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reported for the Perceived Benefits variable. Commitment to stop smoking was not
associated with any demographic or clinical characteristics of the women except the
number of daily cigarettes at T1 and T2. Therefore, the number of cigarettes at T1 was
included as a covariate in hypothesis testing.
Relationships among Theoretical Variables at T1
Greater commitment to stop smoking (T1) was associated with smoking fewer
cigarettes, more confidence in their ability to stop smoking, perceiving more benefits to
smoking cessation, and perceiving fewer barriers to smoking cessation. Higher perceived
threat of CHD and of having a future CV intervention was associated with higher
autonomous motivation to stop smoking. Greater confidence to stop smoking was
associated with smoking fewer cigarettes per day and being more likely to stop smoking
at three months. Perceiving more benefits of and fewer barriers to quitting smoking was
associated with being more autonomously motivated to stop smoking. Perceiving greater
benefits to smoking cessation was associated with higher perceived disease threat and
threat of having a future CV intervention, and being more autonomously motivated to
stop smoking. Fewer perceived barriers to smoking cessation was associated with
smoking for less years, having fewer concerns of weight gain, and fewer depressive
symptoms. Receiving more cues to action from their HCP was associated with smoking
for fewer years, perceiving more threat of future CV interventions, and being more
autonomously motivated to stop smoking. Women who were more threatened by their
CHD also reported taking anti-anxiety medications, greater depressive symptoms, were
more autonomously motivated to stop smoking, and perceived higher threat of having
future CV interventions. Likewise, women who were threatened by future CV
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interventions also reported taking anti-anxiety medications, greater depressive symptoms,
and were more motivated to stop smoking. Higher depressive symptoms at T1 were
associated with higher depressive symptoms at T2. Women reporting more motivation to
stop smoking were also likely to report no history of myocardial infarction, taking antianxiety medications, smoking for fewer years, and smoking fewer cigarettes per day.
They were also more likely to report more commitment to stop smoking and feel more
confident in their ability to stop smoking. Finally, they perceived more benefits to
smoking cessation and were more threatened by their CHD and future CV interventions.
Three-Month Follow Up after Invasive Cardiac Procedure
Women who were more committed to stopping smoking at T1 continued having
more commitment to stop smoking at T2. More commitment to stop smoking at T2 was
associated with smoking fewer daily cigarettes at T1 and at T2, smoking for fewer years,
and being more likely to quit smoking at T2. They also had more confidence in their
ability to stop smoking and perceived many benefits to stopping smoking at T1. Women
perceiving fewer barriers to stopping smoking at T1 were more likely to stop smoking at
T2. Receiving more cues to action about smoking cessation from their HCP at T1 was
associated with fewer depressive symptoms at T2. In addressing Research Question 4,
depressive symptoms at T2 were not associated with commitment to stop smoking at T2.

Table 7
Relationships among Women Characteristics and Theoretical Predictor Variables
CQSS
(T1)

CQSS
(T2)

SEQ-12

a

PBQ

BCS

WCSS

CTAS

HDTS

TFCIS

CESD
(T1)

CESD
(T2)

TSRQa

Age

.05

.03

.04

-.06

.02

.14

-.07

-.18

-.03

-.03

-.13

.01

College vs. None

.05

-.01

.03

.20

-.10

.03

-.08

-.04

-.14

-.03

-.08

.03

Hx of Cath

.01

.07

.01

-.09

.06

.16

-.16

.00

.11

-.05

.14

-.09

Hx of MI

-.09

.06

-.08

.14

.08

.13

.00

-.14

-.08

-.07

-.08

-.19

Hx of Stent

-.11

.03

-.02

.01

.22

.13

-.05

-.09

-.05

-.06

.10

-.10

Hx of CABG

-.07

-.07

-.04

.10

.05

.02

-.09

-.09

-.11

-.07

-.11

-.05

Anti-Depressant
Med

.02

-.02

.11

-.09

-.15

-.15

-.07

.18

.10

.06

.08

.11

Anti-Anxiety
Med

-.01

.01

.10

-.03

-.20

-.13

.12

.31**

.34**

.10

.13

.25*

Years Smoked

-.17

-.29*

-.22

.03

.23*

.20

-.26*

-.00

.01

.05

.04

- .11

Number of Daily
Cigarettes (T1)

-.36**

-.29*

-.23*

-.11

.20

.01

.01

-.17

-.14

-.11

-.17

-.28*

Smoking Status
at 3 Months
Number of Daily
Cigarettes (T2)

-.18
-.371**

-.58**
-.658**

-.38**
-.335*

-.22
-.123

.31*
.256

.21
-.019

- .10
-.09

.19
.069

06
.018

.25
.164

.14
.102

.05
-.23

Note. *p < .05, **p < .01, aSpearman‟s rho reported. CQSS= Commitment to Quitting Smoking Questionnaire; SEQ-12 = Smoking Self-Efficacy
Questionnaire; PBQ= Perceived Benefits Questionnaire; BCS= Barriers to Cessation Scale; WCSS= Weight Control Smoking Scale; CTAS= Cues to Action
Scale; HDTS= Heart Disease Threat Scale; TFCIS= Threat of Future CV Interventions Scale; CESD= Center for Epidemiologic Studies Depression Scale;
TSRQa= Autonomous Subscale of Treatment Self-Regulation Questionnaire.
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Table 8
Relationships among Theoretical Predictor Variables
CQSS
(T1)

CQSS
(T2)

SEQ12

a

PBQ

BCS

WCSS

CTAS

HDTS

TFCIS

CESD
(T1)

CESD
(T2)

CQSS (T1)
CQSS (T2)

.38**

SEQ-12

.69**

.34*

a

PBQ

.46**

.30*

BCS

-.42**

-.17

-.41**

-.14

WCSS

-.06

.05

.01

.00

.25*

CTAS

.17

.17

.09

.18

.05

-.06

HDTS

.29*

-.02

.16

.40**

.08

.06

.18

TFCIS

.28

*

-.01

.13

.37

**

.08

.10

.27*

.69**

CESD (T1)

.05

-.05

-.00

.11

.28*

.10

.16

.41**

.28*

CESD (T2)

-.02

-.20

-.06

.07

.20

.16

-.29*

.34*

.25

.62**

TSRQa

.60**

.38**

.38**

-.01

-.03

.24*

.42**

.34**

.02

.17

32**

.02

Note. *p < .05, **p < .01, aSpearman‟s rho reported; CQSS= Commitment to Quitting Smoking Questionnaire; SEQ-12 = Smoking Self-Efficacy
Questionnaire; PBQ= Perceived Benefits Questionnaire; BCS= Barriers to Cessation Scale; WCSS= Weight Control Smoking Scale; CTAS= Cues to Action
Scale; HDTS= Heart Disease Threat Scale; TFCIS= Threat of Future CV Interventions Scale; CESD= Center for Epidemiologic Studies Depression Scale;
TSRQa= Autonomous Subscale of Treatment Self-Regulation Questionnaire.
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Hypothesis Testing
Hypothesis 1: Higher perceived threat of heart disease and higher threat of future CV
interventions will be associated with commitment to stop smoking, controlling for
depression.
Table 9
Summary of Hierarchical Regression Analysis for the Variables Predicting T1
Commitment to Stop Smoking (N = 75)
Step1
Variable
T1 Daily
Cigarettes
Threat of
CHD
Threat of
Future CV
Interventions

B
-.29

Step 2
SE B

Β

.06

-.39**

SE B

β

-.20

.06

-.35**

1.12

1.25

.13

.08

.08

B

.15

R2 Change
R2
Adjusted R2
F

0.15
.06
0.15
.21
.14
.18
12.96
6.41
(p value model)
p=.001
p=.001
*
p < .05 two tailed ** p < .01 two tailed *** p < .001 two tailed

In the bivariate correlational analysis, depression was not associated with
commitment to stop smoking at T1 or T2. Therefore, it was not included as a covariate in
the model. The number of daily cigarettes at T1 was significantly correlated with
commitment to stop smoking at T1 and was included as a covariate. Hierarchical multiple
linear regression was conducted to test the hypothesis, and the results of the regression
analysis are in Table 9. The full model was significant (F (2, 71) = 6.41, p < .01) and
100
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accounted for 21.3% of the variance in commitment to stop smoking. While the number
of daily cigarettes was an independent predictor of commitment to stop smoking, neither
threat of heart disease or future CV interventions were significant; therefore, this
hypothesis was not supported.
Hypothesis 2: Receiving cues to action about smoking cessation from a HCP will be
associated with higher perceived threat of future CV interventions and higher threat of
heart disease.
HCP providing more cues to action for smoking cessation was associated with
women‟s higher perceived threat of future CV interventions (r = .27, p = .02). However,
receiving more cues to action from one‟s HCP was not associated with perceived threat
of heart disease (r =.18, p =.12) (Table 8). Therefore, this hypothesis was partially
supported.
Hypothesis 3: Higher perceived threat of CHD, higher perceived threat of future CV
interventions, higher smoking cessation self-efficacy, and fewer perceived barriers will
be associated with greater commitment to stop smoking (T1), controlling for depression.
As previously stated, depression at T1 was not associated with the CQSS and was
not included as a covariate; however, the number of daily cigarettes was included as a
covariate. Hierarchical multiple linear regression was conducted to test Hypothesis 3
(Table 10) with number of daily cigarettes entered in the first step and in the second step
threat of heart disease, threat of future CV interventions, smoking cessation self-efficacy,
and barriers to smoking cessation. Daily number of cigarettes did account for significant
variance in Step 1. Variables in Step 2 accounted for significant additional variance in
commitment to stop smoking (see Table 10). While the total model was significant (F (2,
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68) = 15.55, p < .001) and explained 57.8% of the variance in commitment to stop
smoking, self-efficacy was the only independent predictor of commitment to stop
smoking in addition to the number of daily cigarettes which remained significant in the
final model. Higher confidence in one‟s ability to stop smoking and smoking fewer
cigarettes daily was associated with higher commitment to stop smoking. Hypothesis 3
was partially supported.
Table 10
Summary of Hierarchical Regression Analysis for the Variables Predicting T1
Commitment to Stop Smoking (N = 75)
Step
2

Step1

B

SE B

β

-.11

.05

-.19*

Threat of CHD

.74

.94

.09

Threat of Future CV
Interventions

.08

.06

.14

.27

.04

.54***

-.08

.04

-.17

Variable
Daily Cigarettes

B
-.23

SE B
.06

Β
-.39

**

Self-Efficacy
Perceived Barriers
R2 Change
R2
Adjusted R2
F

0.15
0.15
0.14
12.96

(p value model)

p=.001

.43***
.58
.55
18.94
p=.000

*

p < .05 two tailed ** p < .01 two tailed *** p < .001 two tailed

Hypothesis 4: Those with greater commitment to stop smoking after an invasive CV
procedure will report higher smoking cessation rates at three months than those with
lower commitment to stop smoking.
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Women smokers reporting higher commitment to stop smoking did not report
higher rates of smoking cessation at three months (r = -.18, p =.20). See Table 7.
Therefore, this hypothesis was not supported.
Hypothesis 5: Fewer perceived barriers to smoking cessation, greater perceived threat of
CHD, greater perceived threat of future CV interventions, receiving cues to action, fewer
depressive symptoms, and higher smoking cessation self-efficacy will be associated with
higher commitment to stop smoking (T1).
The number of daily cigarettes (T1) was entered in the first step as a covariate,
and autonomous motivation to stop smoking was entered along with the hypothesized
variables in step two because it was significantly related to commitment to stop smoking.
Depression was not included because of its lack of relationship with the CSSQ. The full
model was significant (F (6, 67) = 19.37, p < .001) and contributed 66.9% of variance to
commitment to stop smoking. The covariate was not significant in the final model.
Fewer perceived barriers to smoking cessation, high smoking cessation self-efficacy, and
being more autonomously motivated to quit smoking were independent predictors of
higher commitment to stop smoking at T1 (see Table 11). Therefore hypothesis 5 was
partially supported. This hypothesis was also tested using baseline independent variables
and commitment to stop smoking (T2); the final model was not significant.
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Table 11
Summary of Hierarchical Regression Analysis for the Variables Predicting T1
Commitment to Stop Smoking (N = 75)
Step1
Variable
Daily Cigarettes

B

SE B

B

-.39

**

SE B

Β

.04

-.13

Threat of CHD

-.10

.89

-.01

Threat of Future
CV Interventions

.06

.06

.11

Self-Efficacy

.21

.04

.42***

Perceived Barriers

-.11

.04

-.22**

Cues to Action

.12

.38

.02

Autonomous
Motivation

1.37

.33

.36***

(p value model)

.06

Β

-.08

R2 Change
R2
Adjusted R2
F

-.23

Step 2

0.15
0.15
.14

.52***
.67
.64

12.96
p=.001

19.37
p=.000

*

p < .05 two tailed ** p < .01 two tailed *** p < .001 two tailed

Hypothesis 6: Fewer perceived barriers to smoking cessation, greater perceived threat of
future CV interventions, receiving cues to action, fewer depressive symptoms, higher
smoking cessation self-efficacy, and higher commitment to stop smoking will be
associated with quitting smoking at 3 months.
Logistic Regression was used to determine factors associated with stopping
smoking at 3 months, where 0= quit smoking and 1= continued smoking. The dependent
variable was smoking at 3 month follow up or not smoking at 3 month follow- up.

105
Depression, fear of weight gain (specific perceived barrier to smoking cessation),
commitment, and cues to action were not included because of their lack of relationship
with stopping smoking at 3 months. The overall model was significant (X2 (4, N=54) =
18.67, p = .001). However, the only variables that were significantly different between
the two groups were smoking cessation self-efficacy and threat of CHD. Those women
who had quit smoking at the 3 month follow up had higher smoking cessation selfefficacy at T1 and lower perceived threat of heart disease (Table 12). Threats of future
CV interventions and barriers to smoking cessation were not associated with whether
women quit smoking or not. This hypothesis was only partially supported. See Table 12.
Table 12
Summary of Logistic Regression Analysis for Factors Associated with those Continuing
to Smoke at Three Months (n =46) and those Quitting (n =8)
B

SE

Wald p-value

Step 1
Threat of Heart Disease

3.10 1.39

4.97

.03

Threat of Future CV Interventions

-.10

.07

1.99

.16

Smoking Cessation Self-Efficacy

-.16

.07

5.46

.02

.08

.06

1.67

.20

Barriers to Smoking Cessation
Note. X2 (4, N= 54) = 18.67, p = .001.
Smoking Characteristics at Three Months

Table 13 summarizes descriptive statistics for women smokers‟ behaviors three
months following an invasive CV intervention. Of the 54 women who participated in
telephone interviews at T2, the vast majority continued smoking and less than one fifth
stopped smoking. Of the participants continuing to smoke, the majority were smoking
daily. Slightly less than half of the women did not attempt to stop smoking, 42% made at
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least one attempt with 13% making multiple attempts. Of those women attempting to
quit smoking, the majority described their quit attempt as “cold turkey” with few using
medications, cutting back the number of daily cigarettes, or trying electronic cigarettes.
Of the few that tried smoking cessation medications, varenicline was the one most
commonly tried.
About half the women indicated they did not receive any help to with smoking
cessation after the procedure. Women were then asked about specific types of help,
including counseling, and about one quarter had counseling from their physician and
almost none from nurses (Table 13). Differences in these perceptions between women
who stopped smoking and who continued smoking were examined and are presented in
Table 14. For those who quit smoking and those who continued, almost all indicated that
they would have never started smoking if they knew looking back what they know now
about their health. Of participants continuing to smoke at T2, most expressed the desire
to continue trying to stop smoking. Less than twenty percent that said they did not want
to try and quit smoking the most common reason was that “too much was going on in
their lives right now” to try to quit.
Table 13
Post Heart Catheterization Women’s Smoking Behaviors at Three Months (n = 54)
Smoking Behavior Since Procedure

N

(%)

Continued Smoking

46

(85.2)

Stopped Smoking

8

(14.8)

Daily Cigarettes (number) at Three Months

M

10.63

(SD)

(8.5)

Smoking Frequency Since Procedure
Daily

(71.7)
(Table 1338Continued)
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(Table 13 Continues)
Smoking Behavior Since Procedure

M

N

(%)

10

(18.9)

Zero

24

(44.4)

One

23

(42.6)

Two

2

(3.7)

Three

5

(9.3)

Cold Turkey

42

(77.8)

Medications

4

(31.6)

Decreased Number of Cigarettes

2

(3.7)

Electronic Cigarettes

1

(1.9)

None

29

(53.7)

Physician

20

(26.3)

Medication

8

(14.8)

Family

2

(3.7)

Therapist

1

(1.9)

None

29

(53.7)

From Physician

15

(27.8)

From Physician

7

(13)

From Counselor

2

(3.7)

From Nurse

1

(1.9)

No

41

(75.9)

Yes

13

(24.1)

Varenicline

6

(11.3)

Nicotine Patch

2

(3.8)

Zyban

3

(5.7)

Some Days

(SD)

Number of Quit Attempts Since Procedure

a

Description of Quit Attempt Strategies Used Since Procedure

Help with Smoking Cessation Received Since Procedure

Counseling Received About Smoking Cessation Since Procedure

Smoking Cessation Medications Since Procedure

Type of Smoking Cessation Medication Tried Since Procedure
(n=13)

(Table 13 Continued)
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(Table 13 Continues)
Smoking Behavior Since Procedure

N

(%)

1

(1.9)

No

33

(61.6)

Yes

21

(38.9)

Spouse

14

(25.9)

Other

6

(11.1)

Children

1

(1.9)

No

16

(29.6)

Yes

5

(9.3)

Nicotrol

M

(SD)

Other Smokers in Home Since Procedure

Relationship of Smoker (n=21)

Did Other Smokers in Home Try to Stop Smoking After
Procedure

a

Some participants made quit attempts with multiple quit aids.

As part of the 3 month follow up, a semi-structured interview was used to ask
women specifically about the help with stopping smoking they had received between
time of the invasive procedure and the follow up. Participant responses were content
coded (See Table 14). Some women who had not quit smoking indicated they received
some counseling from their physician (30%) with almost none received from nurses. The
majority of women perceived receiving no additional help with smoking cessation. A
small percentage indicated receiving medications. For those few who had stopped
smoking, half indicated receiving counseling. However, three fourths of quitters
indicated receiving no help, suggesting that some quitters did not perceive counseling as
help.
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Table 14
Perceptions of Post Heart Catheterization Women Smokers towards Smoking Cessation
Three Months after Invasive CV Procedure (n = 54)
Continued Smoking
Help Received
None

a

Quit Smoking

(n=46)

(n=8)

N

(%)

n (%)

(73.9)

6 (75)

34

Medication

6

(13)

2 (25)

Physician

3

(6.5)

- -

Therapist

1

(2.2)

- -

Family

2

(4.3)

- -

None

25

(54.3)

4 (50)

Physician

14

(30.4)

1 (12.5)

Family

4

(8.7)

3 (37.5)

Counselor

2

(4.3)

- -

Nurse

1

(2.2)

- -

11

(24.5)

- -

11

(24.4)

- -

Stress

8

(17.8)

- -

Habit/Boredom

7

(15.6)

1 (12.5)

Weight Gain

3

(6.7)

- -

Enjoy Smoking

2

(4.4)

1 (12.5)

Depressive

2

(4.4)

- -

2

(4.4)

2 (25)

Counseling
Received

Most Challenging
About Smoking
Cessation
Cravings for
Cigarettes
Anxiety

Symptoms
Being Around
Other

(Table 14 Continued)
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(Table 14 Continues)
Continued Smoking
Help Received

a

Quit Smoking

(n=46)

(n=8)

N

n (%)

(%)

Smokers
Not Challenging

-

-

3 (37.5)

Other

3

(6.6)

1 (12.5)

Meaning of Cigarettes
Nerves/Anxiety

14

(30.5)

2 (25)

Stress

14

(30.5)

- -

Bad Habit

8

(17.4)

1 (12.5)

Pleasurable

5

(10.9)

1 (12.5)

Nothing

4

(8.7)

2 (25)

Harmful to

3

(6.5)

2 (25)

15

(32.6)

- -

13

(28.3)

2 (25)

3

(6.5)

1 (12.5)

3

(6.5)

- -

3

(6.5)

- -

I Like It

3

(6.5)

- -

Smoking

2

(4.3)

1 (12.5)

-

-

2 (25)

4

(8.8)

2 (25)

Health
Feel Towards Smoking
Wish I Could
Quit
Hate It /Nasty/
Embarrassing
I Know I Need
to Quit
I‟m Okay with
It/ Can‟t Stop
It‟s Hard to
Quit

Scares Me
Still Have Urge
to Smoke
Other
What Else Could the
(Table 14 Continued)
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(Table 14 Continues)
Continued Smoking

a

Quit Smoking

(n=46)

(n=8)

N

(%)

n (%)

Nothing

34

(73.9)

8 (100)

Medicine

6

(13)

- -

Smoking

3

(6.5)

- -

3

(6.5)

- -

Help Received
Hospital Have Done to
Help

Cessation
Classes
Talk More
about Affects
of Cigarettes
Plans to Continue
Trying to Stop
Smoking

n=44

Yes

37

(84.1)

-

No

7

(15.9)

-

3

(42.9)

- -

2

(28.6)

- -

2

(28.6)

- -

Reason for No Plan to
Continue Trying to
Stop Smoking
Too Much

n=7

Going on
Right Now
I Enjoy
Smoking
I Feel Better
When I
Smoke
a

Note. n varied due to
missing data in quit group.

The most common challenges to quitting for smokers at T2 were cravings for
cigarettes and their nerves (anxiety), with few endorsing that habit or stress were the
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issue. A large portion of non-smokers indicated stopping smoking was not challenging,
while others indicated being around other smokers and habit were challenging. Slightly
more than one third of women lived with another smoker, primarily their spouse or
significant other. Of these, less than one quarter made a quit attempt with the participant
following T1. A large majority of the women did not think the hospital could have done
anything more to help them stop smoking. Of the smokers who indicated the hospital
could have helped them stop smoking, providing medication was most often suggested.
Participants were asked to describe their feelings about their smoking. See Table
14. When smokers at T2 describing the meaning of cigarettes in their lives, almost one
third indicated cigarettes calmed their nerves/anxiety and one third indicated cigarettes to
be a stress reliever, while approximately one fifth described cigarettes as a bad habit. Of
non-smokers at T2, about one quarter indicated that smoking calmed their nerves/anxiety.
Terms used by participants to describe the meaning of cigarettes in their lives included
things that might be perceived as positive (e.g., “calms you down”, “helps you cope”
“my nerve pill”, “relaxing”), negative ( e.g., “crutch”, “death”, “Russian roulette”, “they
can damage your heart”, “oppressive dictator”, “it‟s like a tranquilizer”, “mental copout”, “killing you”, “I‟m going to die if I smoke”) and neutral (e.g., “part of my every
day”, like water”, “something to do with your hands”, “they don‟t mean anything to
me”).
When asked to describe how participants felt now towards their smoking, almost
two-thirds of smokers at the three month follow up indicated negative feelings towards
smoking (i.e., nasty, embarrassing, or they hated it (See Table 14). About one quarter of
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non-Smokers at T2 also indicated they hated smoking and they still had the urge to
smoke.
Table 15
Frequencies of Reasons for Continuing to Smoke and Barriers to Stopping (n=46)
Reasons for Continued Smoking

n

(%)

Emotional Reasons (anxiety, depressive symptoms, etc.) 20 (44.4)
Addiction

6

(13.3)

Habit

5

(11.1)

Enjoy Smoking

5

(11.1)

Stress

3

(6.7)

Lack of Self Control

2

(4.4)

Don‟t Know

2

(4.4)

Other

2

(4.4)

What Got in Participant‟s Way of Stopping Smoking
Anxiety

24 (55.8)

Other Smoker Around

5

(11.6)

Stress

4

(9.3)

Weight

3

(7)

Enjoyment/ Desire to Smoke

3

(6.9)

Other

2

(4.5)

Women who continued to smoke were next asked to describe why they believed
they still smoked and what they believed got in their way of successfully stopping
smoking (See Table 15). Almost half indicated they still smoked due to emotional issues
(i.e., depression, anxiety, anger, etc.), while a small number believed it was due to
addiction, enjoyment of smoking, and habit. More than half believed that anxiety got in
their way of smoking cessation, and some believed it was due to being around other
smokers, stress, weight gain, depressive symptoms, and enjoyment of smoking.
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This chapter presented the results of a prospective, correlational study to
determine the relationship between smoking cessation and commitment to stop smoking,
perceived threat of both cardiovascular disease and future invasive cardiovascular
interventions, perceived benefits of smoking cessation, perceived barriers to smoking
cessation, smoking cessation self-efficacy, cues to action, motivation to stop smoking,
and depressive symptoms. A description of participants‟ characteristics, findings from
the questionnaires and results of hypothesis testing were reported.

CHAPTER V
Discussion and Conclusions
Chapter V presents a discussion of study findings and conclusions of study
results. This chapter ends with a discussion of the study limitations, strengths of the
study, implications for practice, use of the HBM model, and future research.
Because smoking is the most preventable risk factor for CHD and has been
deemed as a “winnable” health problem by the CDC (Stobbe, 2010), it is imperative for
clinicians to understand what factors influence patients‟ smoking cessation following an
invasive CV procedure. This study adds to the limited body of literature related to
smoking behaviors of women following an invasive CV procedure. While smoking
cessation behaviors have been the study of numerous studies, none were found in the
literature that used the HBM to predict smoking cessation among women with CHD three
months following an invasive CV procedure.
Smoking Behaviors Following an Invasive CV Procedure
In general, women had high commitment and were autonomously motivated to
stop smoking, were confident in their ability to stop smoking, and perceived benefits of
and few barriers to stopping smoking. They also viewed CHD and their invasive CV
procedures as a threat. Despite these positive psychological attributes, these perceptions
did not translate into the behavior of stopping smoking and few women had stopped
smoking at three months following an invasive procedure for their heart disease. If the
women in this study who were lost to follow-up at three months were considered
115
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smokers, only 10.5% of the women stopped smoking. One explanation may be that
although they want to stop smoking, women may not realize that they need more than
“will power” to support them in making this behavior change. Most women indicated
they were going to quit immediately “cold turkey” and most did not receive assistance
from their health care provider or from other sources. From interviews at the three month
follow up, women indicated that the most common barrier to stopping smoking was
anxiety and depression and suggested that smoking was a coping strategy. On average,
these women had been smoking for most of their adult life and smoking may be a wellestablished coping mechanism. Finding alternative ways to cope, particularly after
experiencing an invasive procedure for their cardiac disease, may be more challenging
than health care professionals and the women themselves recognize. There is evidence
that brief interventions for hospitalized patients to reduce CV risks including smoking
have not been successful (Thomsen, Esbensen, Samuelson, Tonnesen, & Moller, 2009).
In fact, women may relapse with smoking due to emotional distress and may benefit from
long-term smoking cessation support (Thomsen et al., 2009). Therefore, HCP should
continue providing follow up about smoking long after an invasive cardiac procedure and
offer referral resources. In addition, the issue of smoking as an addiction may not be well
understood by patients or health care providers and theories of addiction behavior may be
more useful than the HBM in addressing smoking cessation.
Having confidence in one‟s ability to stop smoking was one significant
independent predictor of smoking cessation at three months, which is similar to previous
findings in men and women with and without CHD, but not following an invasive CV
procedure (Etter et al. 2002; Johnston et al., 2004; Manfredi et al., 2007). This
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association between cessation self-efficacy and quitting smoking presents an opportunity
for clinical focus, particularly with how to increase a woman‟s confidence in resisting
cigarettes after a meal and when around other smokers, which were identified in this
study as situations with the lowest self-efficacy. Providing women with specific skills to
help them not smoke and with what to expect when trying to quit may be more effective
than general encouragement to stop smoking. Intrusive thoughts about smoking have
been associated with increased smoking slips and urge levels within the first week of
stopping smoking (Ginex & O‟Connell). Cigarette availability and being around other
smokers can also decrease a smoker‟s ability to resist temptation to smoke (Ginex &
O‟Connell, 2010). Including these teaching points during follow-up may provide patients
with more tools for making a quit attempt.
Participants had smoked for an average of 30 years and an average of threefourths of a pack daily, thus stopping may have been extremely difficult. While many
patients in previous studies have successfully stopped smoking following an MI (Reimer
et al., 2006), this study differed since more than one third of women had a previous MI
but continued to smoke. The number of daily cigarettes smoked was significantly
reduced from time of the procedure to the three month follow up; however, studies
suggest no real health benefit from this since smokers can adjust the amount of inhaled
nicotine regardless of the actual number of cigarettes smoked (i.e. can inhale deeper
when smoking fewer cigarettes) (Le Houezec & Sawe, 2003; Millatmal et al., 1994).
Research regarding gradual versus abrupt quitting methods is mixed. Cold turkey was
identified as a more effective quitting method than gradually reducing the number of
daily cigarettes in one recent study with a large sample of young men (Cheong, Yong, &
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Borland, 2007). However, reducing the number of daily cigarettes may be an effective
way that may lead to total smoking cessation (Berg et al., 2010), and thus could be a
focus of encouragement and counseling from HCP. Asking the smokers who are using
this method to track the number of cigarettes may be helpful along with offering other
support so they do not revert to smoking more. Helping the smoker to identify which
method is preferable and then offering appropriate support for that method may be the
best approach for HCP when counseling patients.
Commitment to stop smoking was high at the time of the procedure and many of
the women continued to be highly committed to trying to quit, expressed a desire to quit,
and had negative feelings associated with smoking. Three fourths of smokers at followup had high commitment to stop smoking, which is consistent with AHA statistics that
70% of smokers desire to stop but less than 5% can remain tobacco free for more than 312 months (AHA, 2009), although the quit rate in this study was 15%. The lack of
relationship of commitment to stop smoking and smoking cessation in this study differed
from others where commitment to stop smoking was linked to successful smoking
cessation (Dalum et al., 2008; Kahler et al., 2007; Kleinjan et al., 2008). However,
sample sizes in those studies were larger and patients did not necessarily have a diagnosis
of CHD.
Older women may be more successful in achieving smoking cessation and
experience decrease relapse with smoking (Doolan, 2007; Reimer et al., 2006). Evidence
suggests that women 62 years or older with CHD are more likely to quit smoking than
younger women (52% versus 38% at 12 month follow up) and are less likely to relapse
with smoking (Doolan). The sample in our study was slightly younger on average (55.9
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years); however, with the extensive CV history at this younger age, one might think this
group would be highly motivated to stop smoking, especially since the most common
reason given for wanting to quit smoking was for their health.
Addiction to and withdrawal from cigarettes was identified on the standard
questionnaire used (BCS) as a medium to large barrier to smoking cessation at the time of
the procedure. Of the women continuing to smoke at the three month interview, only a
few women gave addiction to cigarettes as a reason for continued smoking. This
suggests that women may minimize the effects of cigarette addiction or may not view
themselves as possibly being addicted and consequently not seek help when trying to stop
smoking. While few studies were found to explore smokers‟ perceptions of cigarettes
and addiction, one study of college students found that students, both smokers and nonsmokers, did perceive smoking as addictive (Murphy-Hoefer, Alder, & Higbee, 2004).
Health care providers may also not have knowledge of how to address smoking as an
addictive behavior (Neil-Urban, LaSala, & Scott, 2001), which could limit the
effectiveness of their approach when counseling smokers to quit. Finding ways to educate
HCP about smoking as an addictive behavior may help providers think differently about
the support needed for behavior change as in other addictive behaviors such as alcohol
addiction. For example, relapse is common and one needs to realize that this is likely and
develop skills to get back on track after a relapse.
Forty percent of women in this study indicated they had tried to quit smoking
within the three months prior to their heart catheterization and the most common reason
given for attempting to quit was their health. This suggests that the women may have
been ready for change with appropriate help from HCPs, especially if the provider could
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assist with adequate supportive services. The timeframe surrounding an invasive CV
procedure such as a heart catheterization may be an appropriate time to conduct
screenings for commitment to stop smoking, depressive symptoms, anxiety, etc., since
this would be an optimal time for assisting patients with making lifestyle changes as part
of secondary prevention for CHD risk.
Most smokers in this study had plans to continue trying to stop smoking. Because
many were successful in reducing the number of daily cigarettes, most identified this
method to continue with hopes of quitting all together without additional support. Few
women had no plans to continue trying to stop smoking and the lack of plan was
primarily due to “having too much going on in [their] lives”. These women may need
additional counseling to determine alternative approaches to handling stress.
Many participants lived with another smoker in the home. Most spouses or
children who also smoked in the home did not make a quit attempt with the participant.
This may have presented more difficulty in stopping, as more women who continued to
smoke lived with another smoker than those who had quit at follow up. Relapse of
smoking and exposure to second hand smoke may be a concern for participants who want
to quit smoking and for those who quit at follow up but who live with a smoker, as
relapse has been linked to exposure to smoking cues (Ginex & O‟Connell, 2010; Mills,
Messer, Gilpin, & Pierce, 2009; Zhou et al, 2009). To be most effective, interventions
may need to be targeted toward the family or all smokers and clinicians might consider
including other smokers in the home in counseling sessions when appropriate and offer
encouragement to them as well as the patient to increase chances for smoking cessation.
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Depressive Symptoms, Anxiety, and Stress
Women in this study experienced high levels of depressive symptoms, anxiety,
and stress, which may help explain the low smoking cessation rate at follow up. This
finding is supported by previous research which also found high levels of depression and
stress pre- and post-cessation (Schnoll et al., 2007). Women with CHD are also more
likely to experience higher depressive symptoms (Czajkowski et al., 1997; Dunkel et al.,
2009; Gravely-Witte, et al., 2007).
While anxiety was not directly measured in this study, qualitative data from
women indicated that cravings for cigarettes and anxiety symptoms were most
challenging for them and that anxiety got in their way of successful smoking cessation.
This finding is similar to two studies which identified anxiety as a barrier to smoking
cessation (Agrawal, Sartor, Pergadia, Huizink, & Lynskey, 2008; Schofield et al., 2007).
Women, both smokers and quitters at follow up, also described the meaning of their
cigarettes as a relief for their anxiety and stress. Given that some women reported
medications to treat depressive and anxiety symptoms and yet these were reasons given
for continuing smoking, one possible explanation may be that their depressive and
anxiety symptoms were undertreated (Friedman & Clancy, 2003; Kocsis et al., 2008;
Sable & Jeste, 2001). Those participants who were not taking medications for depressive
or anxiety symptoms and those that were but still with high symptoms may have
benefited from an evaluation for medications or increases in existing medications to
address these problems when attempting smoking cessation. Clinicians, particularly
those involved in cardiac care, may consider screening for depressive and anxiety
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symptoms before and after an invasive CV procedure in an attempt to address this barrier
for women smokers.
Possible reasons for high depressive and anxiety symptoms in this sample can be
identified. In general, the women were of low socioeconomic status. A relationship has
been found to exist between low SES and anxiety (Alegria, Bijl, Lin, Walters, & Kessler,
2000; Wang, Berglund, & Kessler, 2000). Limited resources may be a stressor which
may be associated with higher levels of depressive and/or anxiety symptoms.
Additionally, most of the women had multiple chronic illnesses, such as diabetes mellitus
and arthritis in which higher rates of depression are found (Pan et al., 2010; Shen,
Findley, Banerjea, & Sambamoorthi, 2010). Many women also indicated taking pain
medications for chronic pain. Perhaps multiple co-morbidities and chronic pain may
contribute to depression or anxiety symptoms and make quitting smoking more
challenging.
High levels of stress have been associated with less smoking cessation selfefficacy (Manfredi et al., 2007). Although few women (9%) in this study specifically
reported stress as a barrier to quitting, the effects of stress on their smoking cessation
self-efficacy is an important consideration since self-efficacy was a significant predictor
of smoking cessation at follow-up. Given how women reported using smoking to calm
them, they may not make the link of stress and use of the smoking as a coping
mechanism. As such, assistance from HCP in reducing stress and identifying alterative
coping strategies may be an important focus for increasing smoking cessation.
Education from the HCP about ways to reduce stress or use alternative coping
strategies may be an important focus. Nurses can teach ways to reduce stress, such as
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encouraging improved lifestyle changes (e.g. healthy eating, routine exercise),
surrounding oneself with a support system, and being more assertive with voicing needs
(Patterson, 2010). Examples of alternative coping strategies include cognitive behavioral
therapy, group therapy, helping patients acknowledge their feelings, and starting a journal
to release negative feelings (Rossman, 2011). Implications for clinical practice include
counseling and treatment for anxiety and stress for non-quitters in order to assist them
with smoking cessation, and the similar recommendations for quitters are needed in order
to help prevent relapse of smoking.
Cues to Action for Smoking Cessation from HCP
According to one study, women rate support systems for making positive lifestyle
changes as important, especially with smoking cessation (Park, Chang, Quinn, Ross, &
Rigotti, 2009). While women in this study were highly committed to stopping smoking
and had high confidence that they could quit, they reported receiving little help from their
physician or nurse other than simple advice to quit. This finding is similar to another
study (Duffy et al., 2008) in which few of the highly motivated smokers were offered
smoking cessation services during hospitalization. Most women in this study were asked
if they smoked and were advised to stop smoking; however, less than half were asked if
they were willing to stop smoking and few were given assistance with stopping. Almost
no follow-up appointments related to stopping smoking were made with the participants.
Given our understanding of how challenging quitting smoking can be, HCP need to be
more skilled in making referrals for follow up help for smokers as recommended by
treatment guidelines for smoking cessation. Referrals made to smoking cessation
programs should therefore be included in follow up appointments since these specific
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referrals have been associated with higher cessation rates (Richardson et al., 2008).
Follow up appointments related to smoking cessation may give women the opportunity to
discuss individual needs associated with cessation such as anxiety or depression
medications, counseling, etc.
Although HCPs, and especially physicians, have a major role in tobacco control
and prevention because of their educator and researcher roles (Muromoto & Lando,
2009), there are factors that may influence their role. Reimbursement is one factor may
influence the level of support for smoking cessation that a HCP provides.
Reimbursement to the HCP for smoking cessation services varies in each state and within
insurance plans. According to the ALA, only five states provide comprehensive
cessation benefits, and include Indiana, Massachusetts, Minnesota, Nevada, Oregon, and
Pennsylvania (ALA, 2011). Six states provide no cessation benefits with the exception of
pregnant women, and include Alabama, Connecticut, Georgia, Missouri, and Tennessee.
Seven states are requiring all insurance companies operating within their state to cover
some level of cessation benefit, and these states include Colorado, Maryland, Oregon,
New Jersey, New Mexico, North Dakota, and Rhode Island (ALA, 2011). Healthcare
Common Procedure Coding System (HCPCS) codes and International Statistical
Classification of Diseases and Related Health Problems (ICD-9) diagnosis codes related
to tobacco cessation counseling are available for billing by the HCP (American Academy
of Family Physicians, 2011). These codes are based on the underlying disease process
related to smoking (ICD-9 codes) and based on the length of counseling visit or class
(HCPCS codes) (American Academy of Family Physicians, 2011). Because a financial
incentive may exist for the HCP, knowledge of reimbursement information specific to his
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or her practicing state may increase the volume of follow-up appointments related to
smoking cessation.
Another factor that may influence HCP in providing smoking cessation advice is
lack of education about smoking cessation programs. Two aspects of smoking are
important in medical school curriculum and include the health risks of tobacco and
interventions for prevention and cessation (Pederson, Blumenthal, Dever, & McGrady,
2006). However, many medical schools may only emphasize the health risks of tobacco
which could limit physicians‟ knowledge of or focus on prevention and cessation. This
could result in limited physician counseling and referrals for smoking cessation.
Evidence suggests that an interdisciplinary approach to teaching smoking cessation to
medical students may be beneficial and may also serve as a referral source (Mitchell,
Brown, & Smith, 2009). The focus of tobacco risks and lack of education specifically on
strategies for smoking cessation is also likely apply to nursing education as well (Scanlon
et al., 2008).
Almost none of the women reported receiving help with smoking cessation
specifically from nurses. However, nurses have a large role in educating patients about
secondary prevention and specific recommendations for reducing risk factors. Evidence
suggests that smoking cessation counseling may not be included in all nursing curriculum
(Neil-Urban et al., 2001), therefore possibly limiting nurses‟ knowledge and skills to
effectively address smoking with patients. Evidence also shows that nurses‟ integration
of smoking cessation efforts with patients is inconsistent, and can be influenced by the
nurse‟s age, education level, workplace environment, smoking status, etc. (Schultz,
Hossain, & Johnson, 2009). These findings indicate that nurses need a work environment
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which adequately trains and supports them in addressing smoking cessation. This can
then present an opportunity for nursing to take a larger role in smoking cessation
counseling and education surrounding a heart catheterization procedure.
Smoking is a well known risk factor to health professionals. Many women
indicated receiving no help or counseling from their health care provider with stopping
smoking. Most women felt that there was nothing more the hospital could have done to
assist them with smoking cessation because this was a personal challenge they would
have to “make up [their] own mind to do”. HCP may have a role in reframing women‟s
thinking about having help with smoking cessation efforts which could make a difference
in their success by helping women understand that it is okay to need support. Smoking
cessation counseling has been found to be effective in smokers of all ages, including the
elderly (Abdullah & Simon, 2006) and is therefore an important aspect of follow-up. In
addition, HCP can have lists of web sites with smoking cessation programs on line, such
as smokefree.gov, QuitAssist.com, americanheart.org, etc., for smokers. While a totally
on-line approach to smoking cessation may not have the highest success rate of all
counseling options versus in-person or help lines (An et al., 2010), the use of on-line
cessation programs may be a beneficial addition to in-person counseling (Thieleke,
McMahon, Meyer, & AhYun, 2005) or may be a better option for younger smokers (An
et al., 2010). Because some women suggested that free smoking cessation medications
could be helpful, referrals from HCP to a free drug prescription program where available
may be beneficial.
The HCP‟s approach in providing smoking cessation information is important and
may have a bearing on successful cessation (Williams et al., 2006). Evidence suggests
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that the HCP‟s use of threat to encourage smoking cessation may be unsuccessful
(Williams et al., 2006). Instead, increased autonomy support from the HCP did increase
autonomous motivation for smoking cessation, and resulted in increased cessation
success in one large study (Williams et al., 2006). Williams‟ 2006 study (N= 1006)
included 69% women and reported a cessation rate of 11.8% for participants receiving
increased autonomy support versus 4.1% cessation rate for the community care group.
This approach allows the patient to freely choose to stop smoking because they desire to
improve their health, which has been linked to long-term smoking abstinence in adults
(Williams, Gagne, Ryan, & Deci, 2002). Similarly, smokers who set life goals
(aspirations) related to their health may be more likely to maintain their health goals and
sustain smoking abstinence for longer when receiving cessation interventions based on
the self-determination theory which emphasizes autonomy (Niemiec, Ryan, Deci, &
Williams, 2009). HCPs can incorporate the discussion of life goals and provide support
for autonomy in smoking cessation during follow-up.
Individual Perceptions and Smoking Cessation
According to Hampson et al. (2006), when patients correctly perceive their risk of
CHD, they are more likely to report risk reducing behaviors. Patients may also perceive
an MI as threatening to their health since 40-60% of patients quit smoking after having an
MI in a meta-analysis of 13 studies (Wilson et al., 2000). However, in this study, women
perceived high threat of CHD and high threat of future invasive CV procedures, and yet
few women stopped smoking three months following their heart catheterization. Higher
threat of both CHD and procedures was not associated with commitment to stop smoking.
Although higher threat of heart disease was an independent predictor of continuing to
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smoke at three months, the threat had an opposite effect on smoking than theorized. One
explanation for this finding may be because being more threatened by heart disease may
contribute to increased anxiety which was reported as a barrier to stopping smoking.
Another explanation for this finding may be comparison of the groups with a small
number in the quit smoking group. Future research will be needed to better understand
these relationships
Women in this study may have underestimated their risk for CHD and future
invasive CV procedures, especially given that many participants had experienced an MI.
Women may have seen their previous heart catheterization, stent, or CABG surgery as a
“fix” for their disease as did women with CHD in another study (Moore, Kimble, &
Minick, 2010), therefore reducing the need for risk reduction in the form of smoking
cessation. They also may not have perceived their smoking as a personal risk for CHD
(Kayaniyil et al., 2009). Since participants did not stop smoking following their MI, they
may not have been likely then to stop following their heart catheterization. These
findings in the current study regarding perceived threat of CHD risk are similar to
previous studies (Hammond et al, 2004; King et al., 2002; Oliver-McNeil & Artinian,
2002). Therefore clinically, using the threat of the illness or future procedures may not
be a good focus for patient education following a heart catheterization.
Women had an extensive cardiac history as well. A large number had
experienced a previous heart catheterization, myocardial infarction, stent placement, and
CABG surgery. Over two thirds reported experiencing chest pain prior to their
procedure, which would serve as a reminder of having CHD. Most also reported a family
history of CHD, and may have witnessed the effects CHD has or had on their family
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members. Even with an extensive cardiac history and high perceived threat from their
CHD and procedure, women still continued to smoke following their heart
catheterization. It may be that having another procedure creates additional anxiety and
that they rely on their past coping strategy of smoking. The stress surrounding the
procedure may not be the optimal time for women to learn new coping strategies. A
better time may be when some of the anxiety may have lessened, making follow up
appointments about smoking to discuss these areas more important. However, almost no
women received a follow up appointment about their smoking and reasons for HCP not
providing this were discussed earlier.
Fear of weight gain has been identified as a barrier to smoking cessation for
women (Levine, Marcus, & Perkins, 2001; Levine, Perkins, & Marcus, 2003; NIH, 2001;
Perkins, 2001). However, in this study fear of weight gain was not a concern for most
participants and therefore did not serve as a barrier to smoking cessation. It may be for
women with CHD, the benefits of stopping smoking are viewed as a priority over
possible weight gain.
Limitations of the Study
Study limitations must be taken into account when considering these findings.
The sample size did not provide sufficient power to adequately test the hypotheses.
While the enrollment rate was high at the time women were undergoing their heart
catheterization, the attrition rate for follow up was high (28.9%). This was higher than
the attrition rate of 13.7% in a study of men and women predicting smoking abstinence
both in-patient and two months post-discharge (Ong, Cheong, Prabhakaran, & Earnest,
2005), and lower than the 31.5% attrition rate in a study of women testing the
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effectiveness of weekly nurse-delivered phone social support to women smokers (Bullock
et al., 2009), and lower than the 62.5% attrition rate in a nurse-led six week smoking
cessation intervention study of men and women (Thompson, Parahoo, & Blair, 2007).
Participants may have agreed to participate in the study at time of the procedure because
they were optimistic that they could stop smoking. While the same incentive pay was
offered at the 3 month follow up, contact was made via telephone and many participants
were lost to follow-up. A possible explanation could be that it may have been difficult
for some women at follow up to admit they did not stop smoking for fear of judgment
and therefore may have screened calls or did not respond to messages left. Finally, the
number of women smokers undergoing a CABG surgery was lower than expected,
possibly due to more aggressive treatment by the cardiologist rather than referral for
surgery.
Another limitation of the study was using self-reported smoking status versus a
biochemical test for verification of nicotine levels. While the literature suggests that
verifying smoking status with an objective measure is the best method, this study was
limited in funding and used self-report. However, few women reported that they had
stopped smoking so inaccurate reporting of their smoking status is not a major concern.
Finally, no standard measure of anxiety was used in this study. However, anxiety
was reported by women as a major reason for not stopping smoking at follow up.
Measurement of this variable using a standardized questionnaire may have provided more
understanding of women‟s smoking behaviors after their invasive CV procedure. Future
studies may want to include a measure of anxiety.
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The reliability of the Cues to Action scale was below acceptable standards. This
may have contributed to a lack of significance of this variable. Better measures to assess
HCP interactions about smoking cessations are needed to better assess the influence of
the HCP on smoking cessation.
Strengths of the Study
This study used a well-established theoretical model, HBM, to examine smoking
cessation in women experiencing an invasive CV procedure. This study used a
prospective design of following women three months after their procedure, thus allowing
sufficient time to assess lasting smoking cessation behaviors. Using a semi-structured
interview, this study obtained specific information about the types of help women
received from their HCP about smoking cessation. Finally, unique to this study was the
incorporation of recommended smoking treatment guidelines and the extent to which the
patient perceived the guidelines were followed by the HCP.
Implications for Theory Building
Several variables suggested by the HBM were not found to significantly predict
commitment to stop smoking or smoking cessation behaviors. Possible explanations can
be suggested. First, many of these women had reported having a previous MI and/or
heart catheterization and continued to smoke following this event. Most of these women
also had been smoking for many years. This suggests that these women may have a
strong physiological addiction and maybe dependent psychologically to make quitting
extremely difficult even in the face of health challenges. Using models for addiction or
motivation theories may be a better fit for examining smoking cessation in women with
heart disease. Second, the relationships in the HBM include that increased perceived
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threat of disease and future CV interventions would result in smoking cessation, when in
actuality, lower perceived threat of disease was an independent predictor of cessation.
Women reported that smoking played a major role in their coping with anxiety, which
may explain why women continued to smoke with high perceived threat of
cardiovascular disease. Opposite of the theoretical model, higher threat of heart disease
was associated with continuing to smoke. Perhaps smoking is how they coped with the
stress of their threatening disease and/or event. However, there were few women that
were able to quit at three months and a larger sample may be needed to have sufficient
numbers of women smokers who quit to make comparisons. Third, it was hypothesized
that receiving more cues to action from one‟s HCP would be associated with higher threat
of disease and future CV interventions, but cues to action as associated only with threat
of future intervention and not a predictor of smoking cessation at three months. It may
be expected that HCP would emphasize the possibility of future CV procedures to
smokers at the time they are undergoing a procedure. Drawing conclusions about the
role of cues to action in this study must be viewed with caution as the instrument had a
low reliability coefficient. Therefore, cues to action may be important theoretically;
however, a more reliable instrument is needed for adequate testing. Lastly, the small
sample size may not have provided enough power to determine which variables can
indeed predict smoking cessation in this patient population following an invasive CV
procedure. A larger sample size is needed before drawing conclusions about the
explanatory power of the HBM.
Based on findings from this study, the HBM may not have been adequate for
examining smoking behavior after an invasive CV procedure. Other theories that address
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addiction behavior, anxiety, stress, which are not separate components of the HBM
model, but addressed under the concept barriers, may need to be addressed more fully.
Few studies have examined the HBM in predicting whether smoking cessation was
attained or not as the current study rather than smoking behavior in general. Research
findings from the current study are similar to other studies in suggesting that greater
smoking cessation self-efficacy was significantly associated with smoking cessation
(Haug et al., 2010; Schnoll et al., 2011; Turner, Mermelstein, Hitsman, & Warnecke,
2008). While previous studies suggest that women underestimate their risk for CHD
(Arslanian-Engoren, 2007; Hammond et al., 2007; Hart, 2005; King et al., 2002; OliverMcNeil & Artinian, 2002; Zerwic, King, & Wlasowicz, 1997) and that perceived threat
of CHD can predict smoking cessation (Ali, 2002; Bursey, & Craig, 2000; Honda, 2005;
Manfredi et al., 2007; Thanavaro et al., 2006), the current study differs because lower
threat of CHD, not higher threat, predicted smoking cessation at three months.
Because smoking and smoking cessation are multi-faceted and involve many
emotional and physiological aspects, other theories such as motivation theories (e.g.,
Self-Determination Theory) or theories used in addiction may provide better explanatory
power. This study found anxiety to be a major reason for continuing to smoke, which
could be included in future research as a modifiable sociopsychological variable.
Addiction to nicotine must also be considered, and the HBM does not address
physiological components related to modifying behaviors. Further studies with a larger
sample size may help identify variables specific to smoking which should be included
when testing this model with smokers.
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Implications for Practice
Given the complexities of the women and their health as well as the addiction of
smoking and using it as a coping mechanism, the HBM components may not be the best
ones for explaining smoking cessation behaviors in women following an invasive CV
intervention. However, findings from this study add insight into opportunities to improve
clinical practice.
Counseling is one area which has potential for improving women‟s success in
smoking cessation. Because anxiety was a major barrier identified by women for
smoking cessation, identification and treatment of these symptoms may improve smoking
cessation outcomes. Stress was also identified as a barrier to smoking cessation. An
opportunity exists for HCPs to assist patients in identifying alternative ways of coping
with stress rather than relying on cigarettes. Counseling is needed related to increasing
smoking cessation self-efficacy since this variable was found to predict smoking
cessation at follow up. When possible, including other smokers in the home in smoking
cessation counseling may increase the likelihood that he or she may be willing to try to
stop smoking along with the patient and in turn make the quit attempt for the patient
easier. Clinicians should also continue counseling women who have recently stopped
smoking in order to prevent relapse. An individual approach with counseling and
adequate screening may help remove these barriers and increase their confidence in their
ability to stop smoking.
Women in this study also reported high commitment to stop smoking and multiple
quit attempts at the time of their procedure and at follow up which indicates a willingness
to continue trying to quit smoking. A thorough screening surrounding the time of an
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invasive cardiac procedure could identify patients who are willing to stop smoking and
perhaps an individualized plan for smoking cessation could be established.
Providing more cues to action (i.e., following current recommended guidelines for
treating smoking) may result in better smoking cessation outcomes. Achieving this may
be more attainable if nurses are knowledgeable and feel supported in providing education
and counseling in their work environment. Particular focus on the appointment related to
smoking cessation could provide an opportunity for individualized help with smoking
cessation. For patients willing to try smoking cessation medications but who cannot
afford them, assisting the patient with identifying resources for medications may increase
smoking cessation success.
Future Research
Findings from this study suggest implications for future research. First, a
replication of this study with a larger sample of women smokers is needed to determine
whether the HBM variables can predict smoking cessation behaviors. Because
commitment to stop smoking was high in this study and has been found in numerous
studies to predict smoking cessation, it may be that the small sample size in this study led
to inconclusive findings. Since so few women stopped smoking in this study, future
research which includes testing smoking cessation interventions found to be successful in
other patient populations may be beneficial to test with women smokers following an
invasive CV intervention.
Second, as previously discussed, further research is also needed to determine
which variables should be included in the HBM which can better explain smoking
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cessation behaviors. This study found possible additional variables to be anxiety and
stress which could be included in future testing of the HBM.
Third, since smoking cessation self-efficacy was found to predict commitment to
stop smoking and smoking cessation behaviors, future studies are needed for developing
and testing interventions to increase smoking cessation self-efficacy, especially in various
situations where self-efficacy was low in this study such as following meals and being
around other smokers.
Finally, since this study found that participants did not perceive receiving
substantial assistance from HCP or even view the hospital as being able to do anything to
help them, further studies which examine interventions to increase HCP‟s interactions
with patients surrounding smoking cessation current treatment guidelines for smoking
cessation are needed. The effects from a follow-up appointment with the HCP related to
smoking cessation could be studied, especially if barriers specific to the individual patient
could be identified and strategies to remove those barriers could be determined.
Conclusion
This study adds to the body of literature concerning factors which influence
smoking cessation in women following an invasive CV intervention. Although
commitment, motivation, and self-efficacy to stop smoking were high, perceived threat of
CHD and future invasive CV interventions were high, and perceived barriers to smoking
cessation were low, women continued to smoke following their heart catheterization. It is
possible that factors which women identified as barriers to smoking cessation (such as
anxiety and stress) may better explain women‟s smoking behaviors following an invasive
CV intervention. Future research is needed to determine whether the HBM is adequate
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for predicting smoking cessation behavior in women with known CHD following an
invasive CV procedure. While previous research supports the use of the HBM with
smokers, this study suggests that the model may need additional variables which better
explain all components of smoking and smoking cessation.
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obtained and that no human subject will be involved in the research prior to
obtaining informed consent. Ensure that each person giving consent is
provided with a copy of the Informed Consent Form (ICF). The ICF used
must be the one reviewed and approved by the IRB; the approval dates of the
IRB review are stamped on each page of the ICF. Copy and use the stamped
ICF for the coming year. Maintain a single copy of the approved ICF in your
files for this study. However, a waiver to obtain informed consent may be
granted by the IRB as outlined in 45CFR46.116(d).

All of the above referenced forms are available online at https://irbwise.gsu.edu. Please
do not hesitate to contact Susan Vogtner in the Office of Research Integrity (404-4133500) if you have any questions or concerns.
Sincerely,

Susan Laury, IRB Chair
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Federal Wide Assurance Number: 00000129

The Medical Center
Of Central Georgia
February 25, 2010
Leslie Moore, RN, MSN, MBA
118 Horseshoe Bend Ct.
Macon, GA 31211
Re:

H1002509 – “Factors Which Influence Smoking Cessation in Women Who

Experience an Invasive Cardiovascular Procedure.”

Dear Ms. Moore:
The Institutional Review Board reviewed and approved the below on the above protocol
at the February 25, 2010 meeting. Approval for this protocol expires February 25, 2011.
Protocol
Permission to Contact form
Informed Consent form and HIPAA Authorization approved by Georgia State University IRB
February 1, 2010 – January 31, 2011
Smoking Cessation Questionnaire
Heart Disease Threat Scale (patient questionnaire)
Threat to Future Cardiovascular Interventions Scale
Smoking Self-Efficacy Questionnaire
Perceived Benefits Questionnaire
Barriers to Cessation Scale
Weight Control Smoking Scale
Cues to Action Scale
Center for Epidemiologic Studies Depression Scale (CES-D), NIMH
TSRQ (Smoking) questionnaire

The Medical Center of Central Georgia Institutional Review Board is in compliance with
the regulations of the Food and Drug Administration effective July 27, 1981, and all
amendments thereto, contained in Title 21 of the Code of Federal Regulations, Parts 50
and 56.

170
Thank you.

Sincerely,
G. Bernard Meyer von Bremen, Pharm.D.
Chairman
pn
*Drug/Device Studies: Although the Medical Center of Central Georgia IRB has approved this
protocol, contracts for fiscal responsibility should be review by Financial Services prior to start
up of the protocol. Please contact Sheree Mixon at MCCG Hospital Box 204.
C: Dave King

777 Hemlock Street

Macon, Georgia 31201-2102

478-633-1440
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INFORMED CONSENT / HIPAA AUTHORIZATION
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APPENDIX C
DEMOGRAPHIC AND CLINICAL DATA FORM
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Subject ID#______________ Date____________________

Demographic and Clinical Data Form
Marital Status: ______

Age: _______

1. Single
2. Married
3. Divorced
4. Widowed
5. Separated
6. Long Term Relationship

Ethnicity: _____
1. Hispanic or Latina
2. Non-Hispanic or Latina
Race:_______
1. Black or African American
2. White or Caucasian
3. Asian
4. North American Native
5. Other

Education: ______

Occupation: ____________
______________________
______________________
If retired or multiple jobs,
what was primary occup?
______________________
Work Status:___________
1. Retired
2. Full-time
3. Part-time
4. Unemployed
5. Homemaker
6. Disabled
Cardiac Medical History

th

1. Less than 9 grade
2. Partial high school
3. High school graduate
6. 1-3 years college
7. College graduate
8. Post-graduate study
9. Other (i.e. trade school)
Educ Level Spouse______

Medical History
0. No
1. Yes
Diabetes_______________
Hyperlipidemia__________
Dementia______________
Arthritis_______________
Pulmonary
Problems_______________
Describe:
GI Problems:______________
Describe:

0. No
1. Yes
Previous MI______________
Previous heart cath________
Stents___________________
CABG__________________
Current Chest Pain_________
Family hx of CHD_________
CHF____________________
PVD____________________
Cerebrovasc Disease_______
High Blood Pressure_______
Ejection Fraction % _______

Lives With: _________
0. Alone
1. Spouse
2. Other
3. Domestic Partner
Annual Household Income:____
1. Less than $10,000
2. $10,001-$20,000
3. $20,001-$30,000
4. $30,001-$40,000
5. $40,001-$50,000
6. Greater than $50,000
Height___________________
Weight__________________
Date of admission _________
Overnight Stay ____________
0 = No
1 = Yes

Menopause History:
0. No
1. Yes
Post Menopausal __________
Surgically induced_________
Post menopausal = no menses for a
minimum of one year
Exercise Frequency:
0. None
1. < 1 X weekly
2. 1-2 X weekly
3. 3 X weekly
4. > 3 X weekly
Describe type of exercise:
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(To be recorded by interviewer)
List all medications (including over the counter):
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
Have you smoked at least 100 cigarettes in your lifetime and are currently smoking every day or
some days in the last month?
______________________________________________________________________________

How many years have you smoked?
________________________________________________________________________
How many cigarettes do you now smoke per day?
________________________________________________________________________
Have you tried to quit smoking in the past three months?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
How many times have you tried to quit smoking in the past three months?
________________________________________________________________________
________________________________________________________________________
Did you stop just for this procedure?
________________________________________________________________________
What have you done to try to quit smoking?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Has anyone ever talked to you about quitting smoking?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What prompted you to try to quit smoking the last time?
________________________________________________________________________
________________________________________________________________________
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________________________________________________________________________
________________________________________________________________________
Are there other smokers currently living in your home?
______________________________________________________________________________
If so, who?_____________________________________________________________________
______________________________________________________________________________

Who do you turn to for advice about your health?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

Please indicate how much you agree or disagree with each of the following statements.

Strongly Disagree Unsure

Agree

Strongly
Disagree
Agree

1.

I am likely to stop smoking after my heart
procedure.

1

2

3

4

5

2.

I intend to stop smoking after my heart
procedure.

1

2

3

4

5

3.

This heart procedure is stressful to me.

1

2

3

4

5

4.

This heart procedure is more stressful than
other stressful events in my life.

1

2

3

4

5

5.

My physical health is important to me.

1

2

3

4

5
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APPENDIX D
COMMITMENT TO QUITTING SMOKING SCALE
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Commitment to Quitting Smoking Scale
Please indicate how much you agree or disagree with each of the following statements. If
you recently stopped smoking, answer these in terms of staying quit.

Strongly Disagree Unsure

Agree

Strongly
Disagree
Agree

1.

I'm willing to put up with whatever
discomfort I have to in order to quit
smoking.

1

2

3

4

5

2.

No matter how difficult it may be, I won't
let myself smoke once I quit.

1

2

3

4

5

3.

Feeling very anxious or restless won't
prevent me from quitting smoking.

1

2

3

4

5

4.

Even if I really want one, I won't let myself
pick up a cigarette once I quit.

1

2

3

4

5

5.

No matter how much I crave a cigarette
when I quit, I'm going to resist the urge to
smoke.

1

2

3

4

5

6.

Feeling very depressed or sad won't
prevent me from quitting smoking.

1

2

3

4

5

7.

I'm not going to let anything get in the way
of my quitting smoking.

1

2

3

4

5

1

2

3

4

5

8.

Feeling very angry and irritable won't
prevent me from quitting smoking.
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APPENDIX E
PERCEIVED BENEFITS QUESTIONNAIRE
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Subject ID#______________
Date____________________

Perceived Benefits Questionnaire
Instructions: Use the scale below to rate how likely each item would be if
you were to stop smoking. Please place the appropriate number on the line
preceding that item.
1 = No Chance
2 = Very Unlikely
3 = Unlikely
4 = Moderate Chance
5 = Likely
6 = Very Likely
7 = Certain to Happen
_____1.

I will lower my chances of developing bronchitis.

_____2.

I will lower my chances of developing lung cancer.

_____3.

I will lower my chances of developing heart problems.

_____4.

I will avoid health problems down the road.

_____5.

I will live longer.

_____6.

I will get instant health benefits.

_____7.

I will breathe easier.

_____8.

I will feel more energetic.

190
_____9.

I will be healthier.

_____10.

I will feel proud that I was able to quit.

_____11.

I will be more in control of my life.

_____12.

I will feel a sense of achievement.

_____13.

I will prove I can achieve abstinence from cigarettes.

_____14.

I will have more money for items besides cigarettes.

_____15.

I will be able to save more money.

_____16.

I will smell cleaner.

_____17.

My breath will be fresher.

_____18.

The people who care most about me will approve.

_____19.

I will have the respect of my friends.

_____20.

I will set a good example for others (e.g., children).

_____21.

I will no longer offend others by smoking.
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APPENDIX F
BARRIERS TO CESSATION SCALE
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Subject ID#______________
Date____________________

Barriers to Cessation Scale
Please indicate to what degree you consider each item a barrier to quitting
smoking by circling the appropriate number.

Not a

Small

Medium

Large

Barrier

Barrier

Barrier

Barrier

Not
Applicable

1.

No encouragement or help from friends

0

1

2

3

4

2.

Having strong feelings such as anger, or
feeling upset when you are by yourself

0

1

2

3

4

3.

Withdrawal symptoms

0

1

2

3

4

4.

Feeling less in control of your moods

0

1

2

3

4

5.

Family members or significant others
encouraging you to smoke

0

1

2

3

4

6.

Miss the companionship of smoking
0

1

2

3

4

7.

No encouragement or help from family
members or significant others

0

1

2

3

4

8.

Having strong feelings such as anger, or
feeling upset when you are with other
people

0

1

2

3

4

9.

Thinking about never being able to smoke
again

0

1

2

3

4

10.

Friends encouraging you to smoke

0

1

2

3

4

11.

Thinking about cigarettes all the time

0

1

2

3

4

12.

Not knowing for how long it will be very

0

1

2

3

4
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hard not to smoke
13.

No encouragement at work for not
smoking

0

1

2

3

4

14.

Being addicted to cigarettes

0

1

2

3

4

15.

Fear of failing to quit

0

1

2

3

4

16.

Lack of understanding from family and
significant others about what it is like to
quit smoking

0

1

2

3

4

17.

Seeing things or people which remind you
of smoking

0

1

2

3

4

18.

Feeling lost without cigarettes

0

1

2

3

4
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APPENDIX G
CUES TO ACTION SCALE
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Subject ID#______________
Date____________________

Cues to Action Scale
Below is a list of statements which relate to receiving help with quitting
smoking. Please indicate whether you received help with each item by
placing a “yes” or “no” on the line preceding that item.

_____1.

Did your healthcare provider ask you if you smoke?

_____2.

Did your healthcare provider advise you to stop smoking?

_____3.

Did your healthcare provider ask you if you are willing to stop
smoking?

_____4.

Did your healthcare provider offer you assistance with quitting
smoking?

_____5.

Did your healthcare provider schedule a follow-up appointment
related to your quitting smoking?
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APPENDIX H
HEART DISEASE THREAT SCALE
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Subject ID#______________ Date____________________

Heart Disease Threat Scale
Below is a list of statements which relate to having heart disease. You may agree or
disagree with the statements. Using the scale below, indicate your agreement or
disagreement with each item by circling the appropriate number.
Strongly Disagree Neutral

Agree

Strongly
Disagree
Agree

1.

The thought that I really do have heart
disease scares me.

1

2

3

4

5

2.

When I think about having heart disease I
feel sick to my stomach.

1

2

3

4

5

3.

Having heart disease threatens my career
goals.

1

2

3

4

5

4.

When I think about having heart disease
my heart beats faster.

1

2

3

4

5

5.

Having heart disease threatens the
relationships that are important to me.

1

2

3

4

5

6.

My feelings about myself would change if
my heart disease got worse.

1

2

3

4

5

7.

I feel insecure about my future because if
my heart disease.

1

2

3

4

5

8.

Problems I experience from my heart
disease could last a long time.

1

2

3

4

5

9.

I am concerned that my heart disease will
get much worse in the future.

1

2

3

4

5

10.

My retirement plans are endangered by
my heart disease.

1

2

3

4

5
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APPENDIX I
THREAT TO FUTURE INVASIVE CARDIOVASULAR INTERVENTIONS SCALE
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Subject ID#______________
Date____________________

Threat to Future Cardiovascular Interventions Scale
Below is a list of statements which relate to having a heart procedure. You may agree or
disagree with the statements. Using the scale below, indicate your agreement or
disagreement with each item by circling the appropriate number.

Strongly Disagree Neutral

Agree

Strongly
Disagree
Agree

1.

My chances of having another heart
procedure are great.

1

2

3

4

5

2.

My physical health makes it more likely
that I will have another heart procedure.

1

2

3

4

5

3.

I feel that my chances of having another
heart procedure in the future are great.

1

2

3

4

5

4.

There is a good possibility that I will have
another heart procedure.

1

2

3

4

5

5.

I worry a lot about having another heart
procedure.

1

2

3

4

5

6.

Within the near future I will have another
heart procedure.

1

2

3

4

5

7.

The thought of another heart procedure
scares me.

1

2

3

4

5

8.

When I think about another heart
procedure I feel nauseous.

1

2

3

4

5

9.

If I had another heart procedure my career
would be endangered.

1

2

3

4

5
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10.

When I think about another heart
procedure my heart beats faster.

1

2

3

4

5

11.

Another heart procedure would endanger
my marriage (or a significant
relationship).

1

2

3

4

5

12.

Another heart procedure is a hopeless
health problem.

1

2

3

4

5

13.

My feelings about myself would change if
I had another heart procedure.

1

2

3

4

5

14.

I am afraid to even think about having
another heart procedure.

1

2

3

4

5

15.

My financial security would be
endangered if I had another heart
procedure.

1

2

3

4

5

16.

Problems I would experience from having
another heart procedure would last a long
time.

1

2

3

4

5

17.

If I had another heart procedure, it would
be more serious than other health
problems.

1

2

3

4

5

18.

If I had another heart procedure, my
whole life would change.

1

2

3

4

5
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SMOKING SELF-EFFICACY SCALE
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Subject ID#______________
Date____________________

Smoking Self-Efficacy Questionnaire
The following are some situations in which certain people might be tempted to smoke.
Please indicate whether you are sure you could refrain from smoking in each situation.

Not at
all sure

Not very
sure

More or
less sure

Fairly
sure

Absolutely
sure

Not at
all sure

Not very
sure

More or
less sure

Fairly
sure

Absolutely
sure

Internal Stimuli
1. When I feel nervous
2. When I feel depressed
3. When I am angry
4. When I feel very anxious
5. When I want to think about
a difficult problem
6. When I feel the urge
to smoke

External Stimuli
7. When having a drink
with friends
8. When celebrating
something
9. When drinking wine, beer,
or other spirits
10. When I am with smokers
11. After a meal
12. When having coffee
or tea
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APPENDIX K
WEIGHT CONTROL SMOKING SCALE
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Subject ID#______________
Date____________________

Weight Control Smoking Scale
Below are a list of statements which relate to smoking-related concerns
about weight and appetite. You may agree or disagree with the statements.
Using the scale below, indicate your agreement or disagreement with each
item by circling the appropriate number.

Not at

A Little

Quite

Very
All

a Bit

Much So

1.

I smoke to keep from gaining weight.

0

1

2

3

2.

Smoking helps me control my appetite.

0

1

2

3

3.

I don‟t get so hungry when I smoke.

0

1

2

3
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APPENDIX L
TREATMENT SELF-REGULATION QUESTIONNAIRE
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Subject ID#______________

Date____________________

TSRQ (Smoking)
The following question relates to the reasons why you would either stop smoking or
continue not smoking. Different people have different reasons for doing that, and we
want to know how true each of the following reasons is for you. All 12 responses are to
the same question.
Please indicate the extent to which each reason is true for you, using the following 7point scale:
1
2
not at all
true

3

4
5
somewhat
true

6

7
very
true

The reason I would not smoke is:
___1. Because I feel that I want to take responsibility for my own health.
___2. Because I would feel guilty or ashamed of myself if I smoked.
___3. Because I personally believe it is the best thing for my health.
___4. Because others would be upset with me if I smoked.
___5. Because I have carefully thought about it and believe it is very important for
many aspects of my life.
___6. Because I would feel bad about myself if I smoked.
___7. Because it is an important choice I really want to make.
___8. Because I feel pressure from others to not smoke.
___9. Because it is consistent with my life goals.
___10. Because I want others to approve of me.
___11. Because it is very important for being as healthy as possible.
___12. Because I want others to see I can do it.
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APPENDIX M
SMOKING CESSATION QUESTIONNAIRE
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Subject ID#______________
Date____________________

Smoking Cessation Questionnaire
(To be recorded by interviewer)

1. Have you smoked at least 100 cigarettes in your lifetime and are currently smoking
every day

or some days since your heart procedure?

_____Y _____N

2. How many cigarettes (if any) do you now smoke per day?
________________________________________________________________________
3. Do you smoke every day or some days?
________________________________________________________________________
4. How many times (if any) have you tried to quit smoking since your procedure?______
Please describe:_____________________________________________________
________________________________________________________________________
________________________________________________________________________
5. Tell me about any help you‟ve received about stopping smoking since your procedure?
________________________________________________________________________
________________________________________________________________________
6. From whom have you received counseling about stopping smoking? What kind of
advice did they give you?
a.________________________________________________________________
b. ________________________________________________________________
c. ________________________________________________________________
7. Have you taken medication(s) to help you stop smoking since your procedure? _Y _N
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If yes, what medication(s) are you taking to help you stop smoking?__________
________________________________________________________________________
8. What was most challenging about trying to stop smoking?
________________________________________________________________________
________________________________________________________________________
9. Looking back, if you knew then what you know now about your health, would you
have started smoking?
________________________________________________________________________
________________________________________________________________________
10. Tell me about who else (if anyone) has tried to help you (try to) stop smoking?
________________________________________________________________________
________________________________________________________________________
11. Does your spouse (or significant other) or someone else in the house smoke? _ Y _ N
If yes, who:
_______________________________________________________________________
_______________________________________________________________________
12. If yes, did he/she try to stop smoking after your heart procedure? _____ Y _____ N
13. Describe the meaning of cigarettes in your life: ______________________________
________________________________________________________________________
________________________________________________________________________
14. How do you feel about smoking now? _____________________________________
________________________________________________________________________
________________________________________________________________________
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Surrounding your recent heart procedure, what else in the hospital could have been done
to help you stop smoking? _________________________________________________
________________________________________________________________________
________________________________________________________________________
For Current Smokers Only:
16. Why do you believe you still smoke?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
17. What do you believe got in your way of stopping smoking?
_______ Weight
_______ Withdrawal symptoms
_______ Lack of social support
_______ Anxiety
________Depressive Symptoms
________ Smoker in home environment
________ Smoker in social environment
____________________ Other
18. Are you going to continue trying to stop smoking?
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
19. If not, can you tell me your thoughts on not trying to stop smoking?
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
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STUDY PROTOCOL
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Screen woman is having/has had PCI or CABG (from
medical record) (Researcher/Assistant or Nurse on Unit)

Screen she is a smoker (from medical record)
(Researcher/Assistant or Unit Nurse)

(Researcher/Assistant: Approach
patient at bedside after their procedure
& when stable

Unit Nurse (If Researcher/Assistant not present):
Approach patient at bedside after their procedure &
when stable

Provide study information/flyer to
potential participant, ask permission for
researcher to contact potential
participant, if yes: fill out contact
information postcard, leave on unit for
Researcher/Assistant

Contact potential participant by
telephone
Verify eligibility criteria met & willingness
to participate in the study
Enroll participant/Complete informed consent

T1: Administer all questionnaires
Mail reminder card to participant at 8-10
weeks
T2: Call patient to administer Smoking
Cessation Questionnaire
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APPRENDIX O
FLYER
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Research for Women!

Ever wondered why it‟s hard for women
to stop smoking?
Would you like to join a research study
to help us find out?
If you are a woman between ages 40-80 who has had
a heart procedure in the last week and who smokes or
has smoked, you may be eligible.
Participants who finish the study will receive $10 in
gift cards.
If interested, please contact Leslie Moore, RN to find
out more.
(478) 390-2222
Leslie.Moore@gcsu.edu

